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Abstract 
 
Shortages of donor islets, immune rejection, and the need for life-long immuno-suppressors 
remain the clinical challenges of islet transplantation in the treatment of diabetes mellitus. An 
alternative to these challenges is the in vivo generation of beta cells within the patient’s pancreas.  
The animal model of pancreatic injury has been reported to be a potential source of islet cells for 
tissue replacement therapy in type 1 diabetes mellitus. However, the in vitro regenerative 
capacity of endogenous beta cells in this model needs more investigation. This study 
investigated, in vitro, the effect of pancreatic duct ligation (PDL)-induced islet/duct-
mesenchymal stromal cells (MSCs) interactions on islet and duct cells development and assessed 
the long-term transplantation outcome of islet-mesenchymal cells isografts. Islets, duct 
fragments, and MSCs were isolated from post PDL tissues harvested from eighty adult male 
Wistar rats (250 - 300g) 24- and 120 h following duct ligation. Islets or duct fragments were 
cultured with or without MSCs ([Islet/MSC+ or Islet/MSC-] or [PEDC/MSC+ or PEDC/MSC-]). 
Development of islets and duct fragments in culture were evaluated morphologically and by 
immunocytochemistry using antibodies against Pdx1, Ngn3, CK7 and insulin. Islets were also 
transplanted with or without MSCs (Islet/MSC+ or islet/MSC-) in diabetic animals (n = 40). 
Isografts survival and function were evaluated by monitoring blood glucose levels, and 
immunohistochemistry of graft tissues were studied. Results showed activation of Pdx1+ islet 
cells in both cultures with or without MSCs, however, expansion of Pdx1+ cells were promoted 
in the presence of MSCs and this was followed by activation of Ngn3 expression and expansion 
of Ngn3+ cells, which was maintained in islet cells up to 4 weeks. This resulted into low levels of 
insulin expression in islet-like aggregates formed between the third and the fourth week.  Co-
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culturing of duct fragments with MSC similarly resulted into maintenance of endocrine 
precursors that expressed Ngn3, which later formed islet-like aggregates. In cultures with MSCs, 
duct epithelial cells developed growth areas with cells that co-expressed CK7 and Ngn3 in 
periductal cells. When periductal cells formed islet-like aggregates, Ngn3 co-expressed with 
insulin in islet-like cell clusters closer to ducts. Transplantation of early harvested (24 h PPDL) 
islets showed better curative capacity than late (84 h PPDL) islets. The average glucose levels 
were lower throughout the 5 weeks monitoring period in 24 h PPDL transplanted rats.  The 
average time to reverse hyperglycemia in 80% of the 24 h PPDL transplant group was 32 ± 2 
days (~4.5 weeks), while only 20% in the 84 h PPDL transplant group attained normoglycemia 
at 61 ± 2 days (~9 weeks) (p = 0.0011) post transplantation.  Graft survival rate was higher in 
islets co-transplanted with MSC (Islet/MSC+) compared to grafts transplanted with islets alone 
(Islet/MSC-). Islet morphology and distribution of beta cells was normal in Islet/MSC+ similar 
to the endogenous islets in the pancreas. In conclusion, MSCs promote the expansion of Pdx1+ 
cells and maintain the expression of Ngn3 in islet cells and duct–derived neogenetic cells. MSCs 
prolong graft survival and improve the capacity of early harvested post PDL islets to reverse 
hyperglycemia; this novel observation may be applicable to clinical transplantation. 
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Opsomming 
 
'n Tekort aan skenker eilandjies, immuun verwerping, sowel as die behoefte aan lewenslange 
immuno-onderdrukkers is van die grootste kliniese uitdagings in eiland oorplanting in die 
behandeling van diabetes mellitus. 'n Alternatief tot hierdie uitdagings is die in vivo generering 
van betaselle in die pankreas van die pasiënt. 'n Dier model vir pankreas beserings is voorheen 
berig as 'n potensiële bron van eiland selle vir weefsel vervangingsterapie in tipe 1-diabetes 
mellitus, maar verdere ondersoek met betrekking tot die in vitro regeneratiewe kapasiteit van 
endogene betaselle in hierdie model is nodig. Hierdie studie ondersoek, in vitro, die effek van 
post-pankreatiese buis afbinding (PPBA) - gëinduseerde eiland / buis-mesenkiemale stroma sel 
(MSS) interaksies op eiland en buis sel ontwikkeling en beoordeel die langtermyn oorplanting 
uitkoms van eiland-mesenkiemale selle. Eilandjies, buis fragmente, en MSS is geïsoleer vanaf  
tagtig volwasse mannetjie Wistar rotte (250 - 300g) en geoes 24- en 120- ure nadat buis 
afbinding voltooi is. Eilandjies of buis fragmente was gekweek in die aan- of af-wesigheid van 
MSS (eiland / MSS + of eiland / MSS -). Die ontwikkeling van eilandjie en buis fragmente in 
kultuur, is met behulp van morfologie asook die aanwesigheid van teenliggaampies vir Pdx1, 
Ngn3, CK7 en insulien, wat deur immunositochemie evalueer is. Eilandjies is ook in diabeet 
rotte (n = 40) oorgeplant in in die aan- of af - wesigheid van MSS (eiland / MSS + of eiland / 
MSS -). Oorplantingsoorlewing en funksie is evalueer deur bloed glukose vlakke te asseseer en 
ent weefsel immunohistochemie te bestudeer. Resultate het die aktivering van Pdx1+ eiland selle 
in beide die aan- of afwesigheid van MSS aangetoon. Uitbreiding van Pdx1+ selle is bevorder in 
die aanwesigheid van mss wat gevolg is deur 'aktivering van Ngn3 uitdrukking asook uitbreiding 
van Ngn3+ selle, wat in eiland selle is in stand gehou is tot en met vier weke. Dit het gelei tot lae 
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vlakke van insulien uitdrukking in eiland-agtige aggregate wat gevorm het tussen die 3de en die 
4de week. Medekweking van buis fragmente met MSS het tot die instandhouding van endokriene  
voorlopers wat Ngn3 uit druk, en later eilandagtige aggregate gevorm het, tot gevolg gehad. In 
kulture met MSS, ontwikkel buis epiteelsellle groeigebiede met selle wat beide CK7 en Ngn3 
uitdruk in peribuis selle. Nadat peribuis selle eiland-agtige aggregate vorm, is Ngn3 saam met  
insulien uitgedruk binne eiland-agtige sel trosse naastens aan buisies. Oorplanting van vroeë oes 
(24 uur PPBA) eilandjies het beter genesende vermoë as laat (84 uur PPBA) eilandjies getoon. 
Die gemiddelde glucose vlakke was laer deur die 5 weke-lange moniteringstydperk in rotte 
waarin  oorplanting 24 uur PPBA uitgerig is. Die gemiddelde tyd om hiperglisemie om te keer in 
80% van die 24 uur PPBA oorplanting groep was 32 ± 2 dae (~ 4.5 weke), terwyl slegs 20% in 
die 84 uur PPBA oorplanting groep normoglisemie bereik het op 61 ± 2 dae (~ 9 weke) (p = 
0,0011) na oorplanting. Ent oorlewing was hoër in eilandjies wat in die teenwoordigheid van 
MSS (eiland / MSS +) in vergelyking met ente wat oorplant is met eilandjies alleen (eiland / 
MSS -). Eilandjie morfologie en verspreiding van betaselle was normaal in eiland / MSS+, 
soortgelyk aan die endogene eilandjies in die pankreas. Ten slotte, MSS bevorder die uitbreiding 
van Pdx1+ selle en handhaaf die uitdrukking van Ngn3 in eiland selle en-buis afgeleide 
neogenetiese sell. MSS verleng ent oorlewing en verbeter die kapasiteit van die vroeë oes PPBA 
eilandjies om hyperglisemie om te keer; hierdie waarneming mag van toepassing wees op 
kliniese oorplanting. 
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Chapter 1 Introduction 
1.1 Literature Review  
Diabetes  mellitus is characterized by total or relative loss in insulin producing beta cells, 
classified as Type 1(Insulin dependent) and type 2 (Maturity onset),  respectively. In diabetic 
patients, the body produces insufficient amounts of insulin to regulate blood glucose levels. 
Current treatment regimens include daily oral intake of hypoglycemic drugs and injections of 
exogenous insulin. Despite remarkable progress in the treatment of diabetes, in vivo generation 
of new insulin-producing beta cells, to replace the lost or replenish insufficient numbers of beta 
cells appears to be of great potential. Therefore, the search for new sources of beta cells offers 
hope as new therapeutic measures for treatment of diabetes mellitus.  
Many studies currently focus on development of strategies to, either expand existing beta cells 
or, generate new beta cells from exocrine tissue of the pancreas (Bonner-Weir et al. 1993; Gu, 
Sarvetnick 1993; Rosenberg 1995; Bonner-Weir, Weir 2005;  Suarez-Pinzon et al. 2005; Xu et 
al. 2008a; Rooman, Bouwens 2004, Inada et al. 2008). Understanding how insulin-producing 
beta cells are generated within the pancreas may help in the development of regenerative and 
cellular therapies for type 1 and type 2 diabetes mellitus. However, in order to develop protocols 
allowing in vitro generation or in vivo re-generation of beta cells, it is important to understand 
the molecular regulatory factors that control the development of the embryonic pancreas as well 
as the adult pancreatic beta cells in an in vivo model.  
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1.2 Embryonic development of the pancreas 
1.2.1 Early development of the pancreas 
Pancreas organogenesis involves many complex tissue interactions that control and regulate the 
specification and differentiation of the progenitor cells. This process is controlled by a network 
of signaling pathways and their transcription factors (Wilson, Scheel & German 2003).  
1.2.1.1 Development of the definitive endoderm 
The first step in pancreas development is the specification of the primitive endoderm (PrE) from 
pluripotent stem cells arising from the inner cell mass of the blastocysts (3-5 days post 
fertilization in mice) (Kanai-Azuma et al. 2002; Guney, Gannon 2009). Primitive endodermal 
cells are precursors recognized by the expression of sex determining region on Y (SRY)-box 
containing gene 17 (Sox17) that subsequently differentiate into visceral and parietal endodermal 
layers (Kanai-Azuma et al. 2002; Guney, Gannon 2009).  
 
Following PrE specification, the blastocyst gastrulates to give rise to three germ layers: 
endoderm, mesoderm and ectoderm. The definitive endoderm (DE) is formed during this process 
when cells of the epiblast leave the inner cell mass through the primitive streak. In mice, DE 
cells are formed between embryonic (E) day 6.5 and E7.5 and is regulated by key factors such as 
Wnt/beta-catenin, Nodal, Transcription factor 4 and 6 that bind to the DNA sequence "GATA" 
(GATA-4/6), the basic winged helix-loop-helix (bHLH) forkhead box A1 (FoxA1) and FoxA2 
(previously known as hepatocyte nuclear factor 3α and β (Hnf3α and β) respectively) (Fig. 1.1) 
(Shimosato, Shiki & Niwa 2007).   
Before organogenesis, all endodermal cells are uncommitted to specific cell lineages. Later, DE 
becomes patterned into anterior and posterior DE. The anterior DE will form the foregut 
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endoderm from which the pancreas, liver and lungs will bud out, while the posterior DE will 
form midgut and hindgut which will eventually give rise to small and large intestines 
(Dominguez-Bendala, Inverardi & Ricordi 2011). A report by Wells et al. (2000) showed that 
mesectoderm cells produce fibroblast growth factor (Fgf) 4 that induces posteriorization of the 
definitive endoderm. Fibroblast factor 4 induces posteriorization by suppressing the anterior 
endodermal transcription factors NK domain homeobox (Nkx) 2.1 and Antennapedia/Ftz, class 
hematopoietically expressed homeobox (Hhex). These factors control the  formation of foregut 
endoderm, and activates the expression of posterior endodermal transcription factors:  the 
pancreatic and duodenal homeobox 1 (Pdx1) and caudal homeobox 1 / 2 ( Cdx1/Cdx2). Pdx1 and 
Cdx1/Cdx2 define the pancreatic field (Wells, Melton 2000, Dessimoz et al. 2006).  
Additionally, there is evidence that retinoic acid (RA) secretion from paraxial mesoderm controls 
anterior-posterior patterning in gut organs and promote the allocation of the pancreas (Stafford, 
Prince 2002; Chen et al. 2004; Bayha et al. 2009).  
 
1.2.1.2 Specification of the pancreatic endoderm (PE) 
 As a second specification step towards pancreas outcome, the gut endoderm becomes specified 
into organ fields through a series of patterning events that will eventually give rise to tissue and 
glands that line gastrointestinal tract (GIT) (Slack 1995). These processes are regulated by 
extrinsic factors secreted by neighbouring mesodermal derivates as well as factors intrinsically 
produced by the endodermal cells themselves. Through these events, two pancreatic fields are 
specified within the gut definitive endoderm: the anterior and posterior pancreatic fields (Slack 
1995). The Pancreas develops from the posterior and anterior foregut endoderm fields as dorsal 
and ventral pancreatic buds respectively (Kim, Hebrok 2001) (Fig.1.1). 
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Figure 1.1. Early stage of embryo development at E8.5 (saggital view) showing key 
transcription factors controlling specification of the dorsal and ventral pre-pancreatic 
endoderm. Adapted and modified from Pan, Wright 2011. 
 
These buds are formed from multi-potent progenitor cells that give rise to all cell types in the 
pancreas.  Initially, three primordia buds arise from the definitive gut endoderm. The dorsal bud 
arises first from the dorsal side, followed by two ventral buds, which arise from the ventral side 
(Lammert, Cleaver & Melton 2001).  At E9.5 (22 – 25 somites stage in mice or 26th day of 
gestation in humans), a recognizable dorsal pancreatic bud appears as an epithelial thickening of 
the dorsal endoderm, indicating the beginning of pancreatic morphogenesis (Slack 1995) (Fig. 
1.2C).   
1.2.1.3 Early tissue interactions in pancreatic endoderm specification 
The period just before specification of the dorsal pancreatic bud at E9.5, the uncommitted 
endodermal cells in posterior pancreatic field receives interactive inductive signals from the 
mesectoderm. Following this, the dorsal pancreatic bud recieves permissive signals from the 
endothelium and notochord that specifies the location of the pancreatic epithelium, and finally 
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the proliferative signals from mesenchyme that regulate the size of the pancreatic domain ( Kim, 
Hebrok & Melton 1997; Lammert, Cleaver & Melton 2001; Jorgensen et al. 2007). The 
mesectoderm secrete inductive signals, such as Fgf4, which induce competency in the dorsal 
foregut endodermal cells to interact with permissive pro-pancreatic signals from the notochord 
(Wells, Melton 2000). 
 
 
  
Figure 1.2. Schematic diagram showing early patterning of the foregut endoderm: The 
pancreatic domain is established by signaling from adjacent mesodermal derivatives. A: Fgf2 
and Activinβ2 from notochord represses Sonic hedgehog (Shh). Adapted from Pan, Wright 2011. 
 
(i) Notochord–endoderm interactions 
The notochord secretes permissive signals, such as activin-βB and Fgf2, which block the 
endodermal expression of sonic hedgehog (Shh), a member of the Hh signaling family, that 
regulates the formation of the stomach and the duodenum (Fig 1.2A) (Hebrok, Kim & Melton 
1998, Hebrok et al. 2000). Repression of Shh in the pre-pancreatic endoderm leads to activation 
of Pdx1 and pancreas specific transcription factor 1α (Ptf1α), and permits the mesenchymal 
patched homolog 1 (PTCH1) to activate lineage specification of the pancreas (Hebrok, Kim & 
A B C 
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Melton 1998). The expression of Shh in pancreas epithelium inhibits pancreas formation and 
controls organ specification by generating a molecular boundary at the foregut and midgut 
border. In mice, the notochord maintains contact with the dorsal pre-pancreatic endoderm until 
about E8.5 (13-somite stage in mice and 3 weeks in humans) (Kim, Hebrok & Melton 1997) 
(Fig.1.2B). 
 
Prior to the 13-somite stage, when dorsal pre-pancreatic endoderm is cultured alone, Pdx1, islet-
1 (Isl-1) and paired box 6 (Pax6) are not activated. However, when co-cultured with notochord, 
Pdx1, Isl-1 and Pax6 are activated. This suggests that prior to the 13-somite stage, the dorsal pre-
pancreatic endoderm cells are still uncommitted to differentiate to a pancreatic fate 
autonomously, but require inductive signals from the notochord for commitment to pancreatic 
fate (Kim, Hebrok & Melton 1997). After suppression of Shh, pancreas differentiates into cells 
that express Pdx1 and Ptf1α/p48. However, before expression of Pdx1 and Ptf1α, several 
transcription factors that pattern the gut DE toward pancreatic lineage are activated including, 
Hnf6 (onecut1), Hlxb9 (hb9), Hnf3b (Foxa2), Hhex (Hex) and vHnf1 (also known as Tcf2 and 
Hnf1β) (Fig.1.1) (Shimosato, Shiki & Niwa 2007, Gittes 2009).  
 
One of the first transcription factors to be expressed before Pdx1 is a motor neuron-specific 
homeobox gene-9 (Hlxb9) (Li et al. 1999). The Hlxb9 gene encodes the homeobox transcription 
factor Hb9 that is also expressed in the notochord and the dorsal pancreatic bud and is expressed 
before Pdx1. At this early stage, Hb9 is activated in the early pancreatic buds (Li et al. 1999). 
Later, Hlxb9 is activated in pancreatic buds during delamination and migration of the epithelial 
cells. In Hlxb9 mutant mice, Pdx1 is downregulated and the dorsal pancreatic bud is repressed, 
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while the ventral pancreas develops normally, suggesting that Pdx1 functions downstream of 
Hlxb9 in the dorsal but not the ventral pancreatic bud (Li et al. 1999). 
Hnf family: Also working upstream of Pdx1, are members of Hnf family of transcription factors: 
Hnf6 (also known as Onecut1), FoxA2 and vHnf1 (Shimosato, Shiki & Niwa 2007, Gittes 2009). 
Hepatocyte nuclear factor 1β induces the expression of Hnf6 (Barbacci et al. 1999, Pierreux et al. 
2006, Poll et al. 2006) which, in turn, induces the expression of Hnf3β/Foxa2 which along with 
Foxa1 are transcriptional regulators of Pdx1 during pancreas specification (Wu et al. 1997, Gao 
et al. 2008). The expression of Hnf6 is detected early in the epithelial precursor cells of the 
exocrine and endocrine pancreatic beta cells. Hepatocyte nuclear factor 6 is also needed for 
proper Ngn3 expression (Jacquemin et al. 2000). 
Pancreatic duodenal homeobox-1 (Pdx1): Cells of the endodermal region that get committed 
to a pancreatic fate, first  activate the homeodomain transcription factor Pdx1, also known as 
insulin promoter factor 1 (IPF1) (Leonard et al. 1993; Ohlsson, Karlsson & Edlund 1993; 
Ahlgren et al. 1998), Islet/duodenum homeobox 1 (IDX-1) or Somatostatin transcription factor-1 
(STF-1) (Leonard et al. 1993; Miller, McGehee & Habener 1994). Pancreatic and duodenal 
homeobox 1 is a member of the parahox group of homeodomain transcription factors that is 
expressed in the endodermal region committed to a pancreatic fate (Brooke, Garcia-Fernandez & 
Holland 1998). Pancreatic and duodenal homeobox 1 expression is observed in early pancreatic 
progenitors on E8.5 in mouse embryos (E9.5 in rats, Fig.1.2B). In mice or humans lacking Pdx1 
gene, the pancreatic bud is initiated, but it does not develop further (Offield et al. 1996; Ahlgren 
et al. 1998), suggesting that Pdx1 is necessary for the full development of the pancreatic buds. 
This data therefore suggests that Pdx1 is not the only factor that is needed in specification of the 
early pancreatic buds. As mentioned above, it is possible that other factors such as Hlxb9, which 
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is expressed in the dorsal bud before Pdx1 might be involved in the initiation of the early 
pancreatic buds (Li et al. 1999, Hadjantonakis, Papaioannou 2001).  
 
However, although Pdx1 is required for pancreas organogenesis, this gene is also expressed in 
the duodenum, distal stomach and the common bile duct as well. In addition, a report published 
by Spence et al. (2009), demonstrated that Pdx1 is also co-activated with Sox17, a transcription 
factor that is expressed in the bipotential ventral foregut domain that gives rise to both the 
pancreatic and the biliary primordia (Fig.1.1 &1.2C). Sex determining factor (SRY)-homeobox 
17 seems to inhibit development of ventral pancreatic bud and therefore, ventral pancreatic bud 
is only formed when Sox17 is repressed (Spence et al. 2009). Sex determining factor homeobox 
17 is persistently upregulated in the biliary tract and creates a molecular boundary between 
pancreas and the liver. The question of why Pdx1 is co-expressed with Sox17, an inhibitor of 
ventral pancreatic bud development, is not clearly understood. In addition, Pdx1 expression also 
overlaps with p48/PTF1α, a transcription factor that is activated shortly afterwards in the 
pancreatic anlagen. As development proceeds, p48 expression becomes restricted to the acinar 
and ductal compartments. In homozygous p48 mutant mice, all exocrine and most endocrine 
tissue do not develop and neonates die afterbirth (Krapp et al. 1998, Kawaguchi et al. 2002). 
Therefore, Pdx1 is regarded as a marker of early pancreatic progenitor cells. Also co-expressing 
with Pdx1 is Sox9 that is expressed between E9.5 and E12.5, suggesting that Sox9 marks the 
progenitor population in the pancreatic bud and promotes proliferation and their survival 
(Fig.1.1) (Seymour et al. 2007)  
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(ii) Dorsal aorta endothelium-endoderm interactions 
At the 13-somite stage in mice, the paired dorsal aortas fuse at midline displacing and separating   
the notochord from the endoderm (Fig 1.2B, C). Signals from the endothelial cells of the aorta 
have been shown to promote outgrowth of the dorsal bud. When mouse dorsal pre-pancreatic 
endoderm was cultured in the presence of dorsal aorta, Pdx1 and insulin expressions were 
induced (Lammert, Cleaver & Melton 2001, Yoshitomi, Zaret 2004). In a follow-up study, 
transgenic mice that expressed vascular endothelial growth factor A (VEGF-A) under Pdx1 
promoter displayed hyperplastic islets and ectopic insulin+ cells in the stomach (Lammert, 
Cleaver & Melton 2001), a finding that clearly indicates the importance of endothelial signals in 
the initiation of the pancreas.  During this stage, the first endocrine cells detected are glucagon–
producing cells (alpha cells) as early as E9.5 (Pictet et al. 1972; Herrera et al. 1991; Teitelman et 
al. 1993; Upchurch, Aponte & Leiter 1994). 
  
(iii) Mesenchyme-epithelial interactions 
After depending on signals from the aorta, mesenchymal cells condense around the evaginating 
epithelium, separating the aorta from the epithelium (Fig. 1.2C). There is increasing evidence 
that continued interactions with adjacent mesenchymal tissues promote organogenesis of the 
pancreas and their subsequent specification steps (Pictet et al. 1972). Mesenchymal–epithelial 
interactions are regulated by several families of signaling molecules. Studies in knockout animal 
models have identified the roles of individual signaling pathways, however, the complex 
interactions between these signaling pathways demands more investigation.   
Mesechyme-derived fibroblasts growth factors (Fgf) family (Fgf 1, 2, 7 and 10): During this 
early stage of development, Fgfs are some of the factors that are expressed in the  epithelial-
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mesenchymal interface region where they mediate many developmental processes, particularly in 
regulation of branching morphogenesis of the early pancreatic bud (reviewed in Hogan 1999). 
Fibroblast growth factors are ligands that signal by binding to tyrosine kinase Fgf receptors.  In 
the preceding stages of bud development, members of the Fgf family, Fgf1, 7 and 10 were found 
to be highly activated in the mesenchyme while their receptor, Fgf receptor type 2B (FGFR2B) 
were expressed in the epithelium. Secretion of ligands of the Fgf family members, Fgf2 and 
Fgf10, by the notochord and dorsal mesenchyme initiates and maintains critical transcription 
factors that specify the pancreatic primordium (Fig.1.2C) (Jacquemin et al. 2006, Bhushan et al. 
2001). The activated Fgf10 in the pancreatic mesenchyme and its receptor FGFR2 in the 
epithelium (Bhushan et al. 2001, Dichmann et al. 2003, Seymour et al. 2012) regulate  
proliferation of the pancreatic progenitors. In Fgf10 knock-out mice, growth and branching of 
the pancreatic primordium is heavily affected (Bhushan et al. 2001). 
 During later stages, Fgf10 activates Notch signaling, which promotes proliferation and inhibits 
differentiation of endocrine precursors (Hart, Papadopoulou & Edlund 2003; Norgaard, Jensen & 
Jensen 2003; Miralles et al. 2006). In addition, Fgf10 was shown to regulate the expression of 
Sox9 and Ptf1α in the epithelium (Jacquemin et al. 2006, Seymour et al. 2012).  
The Dorsal pancreatic bud: As the mesenchyme thickens round the dorsal pancreatic bud at 
E9.5, LIM homeodomain protein islet-1 (Isl-1) is specifically activated in the mesenchyme 
surrounding the dorsal bud and is required for mesenchyme and dorsal pancreatic bud formation 
(Ahlgren et al. 1997). However, Isl-1 is not expressed in the ventral bud. Accordingly, in Isl-1 
deficient mice, dorsal mesenchyme fails to form and islet cells differentiation, proliferation and 
survival in the endoderm is dramatically affected (Ahlgren et al. 1997). Additional studies went 
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further to show that deletion of aldehyde dehydrogenase family 1 subfamily 2 (Aldh1a2 also 
known as RALDH2), an enzyme that synthesizes RA in mice, abolishes formation of dorsal 
pancreas and early glucagon-expressing cells (Martin et al. 2005, Molotkov, Molotkova & 
Duester 2005), similar to the phenotypes that are observed in Islet-1 (Isl-1) (Ahlgren et al. 1997) 
and N-cadherin (Esni et al. 1999) null mice. These results clearly suggest that mesenchymal-
derived factor, Isl-1, is required for the development of the dorsal pancreas (Ahlgren et al. 1997). 
Moreover, mesenchymal cells produce Ephrin B2, and through its receptor, EphB, induces 
development of the microlumens in the pancreatic epithelial bud (Villasenor et al. 2010).  
The ventral pancreatic bud: Later, at around E10.5 (6 days after evagination of dorsal bud in 
humans), two ventral pancreatic buds appear in close contact with cardiac mesenchyme and two 
vitelline veins (approx. 30 somites stage) [for review see (Zorn, Wells 2009)]. Soon after 
evagination, one of the ventral buds degenerates (as one of the vitelline veins also regresses), 
whereas the remaining ventral bud later fuses with the dorsal bud following rotation of the gut 
tube at around E12.5 (E37.5 in humans) (Lammert, Cleaver & Melton 2001, Jorgensen et al. 
2007).  Development of the ventral pancreas is regulated by signals from the lateral plate, the 
cardiac and the septum transversum mesenchyme (Fig. 1.1). As the ventral bud evaginates into 
cardiac mesenchyme, it comes into direct contact with the lateral plate mesoderm. Lateral plate 
mesoderm produces instructive signals, such as activins, RA and bone morphogenetic proteins 7 
(BMP7) that induce the expression of pancreatic markers similar to the roles of RA and activins 
in the dorsal bud (Fig.1.2A) (Kumar et al. 2003).  
 
In addition, signals from cardiac mesenchyme and septum transversum mesenchyme determine 
the fate of this bipotential ventral endoderm sheet into pancreas or liver progenitors. Increased 
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Fgf signals secreted from cardiac mesoderm inhibits the development of the pancreas and 
promotes liver development (Wandzioch, Zaret 2009). This process is regulated by a delicate 
balance between BMP4/7, Fgf and transforming growth factor (Tgf) β secreted by the septum 
transversum (Wandzioch, Zaret 2009).  Work published by Wandzioch and colleagues further 
showed that activation of BMP through its receptor activin receptor-like kinase 3 (ALK3) by the 
septum transversum mesenchyme induces the endodermal expression of transcription factor 4 
binding to DNA sequence GATA (GATA4) and inhibits ventral pancreatic bud development but 
promotes liver bud development by activating liver-specific genes in the 3-4 somite stage 
embryos (Wandzioch, Zaret 2009). However, hours later (in the 5-6 somite stage), the study 
showed that expression of Noggin (NOG) inhibits mesenchyme-derived BMP signaling and 
induces Pdx1 expression, reversing the inhibitory effects of BMP (Wandzioch, Zaret 2009).  
Therefore, formation of the ventral pancreas is regulated by different signaling pathways, with 
opposing effects, which arise from the surrounding mesenchymal tissues.  In an effort to generate 
therapeutic beta cells for diabetes mellitus, RA, Fgf10, Protein kinase C (PKC) activators, Shh 
(cyclopamine) and BMP inhibitors have been used in directed differentiation protocols to induce 
pancreatic epithelium from DE derived from human pluripotent stem cells (hPSCs) (D'Amour et 
al. 2006; Kroon et al. 2008; Nostro et al. 2011; Cheng et al. 2012;  Rezania et al. 2012) 
 
Phases of pancreas development: Once the organ is specified, the pancreas epithelium thickens 
and expands into the surrounding mesenchyme. Formation of the rodent pancreas occurs in two 
phases of development overlapping each other.  The first phase of development occurs between 
E9.5-E12.5 in a mouse.  Starting from E10.5, the epithelia of the two buds, which are still 
partially differentiated, undergo the first phase of developmental transition. At this phase of 
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development, a few insulin-producing cells (beta cells), often co-expressing the glucagon 
hormone, appear in a cluster–budding process as the first differentiated cells (Pictet et al. 1972; 
Teitelman et al. 1993; Villasenor et al. 2010; Kesavan et al. 2009). Although alpha cells 
(glucagon–producing cells) and a few cells co-expressing insulin and glucagon can be detected 
as early as E9.5, beta cells and other hormone-secreting cells that are fully differentiated become 
first evident in the secondary transition at E13.5 (Hashimoto et al. 1988, Alpert, Hanahan & 
Teitelman 1988, Sander et al. 2000).  This first transition stage is characterized by active 
progenitor proliferation to generate a stratified epithelium followed by formation of microlumens 
that later coalesce. By E12.5, the stratified epithelium undergoes expansion, plexus remodeling 
and branching morphogenesis into a ductal tree, that finally forms two primordial pancreas 
organs with ductal epithelium that consists of predominantly undifferentiated cells.  
 
Role of transcription factors: At E12.5, the dorsal and ventral buds fuse together.  The majority 
of these early progenitors express the transcription factors such as Pdx1, Ptf1α, carboxypeptidase 
A1 (Cpa1), c-Myc, Sox9, Hnf1b, hairy/enhancer-of-split 1 (Hes1) and Nkx6.1 (Jonsson et al. 
1994; Apelqvist et al. 1999; Sander et al. 2000; Haumaitre et al. 2005; Seymour et al. 2007; Hald 
et al. 2008). Based on their cellular markers, these early  Pdx1+, Ptf1a+, Cpal+, Hes1+, Sox9+, 
Nkx6.1+ and Hnf1b+ pancreatic epithelial cells are regarded as pancreatic multipotent progenitor 
cells (MPCs) [comprehensively reviewed in Gittes 2009, Kopp et al. 2011, Pan, Wright 2011, 
Seymour, Sander 2011]. Mutant mice deficient in any one of these factors show varying degrees 
of hypoplasia or agenesis of the pancreas, despite initiating the bud, suggesting that initiation of 
pancreatic program is not completely inhibited by the absence of one single factor [reviewed in   
(Gittes et al. 1996, Pan, Wright 2011, Seymour, Sander 2011, Mastracci, Sussel 2012,)].  
Stellenbosch University  https://scholar.sun.ac.za
14 
Although pancreatic budding is initiated, evidence show that these factors are required for 
driving these progenitors cells into pancreatic fate. Deletion of Ptf1α, for example, converts 
pancreatic-fated progenitors to duodenal and common bile duct endoderms (Kawaguchi et al. 
2002, Burlison et al. 2008), while deletion of both Ptf1α and Pdx1 converts liver progenitors to 
pancreatic lineage, suggesting that Pdx1 and Ptf1α can change the destiny of the non- pancreatic 
genes from non-pancreatic cells to pancreatic lineage genes (Horb et al. 2003, Jarikji et al. 
2007,). However, the mechanism by which Ptf1α and Pdx1 activate non-pancreatic genes in non-
pancreatic cells to pancreatic genes needs more investigation. A better understanding of how 
these factors contextually activate pancreatic gene expression in non-pancreatic cells can help us 
develop novel strategies to re-program, for example, fibroblasts directly into pancreatic cells as 
revealed recently for cardiomyoctes and neurons (Thier et al. 2012, Zhu, Wang & Ding 2015). 
Around E12.5, a subset of these early pancreatic progenitors upregulate Cpa1 and Neurogenin 3 
(Ngn3), markers associated with pre-acinar and pre-endocrine domains respectively (Jorgensen 
et al. 2007, Zhou et al. 2007).  
 
Pancreatic epithelium and organ patterning/specification: Between E13.5 and E16.5, the 
pancreatic epithelium goes through a secondary transition stage of organ domain patterning. This 
stage is characterized by growth, branching and specifications of multi-potent progenitors toward 
differentiated lineages ( Rutter et al. 1968, Pictet et al. 1972,). Organ domain pattering gives rise 
to a network of  branched epithelia that is spatially segregated into ‘tip’ (from which acinar cells 
originate) and ‘trunk’ (from which endocrine and duct cells originate) domains that express 
specific cell-intrinsic markers (Fig.1.3) ( Zhou et al. 2007, Villasenor et al. 2010,).  
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Specification of multipotent progenitors to different lineages occurs by initiation and expression 
of specific gene profiles regulated by distinct transcription factors that are expressed in spatial 
and temporal manner. Lineage tracing studies demonstrated that multipotent progenitor cells 
reside at the tip of the branching epithelium and are marked by the expression of Pdx1, Ptf1a, 
Cpal, and c-Myc (Hebrok, Kim & Melton 1998, Zhou et al. 2007, Schaffer et al. 2010). These 
multipotent progenitors differentiate into acinar, duct, and endocrine cells. After E14.5 of 
development, Ptf1a and its target Cpa1 become restricted to the tip and drive these cells to 
exocrine fate (Zhou et al. 2007, Schaffer et al. 2010). Cells in the trunk sub-compartment are 
marked by Hnf1b, Sox9, Foxa2, Prox1, Tcf2, Hes1 and Nkx6.1/6.2, and differentiate into 
endocrine and duct cells ( Solar et al. 2009, Kopp et al. 2011, Pan, Wright 2011, Kopinke et al. 
2012, Schaffer et al. 2013,).  
From this stage and thereafter, multipotent progenitors in the trunk sub-compartment specify 
towards differentiated lineages (Villasenor et al. 2010). Nkx6.1/6.2 and Ptf1α act as major 
regulators of tip/trunk compartmentalization process. Nkx6.1/6.2 segregate to trunk cells where it 
promotes trunk identity together with Notch, while Ptf1α similarly regulate acinar cell 
development in the tip compartment (Schaffer et al. 2010, Schaffer et al. 2013, Afelik, Jensen 
2013). 
1.2.2 Specification and differentiation of endocrine pancreas from ductal trunk epithelium  
Following the expression of Pdx1, the next step is the differentiation of the pancreatic buds into 
endocrine and exocrine cells. Experiments that use lineage tracing systems have shown that 
Pdx1-expressing progenitor cells give rise to both endocrine and exocrine cells (Herrera 2000, 
Gu, Dubauskaite & Melton 2002). While tip cells are fated to generate acinar cells, the trunk 
compartment is bipotential and gives rise to duct and endocrine cells (Fig. 1.3) (Solar et al. 2009, 
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Kopp et al. 2011, Kopinke et al. 2012). In mice embryos, differentiation of endocrine cells 
occurs in two waves. The first wave occurs during the first epithelial transition stage between 
E9.5 and E13.5 and forms glucagon- and insulin-positive cells plus the other cells co-expressing 
glucagon and insulin but these cells never contribute to adult islet cells (Herrera 2000). The 
second wave of endocrine differentiation occurs during secondary epithelial transition (E13.5-
E15.5) and these cells forms adult islets (Offield et al. 1996).    
 
Differentiation of endocrine progenitors within the trunk epithelium relies on expression of 
transcription factors Pdx1 and Hnf6 (Offield et al. 1996), and this occurs by progressively de-
activating the expression of Hnf1b and Sox9. Concomitantly, at E13.5, the pro-endocrine basic 
helix-loop-helix (bHLH) transcription factor Neurogenin 3 (Ngn3) is transiently activated in a 
subset of cells in progenitor cords. Neurogenin 3 activation in the pro-endocrine progenitor cells 
leads to the differentiation of the endocrine cells and results into separation of endocrine cells 
from duct lineages. 
 
There is now evidence that timing and Ngn3 expression levels are crucial in driving primitive 
ductal epithelial cells entry into either, exocrine or endocrine lineage and fate allocation. Work 
done by Wang et al. (2010) demonstrated that epithelial trunk cells with high Ngn3 expression 
levels become endocrine-committed, while those with low Ngn3 levels remain in the primitive 
ducts (or progenitor cords) as precursors (Fig.1.3). Trunk epithelial cells that do not activate 
Ngn3 eventually differentiate into duct cells (Fig 1.3) (Magenheim et al. 2011a; Beucher et al. 
2012). Although levels of Ngn3 are important in triggering endocrine fate, how this occurs is not 
clearly understood. 
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Some reports show that Ngn3 expression appears to be induced by upstream transcription factors 
such as Hnf3β, Hnf1β, Sox9, Pdx1 and Hnf6 that have been detected to bind to Ngn3 distal 
regulatory region (Jacquemin et al. 2000; Lee et al. 2001; Oliver-Krasinski et al. 2009; Kim et al. 
2012; Shih, Wang & Sander 2013). However, little is known on how these factors regulate Ngn3 
activation. It is also not clearly understood why Ngn3 is expressed in only a subset of cells 
 
 
 
 
 
 
 
 
 
 
Figure 1.3. Model showing organization of epithelium during the secondary transition at 
E.13.5.  At this stage, epithelium is divided into two major domains: tip domain (grey) 
containing multipotent progenitor cells (MPC), and a trunk region containing the endocrine/ duct 
bi-potential progenitor pool. Cells scattered within the trunk express different levels of Ngn3, 
with Ngn3LO cells (light pink) (precursors but not yet committed). Ngn3LO  undergo asymmetric 
cell division that give rise to  one Ngn3HI (darker nucleus, red border) daughter cell that  becomes 
endocrine-committed and rapidly express Snail2 (purple cells) and migrate away via epithelial–
mesenchymal transition (EMT), before aggregating to form the endocrine islets. Adapted and 
modified from Pan , Wright 2011 
 
Inductive signals: Mesenchymal cells?                         
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within the primitive duct epithelium, while in majority of these cells, the gene is repressed. 
Factors arising from the mesenchyme have been postulated to participate in lineage selection 
(Fig.1.3). 
1.2.2.1 Mesenchymal-epithelial interactions in specification of endocrine versus exocrine 
Transforming growth factor-β isoforms (Tgf-β isoforms): In mice, three members of the 
superfamily transforming growth factor-β (Tgf–β) isoforms Tgf-β1, -β2 and –β3,   are 
specifically expressed in the epithelium of the developing pancreas at E12.5 and later localized 
to acinar cells, while their receptors, transforming growth factor receptor type I (TBR-I or Alk5) 
and TBR-II are expressed in the mesenchyme and the epithelium but later localize to duct 
epithelium (Crisera et al. 1999; Crisera, Longaker & Gittes 1999; Crisera et al. 2000; Tulachan et 
al. 2007).  There is evidence that Tgf-β isoforms participate in pancreatic lineage selection. In 
early pancreatic epithelium, it enhances proliferation and accumulation of periductal endocrine 
cells (Tulachan et al. 2007), while in late gestational periods, it restricts the recruitment of ductal 
or periductal cells into endocrine lineages (Fig. 1.3) (Crisera et al. 1999; Crisera, Longaker & 
Gittes 1999; Crisera et al. 2000; Tulachan et al. 2007)   
 
1.2.2.1.1 Role of Activins in lineage specification 
In addition to determining lineage specification and early branching of epithelial cells in the 
pancreatic bud (Ritvos et al. 1995, Kim et al. 2000), notochord-secreted Tgf-β sub-family signals 
such as activin and other growth differentiation factors, determine endocrine and exocrine 
lineage specification during the secondary transition stage (Ritvos et al. 1995, Kim et al. 2000, 
Maldonado et al. 2000).  In a study by Mirales et al. (1998), Tgf-β was shown to activate matrix 
metalloproteinase MMP-2 through type II activin receptors; ActRIIA and ActRIIB (Fig. 1.3), 
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which promotes migration and formation of islets and suppresses exocrine/acinar differentiation 
(Demeterco et al. 2000). These receptors are widely upregulated in the embryonic pancreatic 
epithelium and later in islets of adult pancreas (Kim et al. 2000). In type II activin receptor-
deficient mice, small islets develop (Yamaoka et al. 1998), suggesting that Tgf-β signaling, 
mediated by activin receptor, regulates islet differentiation (Kim et al. 2000). There is also 
evidence that activin enhances insulin-producing cells differentiation by inhibiting aristaless 
homeobox (Arx) (a transcription factor required for differentiation of alpha cells) and pro-
glucagon in human islets and pancreatic duct cells (Mamin, Philippe 2007).  Additional report 
shows that activin also induces Ngn3 through a non-canonical target of activin, p38 mitogen 
activator protein K (MAPK) (Ogihara et al. 2003). 
1.2.2.2 Endocrine versus exocrine differentiation within the duct epithelium  
(i) The notch pathway 
Within the primitive duct epithelium, it is reported that endocrine versus exocrine differentiation 
is regulated by lateral inhibition mediated by Notch signaling pathway (Apelqvist et al. 1999; 
Jensen et al. 2000b; Afelik, Jensen 2013; Shih, Wang & Sander 2013).  Notch signaling controls 
the fates of cells through local cell interactions in many cellular processes and tissues including 
the developing pancreas [reviewed in (Lammert, Brown & Melton 2000; Nam, Aster & 
Blacklow 2002)]. When stimulated by Hnf6 (Jacquemin et al. 2000), committed endocrine 
progenitors expressing Ngn3 autonomously activate the expression of Notch ligands: Jagged 1-2 
( Jag1-2), and Delta-like gene 1 and 3 (Dll-1 and -3) that bind to Notch receptors (Notch 1–3) in 
neighbouring cells and activate the Notch signaling pathway (Heremans et al. 2002). Activated 
Notch translocates to the nucleus and binds to its downstream target, Hes1. Activated Hes1 
represses Ngn3, and therefore prevents widespread Ngn3 activation and subsequent endocrine 
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differentiation (Ahnfelt-Ronne et al. 2012). In addition, Hes1 maintains a pool of proliferative 
progenitor cells within the duct epithelium by repressing the cyclin-dependent kinase p57, the 
cell cycle inhibitor in multipotent progenitor cells (Georgia et al. 2006). Recently, Hes1 was 
further shown to promote Ngn3 protein degradation (Qu et al. 2013). In addition to activating 
Hes1, Notch signaling also regulates Sox9 expression that specifies duct cells (Kageyama, 
Ohtsuka & Kobayashi 2007, Shih et al. 2012). Therefore, duct epithelial progenitor cells in 
which Notch is upregulated are capable of continued proliferation while cells in which Notch is 
downregulated, express Ngn3, exit the cell cycle, and proceed to differentiate into endocrine 
cells. Epithelial cells in which Ngn3 is activated marks the endocrine progenitors (Gu, 
Dubauskaite & Melton 2002; Herrera 2002). Expression of Notch receptors (Notch1–3), ligands 
(Jag-1, Jag-2, Dll-1, and Dll-3), and target Hes1 has been observed in undifferentiated cells 
within the mouse embryonic pancreas but not in differentiated endocrine cells in the embryonic 
or adult pancreas (Murtaugh et al. 2003; Hald et al. 2003; Esni et al. 2004) .  
 
In the developing pancreas the role of the Notch-Hes1 pathway is to promote precursor cell 
replication and prevent premature endocrine differentiation (Murtaugh et al. 2003; Hald et al. 
2003; Esni et al. 2004). As evidence to support this, murine models, deficient of Notch signaling 
molecules such as Dll-1, recombination signal binding protein for immunoglobulin J kappa 
region (Rbp-Jk) and Hes1, show accelerated differentiation of endocrine cells thereby depleting 
the population of progenitor cells, resulting into hypoplastic pancreas (Apelqvist et al. 1999; 
Jensen et al. 2000b).  At the end of this phase , cells express a group of transcription factors such 
as Isl-1, Pax6 (St-Onge et al. 1997), Pax4 (Sosa-Pineda et al. 1997), Nkx2.2 (Sussel et al. 1998), 
Beta2/NeuroD (Naya et al. 1997) and Ngn3 (Gradwohl et al. 2000, Schwitzgebel et al. 2000). 
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which mark them as the endocrine cell precursors,  In principle, the endocrine cell precursors can 
differentiate into different endocrine islet cells. 
 
Between E13.5 and E15.5, high levels of Ngn3 expression occur in the cells of the trunk 
epithelium and signifies the differentiation and expansion of the endocrine cells. Ngn3 is 
required for endocrine cell differentiation as Ngn3-null pancreas is devoid of endocrine cells 
while exocrine tissue is normal (Gradwohl et al. 2000). In  in-vitro and during in-vivo 
regeneration or transplantation, inhibitors of Notch, in addition to other growth factors, have 
been used in directed differentiation protocols to generate Ngn3+ cells   after induction of the 
pancreatic epithelium derived from hPSC in vitro, (D'Amour et al. 2006; Kroon et al. 2008; 
Nostro et al. 2011; Cheng et al. 2012; Rezania et al. 2012). 
 
(ii) Neurogenin 3 (Ngn3) 
The basic helix-loop-helix (bHLH) transcription factor Ngn3 was shown to give rise to all four 
types of endocrine cells of the pancreas (Jensen et al. 2000a). Neurogenin 3 is exclusively and 
transiently expressed in cells scattered within the pancreatic epithelium, while in differentiated 
endocrine cells the gene is downregulated (Schwitzgebel et al. 2000). Neurogenin 3 is required 
for the development of the endocrine pancreas, and mutant mice in which Ngn3 is deleted are 
born without pancreatic endocrine cells (Gradwohl et al. 2000). There is also evidence from cell-
tracing studies that Ngn3-positive cells are endocrine precursors (Gu, Dubauskaite & Melton 
2002). Thus, Ngn3 can be used as a marker to trace the onset of endocrine cell differentiation in 
the pancreas. When Ngn3 is ectopically activated in the gut epithelial cells, differentiation of 
glucagon- and somatostatin-producing cells are induced, at the expense of insulin-producing ß-
cells (Grapin-Botton, Majithia & Melton 2001). Downstrean, Ngn3 proteins bind to the promoter 
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for Neurogenic differentiation 1 (NeuroD1), [also known as beta-cell E-box transactivator 2 
(Beta2)] and activate transcription of the gene (Huang et al. 2000). During pancreatic 
development, expression of NeuroD1/Beta2 occurs slightly later than Ngn3, and its expression, 
unlike Ngn3, persists in differentiated islet cells where it regulates differentiation of islet cells 
and the expression of the insulin gene (Naya et al. 1997).  
1.2.2.3 Specification of endocrine cell subtypes 
While Ngn3 upregulation in the epithelial trunk progenitor cells signifies endocrine 
differentiation (Sander et al. 2000; Zhou et al. 2007; Stanger, Tanaka & Melton 2007), it is not 
completely understood how and when Ngn3+ cells make their choices into appropriate hormone 
cell type. Equally important is the question of whether each high Ngn3–expressing cell is 
multipotent or unipotent. Some studies report that each high Ngn3-expressing cell can 
differentiate into  any of the four possible subtypes of the endocrine cells (Deltour et al. 1991; 
Wilson, Scheel & German 2003; Johansson et al. 2007; Scharfmann et al. 2008), while clonal 
analysis studies suggest that each high Ngn3+ endocrine progenitor may be unipotent and 
postmitotic cell that is already pre-committed to specific endocrine lineage such as  alpha cells, 
beta cells, delta cells, PP cells and  epsilon cells. i.e. a single high Ngn3+cell is a precursor of 
either a beta cell or an alpha cell but not a precursor of both at the same time (Gu, Dubauskaite & 
Melton 2002; Desgraz, Herrera 2009; Miyatsuka et al. 2011). 
  
However, some studies that used a conditional Ngn3 transgene, “Ngn3 addback,” showed that 
differentiation of each endocrine cell type from high Ngn3+ endocrine progenitors occur at 
specific time points and through sequential competence states that arise within the duct cells 
themselves, and lead to generation of alpha cells first (E9.5), then beta cells (E10.5) and δ-cells 
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(E14.5), followed by PP-cells (E18.5) (Johansson et al. 2007).  The time point for differentiation 
of ε cells is unknown. Although these findings postulate a time frame for islet cell allocation, the 
basis of these cell-intrinsic competence periods and the mechanism that controls this change in 
developmental potential have not been established. Furthermore, the origin of the signaling 
molecules guiding Ngn3-expressing progenitor cells to differentiate towards a specific endocrine 
cell type is currently unknown.  The mechanism may likely involve several regulatory factors 
and so many cell intermediates that may change according to the condition.  
 1.2.2.4  Molecular basis in specification of endocrine cell subtypes 
Following activation of Ngn3, several transcription factors have been identified to function in 
endocrine subtype lineage specification, differentiation and maturation. The identified 
transcription factors expressed downstream of Ngn3 include NeuroD1/Beta2, Nkx2.2, Nkx6.1, 
Pdx1, Arx, Motor neuron and pancreas homeobox 1 (Mnx1), Foxa1, Foxa2, V-maf 
musculoaponeurotic fibrosarcoma oncogene family, protein A (MafA), V-maf 
musculoaponeurotic fibrosarcoma oncogene family, protein B (MafB), Regulatory X-box 
binding 6 (Rfx6) , insulin associated 2 (IA2), Paired box-containing gene 4 (Pax4), Pax6 and 
Insulinoma-associated antigen 1 (Insm1), Myeline transcription factor 1 (Myt1) and Snail2/Slug  
( Rukstalis, Habener 2007, Rukstalis, Habener 2009, Seymour, Smith et al. 2010, Soyer et al. 
2010, Sander 2011). However, the mechanism by which these transcription factors specify the 
changes that contribute to allocation of distinct islet cell subsets is not clearly understood. It is 
now postulated that specification and differentiation of each endocrine cell type is regulated by a 
set of “transcription factor codes” that are specific for each cell type (Pan, Wright 2011) (Fig. 
1.4). Using a loss-of-function approach, these endocrine cell-type-specification regulatory factors 
have been divided into three classes based on the phenotypes of the mutant models used: Class 1- 
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endocrine precursor differentiation factors; Class 2- lineage allocation factors and Class 3 - cell-
type maturation factors (Collombat et al. 2006), reviewed in (Pan, Wright 2011). 
  
Figure1.4. Shematic flow diagram showing key transcriptional factors activated at each 
stage of endocrine pancreas development Adapted and modified from Pan, Wright 2011 
 
Class 1: Endocrine precursor differentiation factors 
Endocrine fate determining factors are mostly downstream targets of Ngn3, including 
NeuroD1/Beta2 (Huang et al. 2000), Isl-1, Insm-1, Rfx6 and Nkx6.1 (Pan, Wright 2011). These 
factors are activated early during specification of endocrine subtypes and often co-express with 
Ngn3. Their main role is to ensure the formation of proper numbers of endocrine cells by 
stimulating proliferation of endocrine cell progenitors and their intermediates, and allow these 
progenitors to enter a single-hormone producing state.  
(i) NeuroD1/Beta2:  NeuroD1/Beta2 is basic helix-loop-helix (bHLH) that is first expressed 
in pancreatic endodermal cells at E9.5. During secondary transition at E15.5, the gene is 
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restricted to all endocrine cells except for δ-cells (Chu, Nemoz-Gaillard & Tsai 2001; Anderson 
et al. 2009a; Anderson et al. 2009b). Mutant mice, in which NeuroD1 is deleted, the numbers of 
all endocrine cell types are reduced (Naya et al. 1997), particularly beta cells, fail to form islets 
and die afterbirth due to beta cell apoptosis similar to the phenotypes seen in Isl-1, Insm-1, Rfx6 
null mice ( Mellitzer et al. 2006; Gierl et al. 2006; Du et al. 2009; Smith et al. 2010; Soyer et al. 
2010).  Additionally, another report has shown that Isl-1 is required for islet cells 
differentiation. Mice in which Isl-1is deleted are born without endocrine cells (Ahlgren et al. 
1997), and its expression was found to be critical for development of exocrine tissue of the 
dorsal bud as well, suggesting that morphogenesis of the dorsal and ventral pancreatic buds are 
regulated by different signaling molecules. 
(ii) NKx6.1: Nkx6.1 is first expressed in the pancreatic epithelium from E10.5 and at E15.5. 
The gene is co-localised with Ngn3+ immature progenitors where it induces proliferation of 
these cells (Jorgensen et al. 2007). Later, Nkx6.1 is upregulated in Pdx1+ mature beta cells 
where Ngn3 is downregulated. Nkx6.1 promotes beta cell fate specification from Pdx1+ cells. 
Deletion of Nkx6.1 causes marked reduction in the number of Ngn3- and insulin-positive cells 
in mutant mice (Jensen et al. 1996). 
 
Class II:  Endocrine progenitor lineage specification factors 
Lineage specific transcription factors controls the allocation of the Ngn3+ progenitors and their 
intermediates towards a specific endocrine cell type. These factors include Nkx2.2, Pdx1, Pax4 
and Arx. Deletion of any one of these factors does not change the number of endocrine types, but 
severely alters the fractional islet allocations by causing lineage-switching.  
(i) Nkx2.2: During endocrine differentiation, Nkx2.2 is activated in alpha-, beta- and PP cells, 
exclusive of the somatostatin-producing delta cells (Sussel et al. 1998). In Nkx2.2 mutants, beta 
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cells and big fractions of alpha- and PP cells are replaced by epsilon cells (Sussel et al. 1998, 
Prado et al. 2004). In addition, beta cells are born immature lacking beta cell specific maturation 
factors, glut2 and glucokinase.  
(ii) Pax4 – Arx: Reports show that paired box, Pax4, is a key transcription factor in regulation 
of insulin producing beta cells and somatostatin producing delta cells differentiation (Sosa-
Pineda et al. 1997). Increase in Pax4 expression in Ngn3+ precursor cells marks the beginning of 
beta cell differentiation. In Pax4 knockouts, beta- and alpha cells are lacking while alpha- and 
epsilon- dramatically increase to compensate for their absence. Pax4 also inhibits Arx, a factor 
that specifies alpha cells (Collombat et al. 2003; Collombat et al. 2005). Concomitantly, in Arx 
mutants, alpha cells are lost, while delta/beta cells increase. Thus, Pax4 and Arx specify beta- 
and alpha cells respectively. Activation of Pax6 in precursor cell drives these cells to 
differentiate into glucagon secreting delta cells and maintains a glucagon-producing cell fate (St-
Onge et al. 1997).  
(iii) Pdx1: In addition to promoting expansion of early progenitor cells in the pancreatic buds, 
Pdx1 promotes beta cell proliferation and survival during secondary transition stage. Deletion of 
Pdx1 at this stage, leads to reduction in beta cells while alpha/delta cells increase in number 
(Gannon et al. 2008). In mature beta cells, Pdx1 activates the expression of insulin, Glut-2 
(Ohlsson, Karlsson & Edlund 1993) and Islet amyloid polypeptide (IAPP) (Watada et al. 1996). 
Thus, Pdx1 is activated at all stages of pancreatic development. In the early stages of embryonic 
development, Pdx1 is required for pancreas development, while in the in fetal stages of 
development the gene is required for specific beta cell fate differentiation. In an adult pancreas, 
Pdx1 activates the expression of the insulin gene and for the differentiation of the mature 
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pancreas (Ohlsson, Karlsson & Edlund 1993). Most of these factors are expressed in a spatial 
and temporal manner during development.  
Class III:  Endocrine cells maturation factors 
In addition to endocrine fate determination and lineage specification factors, a third set of 
regulatory factors control the morphological and functional maturation of differentiating 
endocrine cells. Transcription factors involved in endocrine cell maturation include MafA/B, 
Foxa1, Foxa2 and NeuroD1. Loss of these factors does not affect cell lineage specification, but 
cells display abnormal functions after birth    
(i) MafA/B: The basic leucin zipper transcription factors MafA and MafB are activated late in 
differentiating endocrine cells. MafA is required for acquiring  and maintaining the maturity state 
of beta cells by activating Pdx1, Nk6.1, Insulin, GLUT-2, Slc30a8 (zinc transporter) and G6pc2 
(glucose-6-phosphate catalytic subunit 2 protein) genes which are important for beta cell 
function (Aramata et al. 2005; Zhao et al. 2005; Artner et al. 2006; Raum et al. 2006). Beta cells 
arise from immature MafB+ cells which give rise to MafB+/MafA+ cells , then finally to mature 
MafA+ beta cells, a process that results into activation of Pdx1 (Nishimura et al. 2006; Artner et 
al. 2010). MafA interacts with Pdx1 and NeuroD1 and bind to insulin promoter to activate 
transcription of the insulin gene (Olbrot et al. 2002; Aramata et al. 2005). MafB later becomes 
restricted to alpha cells. Therefore, MafB is required for both beta- and alpha cell differentiation 
and maturation.  MafA mutants become glucose intolerant after birth (Zhang et al. 2005) 
(ii) Foxa2/Hnf3β: The bHLH Foxa2 promotes maturation of endocrine cells (Lee et al. 2005) 
by activating Pdx1 that activates the expression of insulin and GLUT-2 in beta cells (Gerrish et 
al. 2000, Sund et al. 2001). Deletion of Foxa2 also reduces the number of alpha cells indicating 
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that Foxa2 is also required for development and activation of glucagon in alpha cells (Lee et al. 
2005). 
 
1.2.2.4.1 Formation of islets of Langerhans 
As development proceeds, committed high-Ngn3-expressing  endocrine precursor cells and their 
immediate downstream intermediates, exit the cell cycle at around E14.5 and delaminate from 
the ductal epithelium through epithelial–mesenchymal transition (EMT) by rapidly activating 
Snail2 (Fig. 1.3) (Rukstalis, Habener 2007), before aggregating into islets of Langerhans (Fig. 
1.3) (Pan, Wright 2011; Miyatsuka et al. 2011; Gouzi et al. 2011).   
 
The final stages of islet development and maturation is characterized by formation of blood 
vessels and nerves (Pictet et al. 1972; Burris, Hebrok 2007). The development of blood vessels 
within the islets is promoted by cellular interactions between vascular endothelial cells and 
endocrine cells, which are critical for the development of functional islets (Lammert, Cleaver & 
Melton 2001; Lammert et al. 2003). This is followed by migration of neural crest cells to the 
aggregates of endocrine cells around E12.5 to innervate islets (Burris, Hebrok 2007; Nekrep et 
al. 2008). Development of sympathetic innervations is critical for regulating beta cell secretory 
functions and survival in mature islets. Toward the end of gestation, these endocrine cell 
aggregates eventually disperse between acini and ducts (Pictet et al. 1972; Slack 1995). Shortly 
before birth at E18.5, pancreatic polypeptide cells (PP-cells) differentiate. In mice, typical rodent 
islet architecture, with insulin-secreting cells located at the center and non-beta cells in the 
periphery, is clearly seen late in gestation (E18.5) (Herrera et al. 1991).  
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1.2.2.5  Physiological and morphological maturation of beta cells 
Physiological and morphological maturation of beta cells is important in order to achieve 
effective glycemic control. A defective beta cell maturity or a failure of beta cell expansion 
promotes development of a metabolic disease, such as diabetes mellitus (Georgia, Bhushan 2004; 
Butler et al. 2007).  After weaning, beta cells undergo two main events to achieve maturity: 1) 
physiological maturity through development of the glucose sensor machinery by increasing 
dense core sensory granules (Kim et al. 2006) and 2) morphological maturity by remodeling to 
establish an appropriate beta cell mass proportional to individual’s body weight (Georgia, 
Bhushan 2004; Butler et al. 2007).  
To achieve beta cell  glucose stimulus-secretion coupling, beta cells activate several genes  
including proinsulin and insulin (genes that maintain identity of islet cells); Glucose transporter 2 
(GLUT-2) and glucokinase (GK) (genes that senses blood glucose concentration); Pdx1, MafA 
and NeuroD1(Tfs for development and maturation); chromogranins (Chg) A and ChgB,  and islet 
amyloid polypeptide (IAPP) (for formation of secretory granules); SUR1 (Sulfonylurea 
regulatory receptor in K (ATP)  channels  e.t.c (Kim et al. 2006; Aguayo-Mazzucato et al. 2011).  
Meanwhile, to achieve morphological maturation, beta cells activate several genes, such as 
Cyclin dependent kinase 4, CyclinD2 and FoxM1 (Seymour, Sander 2011). 
 
In summary, the genetic cascade in endocrine development is particularly important in order to 
understand the pathology of diabetes. Understanding how these factors are regulated or whether 
such an embryonic pathway can be reactivated in adult pancreas, could be used in designing 
therapeutic regenerative protocols for the cure of diabetes.  
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1.3  Role of epithelial-mesenchymal interactions in development of the pancreas as revealed 
by embryonic explant experiments 
 
Mesenchymal stromal/stem cells (MSCs) are a group of heterogeneous multipotent cells that are 
capable of differentiating into various mesodermal tissues such as bone, cartilage, adipose tissue 
and muscle. Various studies have attempted to isolate these cells from various postnatal tissues, 
including the bone marrow and characterize these cells based on their ability to stick on plastic 
plates when cultured under normal standard conditions (reviewed in Mafi et al. 2011; 
Gopurappilly, Bhat & Bhonde 2013a; Scuteri et al. 2014). Most of the data regarding their 
phenotypic properties is based on analyses of isolated cells that have been expanded in vitro and 
whereas their in vivo phenotype and role are largely unknown (reviewed in Mafi et al. 2011; 
Gopurappilly, Bhat & Bhonde 2013a; Scuteri et al. 2014). 
 
In classic explant culture experiments performed more that 6 decades ago, pancreatic epithelial 
tissue explants from embryonic pancreas display low levels of differentiation when cultured 
without MSCs (Golosow, Grobstein 1962). In the same study, when pancreatic epithelial and 
MSC tissues were cultured side by side separated by Millipore filter, differentiation of the 
pancreatic epithelium was induced. Results from these studies clearly demonstrate that MSC 
tissue secretes soluble inductive factors that are required for development of the pancreas 
(Golosow, Grobstein 1962). In these earlier studies, however, these secreted soluble factor(s) 
were not identified. Identification of key MSC-derived factors required during pancreas 
organogenesis is important in development of protocols to direct cell differentiation through 
particular pathways.  
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In addition, these earlier in vitro studies focused on the development of the exocrine pancreas 
rather than the endocrine pancreas (Wessells, Cohen 1967; Pictet et al. 1972). However, the few 
in vitro studies done about two decades ago that focused on the role of the MSCs in 
differentiation of endocrine pancreas obtained contradictory results. Findings from Ruttter and 
his group showed differentiation of the epithelium into endocrine tissue in the absence of MSCs 
(Rutter et al. 1978; Gittes et al. 1996), while others did not observe any endocrine cell 
development in the absence of MSCs (Wessells, Cohen 1967; Andrew, Rawdon & Alison 1994). 
Similar observations on endocrine development in the absence of MSCs were made by Gittes et 
al. (Gittes et al. 1996). In their experiment, when pancreatic allografts were transplanted under 
the kidney capsule with surrounding MSCs, they differentiated into mature pancreatic tissue, 
forming ducts, acini and endocrine tissues. On the other hand, allografts of epithelial tissue 
isolated without MSCs formed only dense spheroid bodies of pure islets suggesting that 
embryonic MSC factors required for the differentiation of the exocrine pancreas differs from 
those needed for differentiation of the endocrine part. However, soluble signals involved in 
repression of endocrine and induction of exocrine tissue during these interactions have not been 
investigated. One candidate molecule could be Follistatin, which was found to regulate the 
relative propotions of endocrine versus exocrine during pancreas development (Miralles, 
Czernichow & Scharfmann 1998). In addition, these experiments did not examine the influence 
of early MSC-derived factors secreted way before isolation of the tissues for culture.  
 
Taken together, findings from these studies show that molecular signals secreted by the 
notochord control the development of the dorsal pancreas in the early stages of embryonic 
development ( Golosow, Grobstein 1962; Kim, Hebrok & Melton 1997; Wells, Melton 2000). In 
later stages, proliferation and differentiation of the pancreatic progenitor cells are controlled by 
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MSC-derived factors that determine the proportion of endocrine versus exocrine tissue 
(Golosow, Grobstein 1962). Although some studies have reported the important role of signals 
from MSCs in the control of development of exocrine tissue, their role in the development of 
endocrine tissue is still not very clear. Whether these extrinsic factors secreted by tissues 
surrounding islets during pancreas development are also activated in normal or injured adult 
pancreas such as pancreatic duct ligation (PDL) is also not known.  Understanding their roles in 
pancreatic endocrine cell proliferation and differentiation can help us to devise new regenerative 
therapeutic strategies in adult pancreas, against the deficiency of beta cells that lead to type 1 and 
type 2 diabetes mellitus  and hence develop appropriate therapeutic solutions to these diseases. 
1.3.1 Epithelial-MSCs interactions in mature pancreas 
As stated in section 1.3 above, the question of whether the epithelial-MSCs interactions play any 
role in maintenance of beta cell mass in adult pancreas under normal physiological or injured 
conditions is not well known. In adult tissue, MSCs are commonly described as a heterogeneous 
population of adult fibroblast-like, multipotent cells characterized by their ability to adhere to 
plastic substrate and differentiate into tissues of mesodermal origin, such as adipocytes, 
chondroblasts, and osteoblasts when cultured in vitro (Friedenstein et al. 1974a; Pittenger et al. 
1999). It was reported that the relative proportion of MSCs to epithelium changes during 
pancreas development. More MSC tissue is found in fetal pancreas than in neonates. A recent 
histological study of fetal mice pancreas showed that relative MSC area is significantly reduced 
to as low as 11% at E15.5 and 6% of the pancreatic area at E18.5 (Landsman et al. 2011).  In 
adult pancreas, the epithelial compartment is the major component of the pancreatic tissue that 
comprises endocrine cells, acinar cells and duct cells. The mesenchymal cell compartment is 
very small and scattered amongst the epithelial tissue, largely composed of endothelial cells and 
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pancreatic fibroblasts. In addition, present in smaller numbers within the MSC tissue are cell 
types such as stellate and vascular smooth muscle cells (Hogan 1999). Despite such dramatic 
reduction in their portion in mature pancreas, embryonic MSCs are, however, still detected 
throughout pancreas development and maturation (Hogan 1999). Whether this developmental 
reduction in MSC area reflects a related reduction in beta cell replication and /or neogenesis in 
adult pancreas is not known. 
 
In a normal adult mouse model, β- cells growth and/ or regeneration occurs very slowly via 
replication of existing beta cells or neogenesis (generation of new beta cells from precursor 
cells).  A study by Teta et al. (2005) reported that beta cells are long-lived, and in one-year-old 
mice, only 1 in 1400 beta cells divide in a 24 h period (Teta et al. 2005). The question of whether 
the epithelial-MSCs interactions play any role in maintenance of beta cell mass in adult pancreas 
under normal physiological or injured conditions is not clearly understood.  Using explant 
systems to address the role of the MSCs in adult pancreas have been difficult because the mature 
pancreas epithelium is highly branched into the surrounding MSCs. This prevents clean physical 
separation of these two layers.  
1.3.2. Mesenchymal stromal cells (MSC) isolation and characterization in culture 
Findings by Friedenstein and colleagues (Friedenstein et al. 1974b; Pittenger et al. 1999) led to 
identification of the bone marrow– derived fibroblast-like cells with chlonogenic differentiation 
potential. After discarding the supernatant containing non-adherent hematopoietic stem cells 
from low density cultures of bone marrow on plastic culture dishes, Friedenstein and colleagues 
were able to identify the plastic adherent cells or colony-forming unit fibroblasts, which were 
later called mesenchymal stromal cells (MSCs) by Owen (1988). Although there are a number of 
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protocols available to isolate rat MSCs, each isolation protocol can vary in the yield, purity, 
quality, and the ability of the cells to proliferate. It is interesting to note that since the first 
description of MSCs by Friedenstein et al.(1966), researchers have used this method of 
adherence of fibroblast-like cells to the plastic substrate of a cell culture plate as s standard 
method when isolating cells recovered from umbilical cord, adipose, pancreas or bone marrow 
tissues etc (Pittenger et al. 1999). Other reports, however, proposed the negative selection 
method to exclude non-adherent hematopoietic stem cells, or using positive selections for some 
of the MSC markers in order to purify MSCs (Tyndall, Furst 2007, or a review Mafi et al. 2011). 
1.3.3.  Characterisation of MSCs in culture 
 
Until now, no specific singular marker has been identified to characterize the mensenchymal 
stromal cells (MSCs). As a result, researchers use a set of positive and negative markers to 
phenotypically characterize these cells. MSCs express variable levels of CD105, CD90/Thy1 and 
CD73 and absence of markers such as CD34, CD45 and CD14 (reviewed in Mafi et al. 2011). A 
number of other cell surface markers have also been identified, although, some study used their 
differentiation potential into several mesenchymal lineages as a creteria to identity these cells 
(Prockop 1997). However, the specificity of some of these markers varies when identifying 
MSCs isolated from humans versus mice/rats (reviewed in Mafi et al. 2011). To date, no study 
has succeeded in the identification of MSCs in vivo.  
 
The main criterion currently used to characterize and identify MSCs is their capacity for self-
renewal and differentiation into tissues of mesodermal origin, combined with a lack in the 
expression of certain hematopoietic molecules. In 2006, the international society for cellular 
therapy (ISCT) developed criteria for characterizing MSCs. Firstly, MScs should possess   
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plastic adherent properties under normal culture conditions and has a fibroblast-like morphology. 
Secondly, MSCs should be capable of differentiating into osteoblasts, adipocytes and 
chondrocytes ex-vivo. Thirdly, MSCs should demonstrate positive markers such as CD105, 
CD90/Thy1 and CD73 and absence of markers such as CD34, CD45 and CD14 (reviewed in 
Mafi et al. 2011). 
1.3.4 Pancreas-derived mesenchymal stromal cells (PMSCs)  
Protocols for the isolation of PMSCs from porcine fetal pancreas (Cao et al. 2011), human fetal 
and adult pancreas (Hu et al. 2003), mice pancreas (Mafi et al. 2011, Gopurappilly, Bhat & 
Bhonde 2013a, Scuteri et al. 2014) have been published. In these studies, it was  shown that 
PMSCs are positive for CD44, CD29, CD 73 (Ecto-5’- nucleotidase) CD 105 (Endoglin), CD 
166 (ALCAM), CD 90 (Thy 1), CD 44( H-CAM), CD 49a (VLA-1) but are negative for CD45, 
CD 14, CD 19, HLA-DR, CD 34,  and CD PECA-1) ( markers of hematopoietic cells) and CDI3 
but negative for CD34 and HLA-DR. These findings demonstrate that PMSCs can be isolated 
from pancreas based on their adherent ability, their capability of self-renewal and their 
multipotent potentials. 
 
In summary, evidence from rodent research has remarkably enhanced our understanding of the 
processes and factors that regulate pancreas development. Development of the pancreas from 
primitive gut endoderm requires complex interactions of molecular factors, some of which play 
important roles in proliferation, migration, differentiation and growth of exocrine and endocrine 
pancreas. Morphogenesis and further differentiation of the pancreas requires the presence of 
extrinsic factors from notochord and mesenchyme. Key factors in endocrine development 
include Pdx-1, Ngn3, Pax4 and Pax6 (Fig. 1.4). Although these transcription factors are required 
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for pancreatic organogenesis, the mechanism by which their expression is regulated is not fully 
understood. Identifying and characterizing the genetic cascade of regulatory molecules in 
endocrine development is particularly important in order to understand the pathology of diabetes. 
Understanding how these factors are regulated or whether such an embryonic pathway can be 
reactivated in adult pancreas can help us in designing therapeutic regenerative protocols for the 
cure of diabetes mellitus.  
1.4  Diabetes mellitus and cell replacement therapy 
Diabetes mellitus is the major chronic metabolic disease that globally affects an estimated 422 
million adults, according to the latest 2016 data from the World Health Organization (WHO) 
(WHO Global Report on Diabetes. Geneva, 2016).  Prevalence for diabetes mellitus for all ages 
worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030 (Wild et al. 2004). Although 
diabetes is associated with developed countries, the incidence is also increasing in developing 
countries (Longo-Mbenza et al. 2010). Some contributing factors to this increase include aging, 
urbanization, population growth, increasing prevalence of obesity and physical inactivity. The 
prevalence estimates for the age groups 20-79 years in  South Africa alone was put at 7% in 2015 
(IDF Diabetes Atlas Group 2015). In developing countries, the disease has worst outcomes, 
largely because the poor cannot access or afford preventable services and treatment. Such 
increase in prevalence requires urgent global attention in order to reduce increase in deaths 
because of complications associated with the disease.  
 
There are two forms of diabetes mellitus, namely, type 1 and type 2 diabetes mellitus. Type I 
diabetes comprises 5–10% of all diabetic mellitus cases while type 2 diabetes , 90–95% of all 
diabetic mellitus cases (Shapiro et al. 2000; Shapiro et al. 2006). The etiology underlying the 
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disease is complex. In Type 1 diabetic patients, insulin producing β- cells are selectively lost due 
to autoimmune reaction while in type 2, beta cell functions are relatively impaired coupled with 
peripheral resistance to insulin action. In addition, type 2 diabetes results into gradual decrease in 
beta cell mass with the progression of the disease (Butler et al. 2003), also requiring replacement 
with new β- cells.  
 
The inability of the body to produce sufficient amounts of insulin, the hormone that regulates the 
level of blood glucose, leads to chronic hyperglycemia, which affects multiple organs such as the 
eyes, kidneys, heart, nerves, and blood vessels. If untreated, the hyperglycemic condition may 
lead to complications such as micro- and macro-vascular damage, blindness, amputation and/or 
death (Fuller et al. 1983).  
1.4.1 Novel treatments for diabetes mellitus 
Current treatment regimens of diabetes require daily oral intake of hypoglycemic agents (for type 
2) combined with injections of exogenous insulin (for type 1) in order to compensate for insulin 
deficiency. However, this treatment regimen does not mimic the biological mechanism of 
controlling the daily fluctuations in systemic blood glucose. Therefore, researchers are 
investigating novel therapies for treating diabetes by beta cell generation in vitro and 
transplantation or re-generation in vivo to restore beta cell mass. Generation or replacement of 
new insulin producing beta cells would provide a real therapy that would mimic the biological 
mechanism capable of restoring normoglycemia. Whole cadaveric pancreas transplantation has 
provided effective treatment to patients with serious complications of diabetes for the past four 
decades (Bonner-Weir, Weir 2005b). The risks associated with this major surgical procedure, 
however, prohibit it from being recommended as a treatment for diabetes (Burke, Ciancio & 
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Sollinger 2004; White, Manas 2008). Islet transplantation, a less invasive procedure, represents a 
substitute to whole organ transplant and insulin therapy (Shapiro et al. 2000; Shapiro et al. 2006). 
The use of this procedure is also limited due to shortage of donors, immune rejection, and the 
need for life-long immuno-suppressors (du Toit et al. 1998; Muller et al. 1998; Inverardi, 
Kenyon & Ricordi 2003; reviewed in Burke, Ciancio & Sollinger 2004; Ricordi, Strom 2004). 
An alternative strategy to islet transplantation is the in vivo generation of beta cells within the 
patient’s pancreas (Bonner-Weir, Weir 2005a).   
1.4.1.1 Beta cell regeneration in adult pancreas 
Several attempts to generate endogenous new beta cells for therapeutic purposes using various 
animal models of pancreatic injuries have been reported (Fig. 1.5). These studies currently focus 
on strategies that promote either the expansion of existing beta cells within the pancreas or the 
generation of new beta cells through neogenesis within the pancreas. Neogenesis debate has 
recently intensified with many cell-tracing studies reporting inconsistent results about the 
sources of these new beta cells (Fig.1.5) (Bonner-Weir et al. 2010, Kopp et al. 2011, Furuyama 
et al. 2011, Criscimanna et al. 2011). Until now, the question of whether facultative beta cell 
progenitors exist in adult pancreas is still under intense investigation. Factors that trigger 
generation of new beta cells in injured pancreas of experimental models have not been clearly 
elucidated. This study was developed to address this conundrum.  
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Figure 1.5. Model showing sources of beta cells during regeneration.  
Adapted and modified  from Pan, Wright 2011. 
 
As stated previously, in a normal adult mouse model, replication of existing beta cells occurs 
very slowly, however, under certain experimental conditions, high levels of growth and 
neogenesis of beta cells have been reported (Peters, Jurgensen & Kloppel 2000; Bouwens 2006). 
The most important of these models are: duct ligation in adult rats (Hultquist, Joensson 1965; 
Wang, Kloppel & Bouwens 1995; Xu et al. 2008a), partial (90%) pancreatectomy in rats 
(Bonner-Weir et al. 1993a), cellophane wrapping in newborn hamster rats and selective beta cell 
destruction by streptozotocin/alloxan perfusion in adult mice (Bonner-Weir et al. 1981; Cantenys 
et al. 1981; Rosenberg, Brown & Duguid 1983; Bonner-Weir et al. 1993a; Waguri et al. 1997).  
In these animal models, endocrine cell regeneration was reported. Although the existence of stem 
/progenitor cell is still questionable and controversial (Solar et al. 2009; Kopp et al. 2011; 
Cavelti-Weder et al. 2013), various sources of islet neogenesis were proposed.  
 
In young adult rats, when 90% of the pancreas is resected, a significant regeneration of both 
endocrine and exocrine pancreas occurs (Bonner-Weir et al. 1993a; Hayashi et al. 2003). In this 
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model, replication of pre-existing and contributions from beta cell neogenesis from ductal 
epithelium were also observed to a lesser extent. However, the signals that trigger the replication 
capacity of the pre-existing beta cells in this model are not well understood. Blaschuk et al. 
(1983) showed that a cell aggregating factor, clusterin, is highly expressed in the pancreatic 
regenerating tissues of this rat model, suggesting an important role for  clusterin in regulation of 
neogenesis in the pancreas (Min et al. 2003).  
 
Waguri et al. (1997) also established a transient diabetic mouse model by selectively perfusing 
the body and tail of the pancreas with alloxan. Following alloxan perfusion, proliferation and 
differentiation of islet cells were observed in the pancreas. Similarly, Peters et al. (2000) detected 
beta cell regeneration occurring by two mechanisms: replication of pre-existing beta cells in non-
alloxan perfused parts and neogenesis from duct cells in beta cell-depleted parts of the pancreas. 
Regeneration of beta cell is also observed in streptozotocin (STZ)-treated neonatal rats (Bonner-
Weir et al. 1981; Cantenys et al. 1981; Wang, Bouwens & Kloppel 1996). In these neonatal STZ-
treated rats, Ngn3 was upregulated, though with contradicting expression patterns i.e. islet cells 
or duct cells. The general conclusion was that these cells differentiated from duct epithelial 
precursor cells.  
 
Further supporting evidence came from studies of transgenic mice, in which interferon gamma 
(IFN- γ) transgene expression was driven by an insulin promoter (Gu, Sarvetnick 1993). IFN- γ 
expression in islets induced tissue destruction, similar to a pancreatic duct ligation model. This 
destruction consequently resulted in islet neogenesis from the duct epithelium from which new 
islets budded off. Similar results were obtained in the pancreas of transgenic mice over-
expressing two growth factors, gastrin and Tgf-α (Wang et al. 1993), where beta cell neogenesis 
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was observed in the ductular epithelium expressing Pdx1 (Gu, Sarvetnick 1993; Wang et al. 
1993). In adult hamsters, wrapping the head of the pancreas with cellophane for 8 weeks also 
induced increase in islet cell mass by 2.5-fold (Rosenberg, Brown & Duguid 1983). Similarly, a 
noticeable increase in endocrine cell volume as well as ductal cell proliferation was observed in 
cellophane wrapped head of Velvet monkey pancreas (Wolfe-Coote et al. 1998). In addition, 
temporarily squeezing the pancreatic main duct for 60 seconds, induced Ngn3 expression in 
Wistar rats, suggesting that signals that promote generation of duct and endocrine cells seem to 
be transmitted rapidly (Ferris, Woodroof 2005)  
 
Evidence from rodent models of duct ligation has provided additional support on pancreas 
regeneration after injury. Many published reports show that injury caused by partial ligation of 
the pancreatic duct (PDL) induces rapid generation of new islets in the post-ligated pancreas. In 
earlier studies of adult PDL rat models by Hultquist et al., (1979), and later by Wang et al., ( 
(1995), destruction of exocrine tissue in the post-ligated portion of the pancreas by duct 
occlusion induced rapid regeneration of exocrine acini by ductular structures and neogenesis of 
islet cells in the post-ligated portion while the unligated portion remained intact. When these rats 
were injected with bromodeoxyuridine (BrdU), double increase of BrdU-positive beta cell 
populations, located near ducts, were observed within the first week after ligation suggesting that 
these cells differentiated from precursors located within the ductal epithelium and not from pre-
existing beta cells (Wang, Kloppel & Bouwens 1995; Xu et al. 2008a). Confirming beta cell 
neogenesis from ducts in this model, the new cells were found to express Ngn3. The general 
conclusion was that beta cell neogenesis from exocrine duct cells is the major mechanism of 
regeneration. In a separate experiment, intermediate cells, which co-expressed insulin and 
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amylase granules, were observed a day after duct occlusion, indicating neogenesis of beta cells 
from acinar cells (Bertelli, Bendayan 1997). 
 
In summary, it appears that one major and dominant mechanism to regenerate insulin-producing 
cells, under injured and physiological conditions, is by replication of the pre-existing beta cells 
(Fig. 1.5) (Dor 2006; Brennand, Huangfu & Melton 2007). However, when special types of 
injuries are applied, beta cell neogenesis is also activated amidst controversy about the origin of 
these new cells. Some studies suggest that these cells arise from duct epithelium (Xu et al. 
2008a; Collombat et al. 2009; Collombat et al. 2010; Lee et al. 2010), while others suggest that 
intra-islet progenitors as well as centroacinar cells are sites of islet neogenesis (Fernandes et al. 
1997; Guz, Nasir & Teitelman 2001; De Haro-Hernandez, Cabrera-Munoz & Mendez 2004; Liu 
et al. 2010; Tchokonte-Nana 2011a). However, although most studies report of beta cell 
neogenesis from duct epithelium, these ductal precursors have not been fully characterized.  
 
Firstly, some studies indicate that the adult pancreas contain a pool of duct-lining precursor cells 
that have the capacity to differentiate into endocrine cells and give rise to functional beta-cells 
(Bonner-Weir, Sharma 2002; Li et al. 2002; Hayashi et al. 2003; Xu et al. 2008a; Inada et al. 
2008; Collombat et al. 2009; Liu et al. 2010), while others suggest that all duct cells are 
precursors which can be reactivated upon stimulus by specific regulatory factors. 
 
 Secondly, even though the general conclusion from most of the animal models of pancreas 
injury discussed above, indicates that beta cells are regenerated by neogenesis from precursor 
cells, the mechanism to regenerate either by neogenesis, or by replication of pre-existing beta 
cells, seem to depend on the type of injuries applied. In uninjured mice, more evidence support 
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the replication of pre-existing beta cells (Dor et al. 2004; Dor 2006). Similarly, in partial 
pancreatectomy, no evidence of beta cell neogenesis was observed (Dor et al. 2004; Lardon, 
Bouwens 2005; reviewed by Bonner-Weir, Weir 2005b). Lee et al. (2006) also failed to find 
Ngn3 (marker of precursor cells) expressing cells in pancreas following partial pancreatectomy. 
Nevertheless, these studies did not examine the specific regions of the pancreas damaged during 
surgery, where neogenesis might have occurred (Sharma et al. 1999).  
 
Thirdly, the severity and type of injuries applied to these animal models differed between 
studies. It is logical to validate conclusions from these studies with evidence from genetic-
lineage-tracing techniques and in vitro studies. Despite controversial results from these in-vivo 
studies, it is possible that beta cell neogenesis can be induced in vitro. For example, when 
isolated human duct cells are cultured with Ngn3, low levels of islet-specific genes, including 
insulin, are expressed (Heremans et al. 2002; Gasa et al. 2004). Similar results were obtained 
when signals from fetal pancreas were applied on cultured human duct cells (Hao et al. 2006) 
and cultured rat duct cells (Dudek et al. 1991), suggesting that beta cell neogenesis can be 
reactivated in adult pancreatic ducts, similar to what is observed in an embryo (Piper et al. 2004; 
Pierreux et al. 2006). Additional evidence on beta cell neogenesis from exocrine tissue came 
from a study that combined in vitro culture with genetic-lineage tracing experiments (Minami et 
al. 2005). Results from this study demonstrated that adult acinar cells could be induced to 
transdifferentiate into a beta cell fate, consistent with results from independent work of Means et 
al. (2005).  
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1.4.1.2 Factors regulating beta cell neogenesis during regeneration 
Factors regulating neogenesis from duct epithelium, however, are largely unknown. It is possible 
that more than one factor, (extrinsic and intrinsic) acting in a sequence similar to the events that 
occur during fetal development, are required for beta cell neogenesis in an adult. The mechanism 
of action for such a complex regulatory pathway in adulthood is unknown.   
 
In a study by Xu et al. (1999), it was demonstrated that exendin-4, an analog of glucagon-like-
protein 1 (GLP-1) increased islet cell mass in adult animals subjected to subtotal (90%) 
pancreatectomy. Similarly, Hui et al. (2001) demonstrated that GLP-1 treatment induced 
neogenesis of islets in Wistar rats. A more recent study demonstrated that Survivin (Birc5), an 
inhibitor of apoptosis protein (IAP) gene family, is required for beta cell mass expansion in adult 
mice subjected to duct ligation (Wu et al. 2012).  
 
Another factor associated with islet neogenesis is a MSC-derived hepatocyte growth factor (HGF 
that induces cell proliferation, cell motility, and morphogenesis in many cell types.  Hepatocyte 
growth factor and its receptor c-met are expressed in the islet cells of many species. In vitro, 
infusion of HGF in the human fetal and adult pancreatic beta cells stimulates proliferation and 
promotes insulin secretion (Otonkoski et al. 1994; Otonkoski, Mally & Hayek 1994; Hayek et al. 
1995; Otonkoski et al. 1996). In genetically engineered mice, in which HGF is expressed under 
the rat insulin II promoter (RIP-HGF), over-expression of this transgene resulted in an increase 
in beta cell mass (Garcia-Ocana et al. 2000; Nakano et al. 2000).  Transgenic RIP-HGF mice 
present with plasma glucose levels that are lower than their normal littermates and have higher 
fluctuating levels of insulin. In an in- vivo study, Nakanobet al. (2000) showed that intra-
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peritoneal administration of HGF ameliorated hyperglycemia in diabetic mice transplanted with 
small numbers of pancreatic islets. Later, the importance of HGF/c-met signaling pathway in 
regulation of islet growth and function was shown in conditional ablation of c-met in beta cells 
(Dai et al. 2005).  In this study, conditional ablation of c-met resulted into hypoplastic islets, low 
levels of insulin, and impaired glucose tolerance. These studies, therefore suggest that extrinsic 
factors from the stimulated surrounding tissue can induce beta cell neogenesis in these animal 
models. 
 
Regenerating genes (Reg) have also been identified in partial pancreatectomy mouse models 
through a differentiatial cDNA screen on regenerative pancreas (Terazono et al. 1988; Unno et 
al. 1992). When Reg genes were cloned both in vivo and in vitro, beta cell growth was promoted 
(Watanabe et al. 1994). In cultures of human fetal islet cells, high levels of Reg proteins were 
detected in proliferating beta cells and low levels were found in mature beta cells (Otonkoski, 
Mally & Hayek 1994)  suggesting an important role of Reg proteins in proliferation of beta cells. 
In cellophane wrapping and STZ-treated animal models, Islet neogenesis-associated protein-
pentadecapeptide (INGAP-PP) were shown to be expressed in proliferating and subsequent 
differentiating islet cells from ducts (Rafaeloff et al. 1997; Rosenberg et al. 2004), suggesting 
that these proteins might be involved in neogenesis of islet cells from ducts during regeneration 
of the pancreas in this model. 
Other hormones and beta cell neogenesis: Gastrin and its receptors are largely produced by G-
cells of the gastric mucosa. However smaller amounts are also detected in the fetal pancreas 
during islet neogenesis. In a duct ligated rat model, gastrin is expressed in the ductal complexes 
of pancreas of the post-ligated tail pancreas (Wang et al. 1993). In a separate study, gastrin 
infusion stimulated proliferation of acinar cells, ductal cells and enhanced beta cell neogenesis 
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from exocrine pancreas, suggesting that gastrin is an additional factor that can promote duct 
ligation-induced islet neogenesis (Rooman et al. 2001, Rooman; Lardon & Bouwens 2002; 
Rooman, Bouwens 2004). In alloxan-treated mice, gastrin induced islet regeneration in pancreas 
when combined with EGF (Rooman, Bouwens 2004; Song et al. 2015). In double-transgenic 
mice established by Wang et al. (1993), it was shown that over-expression of gastrin and TGF-α   
stimulated beta cell differentiation from duct epithelium.  
 
Growth factor, betacellulin (BTC), was found to induce beta cell replication and neogenesis that 
ameliorated glucose intolerance in alloxan- induced diabetic mice (Yamamoto et al. 2000).  In 
vitro, BTC, acting in coordination with activin, stimulated differentiation of AR42J cells into 
insulin producing cells (Yamada, Kojima 2005; Halban et al. 2010). Similar roles of BTC in 
promoting beta cell regeneration acting through multiple steps to in combination with activin 
were reported in vivo, suggesting BTC as an effective treatment for diabetes (Yamada, Kojima 
2005) 
    
Nicotinamide (NIC), also known as niacinamide or nicotinic acid amide, is an amide of nicotinic 
acid or vitamin B3 and an inhibitor of poly (adenosinediphosphateribose) synthetase/polymerase 
that ameliorated glucose intolerance in STZ- and alloxan-induced diabetic animals by 
stimulating proliferation and differentiation of endocrine cells (Fig. 1.5) (Yamamoto, Uchigata & 
Okamoto 1981). In fetal pancreatic cells, NIC stimulated endocrine differentiation (Otonkoski et 
al. 1997). 
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1.4.1.3 Beta celll replacement therapy 
In addition to islet transplantation, which is limited by shortage of donors, immune rejection, and 
the need for life-long immuno-suppression, research has intensified to find other alternative beta 
cell sources in order to efficiently treat the consequences of type 1 and type 2 diabetes mellitus 
such as: expansion of pre-existing beta cells, differentiation of embryonic stem cells into beta 
cells and transdifferentiation from non beta cells (Desgraz, Bonal & Herrera 2011; Guo et al. 
2013). The use of embryonic stem cells (ESC), induced pluripotent stem cells (iPSC), adult 
pancreatic stem cells and non-pancreatic adult cells has been identified as an attractive strategy 
for the differentiation and expansion of insulin producing cells in vitro to obtain a large number 
of beta cells for transplantation in diabetic patients, reviewed in Desgraz, Bonal & Herrera 2011. 
 
(i) Differentiation of insulin producing cells from adult pancreatic stem cells 
The presence and location of adult pancreatic stem cells is still under intense investigation. Two 
populations of stem/progenitor have been identified: (1) intra-islet stem/progenitor cells ( 
Ramiya et al. 2000; Liu et al. 2010) and (2) the pancreatic ductal epithelial cells expressing 
cytokeratin 19 (CK19) and Pdx1 (Ramiya et al. 2000; Liu et al. 2010) that can potentially 
differentiate into endocrine cells. 
Intra-islet stem cells: Precursors of beta cells have been identified within the pancreatic islets 
that express a neural stem cell marker, nestin. Nestin is an intermediate filament that is also 
detected in vascular endothelium and pancreatic stellate cells (Lardon, Rooman & Bouwens 
2002, Klein et al. 2003). When these multipotential cells were isolated and cultured in a media 
favouring neural stem cell proliferation, they differentiated into cells expressing hepatic markers, 
pancreatic exocrine and endocrine genes (Zulewski et al. 2001). Data from this study suggested 
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that nestin-positive cells might be involved in islet neogenesis. A similar result was reported 
where cultured nestin expressing cells from adult mouse pancreas gave rise to neural and 
pancreatic lineages (Seaberg et al. 2004). However, lineage-tracing studies refuted these 
conclusions. On the contrary, a study on early human pancreatic development showed that nestin 
is not expressed in endocrine progenitor cells (Piper et al. 2002). This was supported by 
additional evidence from “pulse” and “chase” experiments in mice, which showed that nestin 
positive cells are not pancreatic islet cells progenitors (Treutelaar et al. 2003; Delacour et al. 
2004).  
Pancreatic ductal epithelial stem/progenitor cells: In many studies, new beta cells have been 
generated in vitro from cultured pancreatic duct cells amid debate about the origin and identity of 
these stem cells in adult pancreas (Ramiya et al. 2000; Bonner-Weir et al. 2000; Yao et al. 2004; 
Suarez-Pinzon et al. 2005; Hao et al. 2006). Epithelial cells, isolated from the pancreatic duct of 
prediabetic non-obese diabetic (NOD) mice, generated the first new islet cells in vitro (Ramiya et 
al. 2000). Cultured cells from these studies formed islet-like structures that expressed insulin and 
glucagon in levels that could reverse hyperglycemia in STZ-induced diabetic mice.   
 
Bonner-Weir et al. (2000) also generated in vitro islet cells from human pancreatic duct cells 
when mixed with cells derived from non-endocrine fractions after human islet isolation. When 
cultured in Matrigel and supplemented with nicotinamide, the expanded monolayer culture cells 
were able to differentiate into three-dimensional cysts from which the islet cells budded off. 
However, the islet-like cells from these cultures expressed lower levels of insulin gene (5%) than 
the one detected in isolated pure islets, but they were able to release insulin in response to 
glucose.  
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In some studies, human pancreatic ductal cells differentiated into beta cells when co-transplanted 
with human fetal pancreatic tissues (Yao et al. 2004; Hao et al. 2006). In addition to 
nicotinamide, a combination of growth factors such as epidermal growth factor (EGF) and 
gastrin stimulated neogenesis of islets in rodents (Wang et al. 1993; Rooman, Lardon & 
Bouwens 2002). Similar results were obtained by Suarez-Pinzon et al. (2005) when both factors 
were supplemented on cultured human adult islet cells. The general conclusion from these 
studies suggested that increase in beta cell mass resulted from beta cell neogenesis from ducts 
rather than from replication of mature differentiated beta cells from islets. Ectopic expression of 
Ngn3 in human ductal cells triggered endocrine neogenesis from ducts cells (Heremans et al. 
2002).  
Nevertheless, findings from these studies suggest that generating functional beta cells from 
pancreatic cells within the adult organ other than from other possible sources is a possible 
therapeutic option to prevent the side effects of immunosuppressive agents. Identification and 
characterization of cell types that express Pdx1 and Ngn3 might provide as a possible source of 
precursor cells of all islet cell types (Jensen et al. 2000a; Wilson, Scheel & German 2003). 
 
 
 
(ii) Transdifferentiation of adult pancreatic cell types 
Transdifferentiation of various pancreatic cell types has been reported in several studies using 
animal models (Beattie et al. 1999; Rooman, Lardon & Bouwens 2002; Lardon et al. 2004; 
Baeyens et al. 2005 ). In animal models of pancreatic duct occlusion, adult acinar cells were 
capable of transdifferentiating into ductal epithelial cells when stimulated by gastrin (Rooman, 
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Lardon & Bouwens 2002). Similar results were obtained in vitro (Lardon et al. 2004). After 
stimulation with specific growth factors, both in vivo and in vitro,  these pancreatic ductal cells 
transdifferentiated and gave rise to new islets (Rooman, Lardon & Bouwens 2002; Baeyens et al. 
2005). On the other hand, other studies have reported de-differentiation of islet cells into a more 
primitive proliferative epithelial phenotype.  
 
In vitro, human islet cells transdifferentiated into precursor-like cells that expressed Pdx-1/Ipf-1 
suggesting that these cells were still not fully differentiated (Beattie et al. 1999). Similarly, a 
study by Gershengorn et al. (2004) reported a transdifferentiation of human islet cells, through 
epithelial-mesenchyme transition, into fibroblastoid cells. Upon expansion, these cells formed 
back aggregates of islet cells that expressed low levels of endocrine genes. When supplemented 
with betacellulin, adult human islet cells expanded and re-differentiated into beta cells (Ouziel-
Yahalom et al. 2006). However, a lineage-tracing study by Chase et al. (2007) challenged the 
results of the  above two studies, and conclusively showed that the fibroblast-like cells were 
derived from  mesenchyme stem cells and not from endocrine cells (Chase et al. 2007; 
Tchokonte-Nana 2011). 
Centroacinar/terminal duct (CA/TD) cells: The question of whether centroacinar and terminal 
duct cells can be sources of new beta cells in experimental injured pancreas has been suggested 
by some studies (Tchokonte-Nana 2011). However, these pancreatic cells are not fully 
investigated and their molecular characteristics not well defined (Leeson, Leeson 1986; Pour 
1994). Few studies of pancreatic injury models reported of proliferation of centroacinar cells 
after injury such as in pancreatectomy, or treatment with caerulein or Streptozotocin (STZ) 
(Gasslander et al. 1991; Hayashi et al. 2003; Nagasao et al. 2003). However, these cells were not 
clearly characterized in these studies. Only seven years ago were these cells characterized by 
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immunhistochemistry and were found to express high levels of class 1 aldehyde dehydrogenase 
(ALDH1) enzymatic activity (Rovira et al. 2010) which allowed their isolation and 
characterization by fluorescence-activated cell sorter (FACS). In vitro, the same study 
demonstrated that CA/TD cells were able to differentiate into endocrine and exocrine cell types.  
In addition, in caerulein-induced pancreatitis, ALDH1+ CA/TD cells increased their cell mass, 
when compared to normal duct cells as controls suggesting clearly that CA/TD cells possess 
characteristics of progenitor cells (Rovira et al. 2010). Similarly, a lineage tracing study of 
Bmi1+ cells identified a subpopulation of acinar-derived cells that were self-renewing and were 
able to maintain homeostasis of the pancreas (Sangiorgi, Capecchi 2009). As previously 
suggested (Hayashi et al. 2003; Nagasao et al. 2003; Tchokonte-Nana 2011) these cells need 
further exploration to ascertain whether CA/TD cells are able to contribute to the regeneration of 
the endocrine pancreas. 
(iii) Differentiation of beta cells from embryonic stem cells (ESCs) 
In the last two decades, research has focused towards  developing efficient protocols to 
differentiate human embryonic stem cells (ESCs) into insulin secreting cells because these cells 
have high proliferation, self-renewal and regulated differentiation capacity. Diffrentiation of 
insulin beta cells from mouse ESCs were first reported (Lumelsky et al. 2001). However, these 
cells secreted low levels of insulin in response to glucose and were not regarded as true beta 
cells.  
 
Five years later, D’Amour and his group developed a protocol  that used Wint  and Tgf-βs 
signaling pathways and growth factors such as activin A, Fgf10 and RA,  to differentiate, with 
high efficiency, hESCs into definitive endodermal cells that expressed Sox 17, Brachyury 
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protein, CXC-kemokine receptor type 4 and Cerberus (Chen et al. 2004; D'Amour et al. 2006, 
Zorn, Wells 2009) which later differentiated into pancreatic lineage expressing Pdx1. Similar 
protocols were published that used RA and inhibitors of Shh and BMP to induce pancreatic 
lineage, recapitulating the in vivo signaling pathway that specifies the pancreas during 
development (Kroon et al. 2008a; Mfopou et al. 2010a; Nostro et al. 2011; Xu, Browning & 
Odorico 2011; Rezania et al. 2012). These in vitro generated progenitors expressed Pdx1, Sox9, 
Nkx6.1 and Ptf1α , and were able to differentiate into endocrine, acinar and ducts when 
engrafted into mice (Kroon et al. 2008b; Kelly et al. 2011; Rezania et al. 2012; Schulz et al. 
2012; Xie et al. 2013). However, the therapeutic option of these progenitors has not been tested 
in humans because of risk of teratoma development (Wakitani et al. 2003) and stringent ethical 
issues to be followed when procuring these cells (Fischbach, Fischbach 2004).  
  
Interestingly, some reports showed that many in vitro studies have generated immature beta cells 
from embryonic stem cells (Guo, Hebrok 2009; Mfopou et al. 2010b). Embryonic stem cell-
derived beta cells produced under culture conditions secret low levels of insulin, respond very 
little to glucose stimulation and express more than one hormone in the same cell (D'Amour et al. 
2006;  Jiang et al. 2007), suggesting that these cells are still not fully differentiated. One possible 
explanation for such results is that many laboratories use protocols (culture conditions) that do 
not mimic the cellular environment in vivo, that require intercellular interactions between MSCs, 
endothelial and epithelial cells of the pancreatic bud similar to what occurs during organogenesis 
of the pancreas. During pancreas organogenesis, different cells from all three embryonic germ 
layers interact and respond to reciprocal inductive signals that direct cell specificity and fate 
(Kim, Hebrok & Melton 1997; Wells, Melton 2000; Lammert, Cleaver & Melton 2001; Lammert 
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et al. 2003; reviewed in Cleaver, Melton 2003). Such components are not supplied in the 
majority of hESC differentiation protocols. 
 
Furthermore, most in vitro differentiation protocols grow cells in two-dimensional cultures as 
monolayers (Segev et al. 2004). Such protocols do not mimic the three-dimensional interactions 
between islet, epithelial and mesenchyme cells as they occur in vivo. Thus, the efficiency of beta 
cell specification and maturation can be enhanced by developing co-culture systems that include 
pancreatic mesenchyme or endothelial cells in the cultures (Guo, Hebrok 2009; Sneddon, 
Borowiak & Melton 2012). In such cultures, inclusion of pancreatic MSCs and/or endothelial 
cells might provide additional soluble factors necessary for the proliferation and functional 
maturation of islet cells (Guo et al. 2013). Pancreatic islets consist of many cell types such as 
endocrine cells, neuronal cells, and vascular endothelial cells that form a complex interactive 
structure. The inductive cellular interactions that occur between endothelial cells, endocrine and 
other non-endocrine cells, play important roles for insulin sensing and secretion (Hauge-Evans et 
al. 1999; Ballian, Brunicardi 2007; Pierreux et al. 2010; Magenheim et al. 2011b; Shih, Wang & 
Sander 2013). But, addition of extracellular matrix, in vitro, promotes beta cell aggregation and 
angiogenesis (Hoeben et al. 2004) and may promote β -cell physiology when transplanted into 
diabetic patients. 
1.5  Research question 
Over the past decades, research has attempted to identify dedicated adult pancreatic progenitor 
cells and direct differentiation of these embryonic-like stem cells, with the aim of producing 
insulin secreting beta cells for use in the treatment of diabetes mellitus. The intrinsic molecular 
mechanisms that specify pancreatic beta cells have been the primary focus of such research. 
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Extrinsic factors, however, are also necessary for beta cell neogenesis in vivo. The lack of a  
better understanding of how extrinsic factors from tissues surrounding islets induce in vitro beta 
cell differentiation has been a hindrance in advancing in vivo differentiation studies.  
In pancreatic injury models, injury to the pancreas by occlusion/ligation (PDL) of the main duct 
induces neoformation of small beta cell clusters - expressing Ngn3, an earliest islet-specific 
transcription factor in embryonic development - with increase in associated numbers of beta cells 
in the post-ligated tail pancreas (Wang, Kloppel & Bouwens1995; Page et al. 2004; Xu et al. 
2008a; Inada et al. 2008; Murtaugh, Kopinke 2008; Solar et al. 2009). In addition, MSC tissue 
and ductal structures proliferate and come into close contact with islet cells in the post PDL 
(PPDL) tail pancreas. Such small clusters of islet cells, located close to ductal structures, later 
migrate and become interspaced within the enlarged fibrous septa and adipose tissue (Xu et al. 
2008a; Tchokonte-Nana 2011; Chintinne et al. 2012).  
Furthermore, several other pancreatic injury models have reported of proliferation of MSCs in 
adult pancreas, besides islet regeneration (Xu et al. 2008a; Tchokonte-Nana 2011). Whether the 
MSCs-ductal epithelial and/or pre-exisiting islet cells interactions play any important role in 
signaling for increased beta cell mass during these conditions of injury has not yet been reported. 
It is also not clear whether they play a role in the normal healthy adult pancreas where many 
studies report beta cell mass increase by replication of pre-existing cells rather than neogenesis 
(Dor et al. 2004;Teta et al. 2005; Teta et al. 2007). In these pancreatic injury models, cellular 
interactions between the newly formed beta cells and the surrounding tissue may play a crucial 
role in proliferation and differentiation of beta cells similar to what is observed during embryonic 
pancreatic development (Pictet et al. 1972). In this regard, a study on the lineage-specific 
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morphogenesis in normal pancreas postulated the importance of epithelial-MSCs interactions 
(Gittes 2009).  
The importance of signals from the pancreatic MSC tissue have been shown to direct a pancreas-
specific fate in the chick (Kramer et al. 1987). Signals from the MSCs may direct epithelial duct 
cells or pre-existing slet cells toward a beta-cell neogenesis or may be required for the 
maintaince of specification or to direct proper timing of differentiation, proliferation, or 
migration of beta cells. In fetal rats, intestinal MSCs when combined with endodermal cells 
induced the differentiation of the main epithelial cell types including endocrine cells (Kedinger 
et al. 1986), suggesting an important role MSCs plays in differentiation of endocrine cells. The 
possibility that MSCs underlying the pancreatic islet may be responsible for beta cell neogenesis 
in PDL model is based on evidence from studies on fetal rats and chick embryos (Haffen et al. 
1983; Kedinger et al. 1986; Yasugi 1993). In these studies, endocrine cells were generated from 
epithelial cells found in places where endocrine cells are not normally found (Haffen et al. 1983; 
Kedinger et al. 1986; Yasugi 1993). Earlier studies by Yasugi (1993) found glucagon cells in 
avian allantoic epithelium associated with intestinal or pancreatic MSCs while Haffen et al. 
(Haffen et al. 1983), noticed endocrine cells in gizzard epithelium associated with intestinal 
MSCs. Recently, Tchokonte-Nana (2011), observed fibroblast mitotic cells in the early hour of 
PPDL, suggesting that MSCs replication precedes endocrine formation (Puri, Hebrok 2010) an 
implication of the requirement of an early extracellular signaling pathway in endocrine cell fate 
specification. 
Futhermore, islet transplantation has therapeutic potential to restore normoglycemia in type I 
diabetes (Shapiro et al. 2000; Ryan et al. 2001). Although, it represents a less invasive approach 
for beta cell replacement compared to whole pancreas transplantation, patients still experience a 
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decline in islet cell survival during the post transplantation period, despite the use of 
glucocorticoid-free immunosuppressive agents to minimize tissue rejection (Shapiro et al. 2000). 
In rodent models of pancreatic injury, regeneration of the pancreas has been reported to be a 
potential source of islet cells for tissue replacement therapy in type 1 diabetes mellitus. Earlier 
transplantation studies that used adult post pancreatic duct ligation (PDL) tail pancreas as donor 
tissue isolated 84 hrs post ligation, found that post PDL-tissue has the same efficacy as fetal islet 
cells after transplantation (Page et al. 2004). However, the graft survival was not sustained in 
recipient animals with only 40% of the treated animals achieving a short-term normoglycemia. 
Later studies conducted by the same laboratory examined the morphochronobiology of post PDL 
pancreas tissues and observed maximum exocrine tissue destruction at 72 and 84 h following 
ligation (Tchokonte-Nana 2011). These times correspond to the period when donor tissue was 
harvested in the study by Page et al. (2004). This may suggest that destruction observed in PDL 
tissues have contributed to the graft failure.  Because of this, Du toit and co-workers (du Toit et 
al. 2013) proposed that an early transplantation time of 12 – 24 h post PDL tissue could sustain 
isograft function and survival. 
1.5.1 Hypothesis 
The interaction between the pre-existing islet and/or duct cells and MSCs in the duct-ligated 
pancreas induces beta cell neogenesis, and can revert diabetes mellitus when transplanted early.   
1.6 Aims and objectives of the study 
1.6.1 Aims : 
• To investigate whether culturing PDL activated-islet cells with pancreas–derived MSCs 
induces islet cell neogenesis, increase beta cell number and function in vitro. 
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• To investigate whether early transplantation of the in vitro co-cultured PDL-induced islet 
cells with MSCs affects the transplantation outcome in STZ-induced diabetic rats.  
1.6.1.1 Objectives 
• To isolate and characterise islet cells and MSCs for culture from PDL and sham operated 
control (SOC) rat pancreas using collagenase enzyme. 
•  To co-culture isolated islets and MSCs from PDL and sham operated control (SOC) 
tissues to determine the effect of islet-MSCs interaction on beta cell neogenesis.  
• To determine the expression patterns of Pdx1, Ngn3, with insulin in cultured islet cells 
using immunocytochemistry (ICC) and immunohistochemistry (IHC). 
• To isolate and characterize pancreatic duct fragments using collagenase enzymes from 
PDL and sham operated control (SOC) rat pancreas for co-culture. 
• To co-culture isolated pancreatic duct fragments and MSCs from PDL and sham operated 
control (SOC) tissues to determine the effect of duct-MSCs interaction on beta cell 
neogenesis. 
• To determine the expression of CK7, Ngn3 and insulin in cultured duct cells to 
investigate the effect of MSC-pancreatic duct fragments on beta cell neogenesis.  
• To transplant islets and MSCs in streptozotocin (STZ)- induced diabetic rats and assess 
the blood glucose profile of diabetic and non-diabetic rats before and after transplantation 
of islet cells isolated 24-hr and 84 hr following ligation. 
• To determine the expression patterns of insulin and proliferation marker, Ki67, in 
isografts of diabetic and non-diabetic rats by immunohistochemical method.  
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Chapter 2    Materials and methods 
2.1  Ethical issues  
The Ethics clearance was obtained from the Stellenbosch University Animal Ethics Committee:  
ethics number SU-ACUM13-00036. This study complied with the guiding principles laid down 
by animal welfare organization and the society for the prevention of cruelty to animals (SPCA), 
and all the recommendations of the declaration therein, as well as, the accepted standards for the 
use of animals for research and teaching as reflected in the South African National Standards 
10386: 2008, and supervised by qualified veterinarian.   
2.2  Choice of laboratory animals 
Rodent models have been used in research for decades to study human diseases because of the 
similarities in morphological, physiological, molecular, genetic and pathological events that take 
place in the pancreas between humans and rodents.  In this study, rats (Rattus norvegicus) were 
used because of the following reasons: (i) they breed fast and are readily available as inbred lines 
at Stellenbosch animal unit and (ii) they have larger pancreas than mice (Mus musculus), making 
it easier to have access to the pancreatic duct for ligation. 
2.2.1 Housing and Caging 
A total of 220 animals were housed in clean laboratory rodent cages. Ten animals were housed in 
each cage. After surgery, each cage contained one post–surgery animal. All post-surgery animals 
were kept under a 60 watt lamp necessary for quick recovery and to encounter hypothermia. All 
animals were kept in a thermally controlled envirnment and had free access to water, and 
standard pelleted rat chow (Epol. Midrand , RSA) throughout the experiments.   
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2.2.2 Experimantal design 
A total of 220 randomly selected adult healthy male Wistar rats were obtained from the Animal 
Unit of the Faculty of Medicine and Health Sciences, University of Stellenbosch. The rats were 
weighed and divided into two main groups: (i) Cell culture group (n = 80) and (ii) Islet 
transplantation group (n = 140) (Fig 2.1).   
2.2.2.1 The cell culture group 
In this group, 80 animals were randomly distributed equally into two experimental groups and 
two control groups.  The experimental groups were composed of 24 h post pancreatic duct 
ligation (PPDL) and 120 h PPDL. The choice of post-PDL times of 24- and 120 h is based on 
evidence from previous studies by Tchokonte-Nana (2011) that chronologically documented the 
cellular mechanisms in a post PDL pancreas and reported that a high peak of exocrine 
destruction occurs at 72 h. The remodeling of these cells following a pancreatic duct ligation 
were observed from 84 h and reaching a healthy state at 120 h. In addition, a recent study 
showed that optimal efficiency of the co-expression of endocrine developmental genes with 
insulin occurs at 24 h after pancreatic duct ligation (du Toit et al. 2015).  To test this, the 
pancreatic duct of the animals was ligated (PDL) or sham operated, and the post pancreatic 
ligated (PPDL) tissue portions were removed at 24 h and 120 h prior to cell isolation and culture. 
Islet from sham operated portion of the pancreas served as control (SOC) to the islet from the 
PPDL tissue portions at the corresponding time periods.  
2.2.1.2 Islet transplantation animal groups 
A total of 140 animals were randomly distributed into three subgroups of  
Stellenbosch University  https://scholar.sun.ac.za
60 
(i) Donor islets (n = 80): these animals were further divided into 24 h PPDL (n = 40), 84 h 
PPDL (n = 20) and Normal group (n = 20). In the former groups (PPDL), animals 
underwent PDL, and islets were harvested at 24- and 84 h respectively, while in the later 
group (Normal/Control group) islets were harvested without PDL. All these islets from the 
three groups served as donor islets to recipient animals. 
(ii) STZ-diabetic recipients (n = 40): After chemically inducing diabetes in this group, the 
animals were randomly grouped as 24 h PPDL recipients (n = 20), 84 h PPDL recipients 
(n= 10) and normal islet recipients (n = 10) corresponding to the islet types of donors. The 
24 h PPDL recipients were further subdivided into Islet/MSC- recipients (n = 10) and 
Islet/MSC+ (n = 10), depending on whether islet cells were combined with mesenchymal 
cells (MSCs) or not.  
(iii) Control animals (n=20): These animals were randomly divided into 2 equal groups where 
diabetes was induced in one group (n = 10), while the other group was untreated. Both 
groups did not receive islet transplantation and served as controls to recipient animals. 
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2.3 Experimental Procedures 
2.3.1  Pancreatic duct ligation in experimental group 
All pancreatic duct ligation (PDL) procedures were done in the fully equipped animal theater at 
Stellenbosch University Central Animal Unit, Tygerberg campus. On the evening prior to PDL 
surgery, animals were weighed (250-350 g) and housed in a clean cages placed in thermally 
controlled temperature with free access to water but not food to put them in a fasting condition 
before surgery.   
Figure 2.1. A
nim
al sam
ples used in this  study. PPD
L = post pancreatic duct 
ligation; SO
C = sham
 operated Control. 
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On the day of PDL surgery, animals were anaesthetized with 5% halothane (Isofor) (Safeline 
pharmaceuticals (PTY) LTD Roodepoort, South Africa) vaporized in O2. Complete anaesthesia 
was verified by pinching the foot and the tail to make sure that there no spontaneous movements 
or withdrawal responses. Thereafter, the animal was carefully transferred to the surgical table 
workstation under a dissecting microscope. Before opening the abdomen, animals under 
anaesthesia were placed in supine position  and the abdominal fur (1 cm form each side of the 
linea alba) was shaved using an electric shaver and the skin was then cleaned with providone-
iodine solution containing antiseptic betadine (10 mg/mL) (Adcock Ingram Pharmaceuticals, 
Industria, Johannesburg, RSA). 
 
After pinching the abdominal skin and foot again, an initial laparotomy incision of about 2 cm 
was made at the linea alba of the anterior abdominal wall cutting through the epidermis, dermis 
and the underlying peritoneal membrane  and the abdominal cavity was accessed. Care was taken 
to avoid cutting the internal organs. After opening the abdomen, the stomach and duodenum 
were pulled out using forceps and reflected superolaterally to expose the tail of the pancreas, 
which is attached to the spleen.  Cotton buds soaked in HBSS were used to prise the pancreas to 
identify the pancreatic splenic duct (i.e. duct to the splenic lobe of the pancreas). 
 
After identifying the confluence of the splenic and the common bile ducts, a single suture was 
made at about 1/3 distal to the junction to occlude the duct using a 5/0 Dexon polycaprolate 
coated braided polyglycolic acid re-absorbable suture material (Fig. 2.2) (Davis and Geck, 
Cyanamid, Hampshire, United Kingdom). Care was taken not to damage the blood vessels that 
run close to the splenic duct of the pancreas. 
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Figure 2.2. Picture of dissected rat pancreas, showing the point of ligation (red arrow) in 
the splenic lobe. 
 
Following ligation, post-PDL dehydration was prevented by introducing approximately 2 mL of 
warm saline solution in the abdominal cavity. The abdominal cavity was closed in two separate 
layers using resorbable 5/0 sterile white braided silicone treated polyester (Davis and Geck, 
Isando, South Africa) sutures soaked in saline solution. The peritoneum and abdominal muscles 
were sutured first, followed by the skin. To prevent infection, each animal was injected with 1 
mL of Baytril (Smith-Kline Beecham Pharmaceuticals, Midrand, South Africa) and 0.5 mg 
streptomycin (Novo-Strep 5g/15 mL, Novo Nordish (Pty) Ltd, Johannesburg, South Africa) 
under the skin of the abdomen in a single dose.  After swabbing the wound with an antiseptic rub 
(Beige Pharmaceuticals Pty. Ltd., Edenvale, South Africa) to minimize scratching, animals were 
returned to clean laboratory rodent cages. Directly after surgery and the following mornings, 
animals received an antibiotic Baytril (Bayer (PTY) LTD. Insando, South Africa) to prevent 
infection and a painkiller, Temgesic (Schering-Plough (PTY) LTD., Woodmead, South Africa). 
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To counter hypothermia, animals were placed under a 60-watt lamp necessary for rapid recovery. 
Temperature was controlled in the housing facility and animals had free access to water and 
standard rat chow (Epol, Midrand, South Africa) under the supervision of a qualified veterinarian 
until they were euthanized at designated time periods.  
2.3.2  Sham operation control group (SOC) 
In this group, a surgical procedure, similar to the ligation group in section 2.4.1, was followed 
except that the duct was not ligated. Animals were anaesthetized with 5% halothane vaporized in 
O2 and prepared for surgery. After laparotomy incision was made at the linea Alba of the anterior 
abdominal wall, the pancreas was just touched twice with a wet cotton swab without ligating the 
duct. The same post surgery treatment regimen was used, as described in section 2.4.1.1, to 
prevent infection and hypothermia.  
2.4 Tissue collection  
2.4.1 Pancreatic tissue harvest 
The day of tissue harvest corresponded to time periods 24- and 120 h post PDL (PPDL) in PDL 
group and an equivalent time period of 24- and 120 h post sham operation (SOC). All surgical 
procedures were carried out under asceptic conditions in the animal theater as follows. Animals 
were anesthetized with 5% halothane (Isofor) vaporized in O2 as previously described in section 
2.3.1.1. Complete anaesthesia was verified by pinching the foot and the tail to make sure that 
there are no spontaneous movements or withdrawal responses. Afterwords, the animal was 
carefully transferred to the surgical table workstation under a dissecting microscope. With the rat 
in supine position, the whole abdominal fur was wetted with 70% ethanol before opening the 
abdomen to avoid fur contaminating the exposed abdominal organs during subsequent steps. A 
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V-shaped incision was made using a standard pattern scissors, starting from the genital area to 
the most extreme lateral sides of the ribcage in order to expose all organs in the peritoneal cavity. 
The abdominal skin, muscles and peritoneum were then reflected over the ribcage to expose 
contents of the abdominal cavity. Using cotton swabs, the stomach and bowels were pulled to the 
left side of the rat to expose the pancreas. Following quick exsanguinations through excision of 
the heart using a sharp pointed pair of scissors, the duodenum, pancreas and spleen were 
dissected together a shown in Figure 2.2. Then, the pancreas was resected from all points of 
attachments. In order to attain a maximum yield of islets, the entire pancreas was removed first 
before excising the tail pancreas distal to the ligation point. For maximum collagenase enzyme 
activity, the resected tail portin of the pancreas was briefly rinsed  in cold Hank’s balanced saline 
solution (HBSS) (Life technologies) to remove any blood. Collagenase A (Sigma) was prepared 
at final concentration of 1.5 mg/mL in cold HBSS. Then each lobe of splenic portions of the 
pancreases distal to the point of ligature in the experimental animals or the pancreatic tail 
portions in the control animals were injected with 2 mLs (1.5 mg/mL) Collagenase A (Sigma) as 
shown in Figure 2.3.  
In experimental animals, the PPDL portion of the pancreas was resected and placed in a sterile 
15 mm- petri dish. In sham operated control (SOC) animals, a similar sized tail portion of the 
pancreas was also surgically resected. After 5 minutes, the pancreata were sliced into 2 mm 
pieces and quickly transferred into conical tubes containing 10 mLs of cold Collagenase A (1.5 
mg/mL in HBSS) ready for islet, ducts and mesenchymal cells isolation. The animals were then 
euthanized by cardiac puncture to allow excess bleeding and the carcasses disposed of in the cold 
room for incineration.   
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Figure 2.3. Picture shows inflation of the splenic portion of the dissected pancreas with 
collagenase enzyme. 
2.5 Tissue Culture 
2.5.1 Experiment 1:  Co-culture of PPDL islet cells with pancreas–derived MSCs 
Experiment 1 describes the methodology taken to isolate islets and MSCs, and co-culture in 
order to investigate whether PDL activated-pre-existing islet cells cultured with pancreas–
derived mesenchymal stromal cells (MSCs) induces islet cell neogenesis and increase in beta cell 
number and function.  
To assess whether MSCs induce de-differentiation in quiescent mature islet cells or de-
differentiated islet cells (Fig.2.4 A), we performed an in vitro experiment as shown in Fig 2.4 B.  
If MSCs stimulate replicating islet cells to serve as pancreatic progenitors after PDL, then we 
should see a loss of differentiated phenotype in mature endocrine cells and our less- 
differentiated endocrine precursor-like cells should originate and be continuous with re-
differentiong mature endocrine cells in our co-cultures in this study.  The  immunostaining (ICC) 
of the proliferating endocrine cells in co-cultures with MSCs should show the expression of Pdx-
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1 – the earliest known pancreas specification marker, and the expression of Ngn3 (a cell marker 
expressed in endocrine precursors). This will present a molecular profile similar to pancreatic 
progenitors, while the re-differentiating beta cells (insulin+ cells) which derived from these 
progenitor cells should follow a maturation pathway similar to that, which occurs during 
embryonic development. Therefore, the  immuno-expression of Pdx1 and Ngn3 on proliferating 
endocrine cells in co-cultures with MSCs served as a guide to ascertain the pathway of endocrine 
development as it occurs during embryonic development. 
                               
Figure 2.4. Experimental approach to test the hypothesis of MSCs as stimulants of beta cell 
neogenesis from pre-existing islet cells.  (A) Our hypothesis is that with MSCs stimulation, 
existing islet cells regress to a lesser differentiated phenotype and act as progenitors to form new 
islets. (B) Islets and mesenchymal cells were enzymatically isolated from PPDL pancreas and 
co-cultured. 
 
2.5.1.1  Pancreatic tissue digestion and washing   
Stage1: Isolation of islets of Langerhan 
The pancreatic tissue was digested with Collagenase A enzyme to isolate Islets of Langerhans 
from the pancreas, as described in previous protocols (Bertera et al. 2012, Gotoh et al. 1985) 
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with some modifications. All subsequent steps were carried out in a tissue culture hood to ensure 
that islets remain sterile for cell culture. After harvesting, the enzyme infused organ was then put 
into a sterile 25 cm2 flask and kept on ice. In order to achieve a substantial yield of islets, up to 
three (3) pancreata were pooled in one flask in which 15 mLs collagenase solution was 
supplemented.  
Stage II:  Digestion of Pancreatic tissue  
Optimization of Colagenase A dilutions 
Pancreatic duct ligation (PDL) causes destruction of exocrine tissue in post ligated pancreas. The 
first goal was to develop and optimize a protocol for isolating islets from a PDL-induced 
distorted pancreas for in vitro and in vivo transplantation studies. Many islet isolation protocols 
use collagenase enzymes to digest pancreatic connective tissues. However, it is reported that 
these enzymes are variable from different manufacturing companies and even between each lot 
(Wolters et al. 1992). A report by de Groot (de Groot et al. 2004) also indicates that some rodent 
strains lend themselves to islet isolation less well than others.  To obtain viable purified islets 
from PPDL pancreas that respond similar to their function in vivo, harvested tissues were first 
digested in varying concentrations (1.4mg/mL, 1.5 mg/mL and 2.0 mg/mL) of the collagenase A. 
The 1.5 mg/ mL Collagenase A concentration was optimal to the Wistar rat’s pancreas exposed 
to PDL as illustrated in Fig 3.1. Hence, 1.5 mg/mL concentration was used in all digestion 
experiments.  
After optimization, the collagenase infused and excised pancreata were incubated for 30 minutes 
at 37oC in a shaking water bath. Every 5 minutes, for 30 minutes, the flask was immediately 
removed from the incubator and vigorously hand shaken for 6–12 seconds to dissociate the tissue 
into a homogenate. In some cases, shaking was done for every 3 minutes. This step is critical for 
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optimal yield of the islets. For this reason, shaking was stopped only when the tissue was 
completely broken up to release islets. Care was also taken not to over-shake, to avoid breaking 
the islets into single cells.  After 30 minutes, digestion was stopped by quickly placing the 
conical tube in ice and diluting the homogenized pancreatic tissue with 20 mL ice cold HBSS. 
Care was taken to dilute the digest quickly to avoid unwanted islet digestion.   
Stage III: Washing of digested pancreatic tissue 
Digested tissue particles were first allowed to settle down by gravity for 5 minutes before the 
supernatant was removed. The digested tissue was then washed in HBSS wash buffer two times 
by centrifuging for 2 minutes at 290 x g each time to form a pellet and decanting the supernatant 
to remove small, light-weight tissue particles such as fats. After the second wash, each digest 
was poured through a large sink strainer size 40 (420 µm) into a 500 mL beaker and forcefully 
pipetted off the screen with wash buffer. After straining, the digest were dispensed into 50 mL 
conical tubes (3 pancreata per tube) and washed again by centrifugation as described above. 
Without loosening the pellet, an estimated 45 mL of the wash supernatant was carefully removed 
and poured in separate flask (for further purification of mesenchyme cells) without disturbing the 
loose pellet. At this stage, the pellet contains the islets and other heavier undigested fragments. 
After re-suspending the pellet in the remining wash buffer in conical tubes, the tubes were filled 
again and the washing steps were repeated until the supernatant appeared clear of the fine tissue 
fragments.  
StageIV:  Islets purification on discontinuous Ficoll gradient 
After the last supernatant wash was removed, the pellet was re-suspended and divided into 
smalller 17 × 100 mm conical  tubes with caps (Cell Star), each containing an equivalent of 2 
organs per tube and centrifuged gently at 290 x g for 1 minute. After decanting the supernatant, 
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tube were inverted with opening facing down the paper towel to remove as much liquid as 
possible from the pellet to avoid diluting the 25% Ficoll solution. Ficoll solutions were prepared 
from Ficoll type 400 (Sigma Aldrich) (Appendix A, Table A1) and construction of a 
discontinuous density gradient was done by first re-suspending (by vortex) the pelleted 
pancreatic tissue in 4 mL of the 25% Ficoll stock solution followed by subsequent layering of 2 
mL each of the other gradients (23%, 20.5%, and lastly 11%) in order of highest density to 
lowest, over the 25% Ficoll/tissue mixture. A total of 10 mL with the pancreatic tissue suspended 
in the 25% fraction at the bottom was contained in each tube (Fig. 2.5) 
   
Figure 2.5. Discontinuous ficoll gradient layers.  
 
Without disturbing the layers of the Ficoll density gradient, the preparation was carefully 
centrifuged for 25 minutes at 800 x g. Islets were usually observed at the 11%–20.5% and/or the 
20.5%–23% interfaces. Each Ficoll layer was separated and put into 15 mL conical tubes, 
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washed with HBSS, and centrifuged for 5 minutes at 800 x g. After removing the supernatant, 
islets were washed again and allowed to settle by gravity to remove the last traces of Ficoll. After 
removing all but I mL, the supernatant containing the islets was transferred to a sterile, non-
tissue culture-coated 60mm Petri dish (Fisher Scientific, Pittsburgh, PA, USA) containing 5-6 
mL of complete medium (RPMI 1640) (Life Technologies). All Ficoll layers in separate tubes 
were examined for islets before collecting all the supernatant into another flask for further 
mesenchyme purification. Islet purification on Ficoll density gradient solution was done quickly 
because Ficoll is toxic to islets.  
Stage V:  Islets morphological assessment and picking 
To separate from any remaining exocrine tissue, islets were finally isolated physically under the 
dissecting microscope (Nikon, Japan) by pipetting, and isolation was based on the morphological 
features of the islets. Pure islets are morphologically round and smooth and golden brown under 
the dissecting microscope (Nikon, Japan), while rough ones contained impurities of 
mesenchymal/exocrine cells and were excluded in pure cultures of islets (i.e. cultures without 
mesenchyme) but included in cultures of islets plus mesenchyme. Islets number and purity were 
morphologically assessed in vitro by dithizone staining (Sigma-Aldrich).  Isolated islets were 
counted and kept in complete media (RPMI 1640) at 37oC in a humidified atmosphere of 95% air 
and 5% CO2 ready for culturing or transplantation. Furthermore, islet viability was determined by 
their capacity to proliferate in culture or revert diabetes in vivo. 
 
2.5.1.2 Mesenchyme stromal cells isolation from pancreatic digest 
Stage I:  Further digest of pancreatic tissue 
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The supernatants from islet isolation were washed thrice with HBSS. After washing, the 
supernatant was further subjected to Dulbecco’s modified minimum essential medium (H-
DMEM [DMEM-with high glucose, HEPES] supplemented with 1 mg/mL collagenase type A 
(Sigma) and 2% BSA fraction V (Sigma) for futher digestion. The islet depleted pancreatic tissue 
was further digested by incubating at 37° C in a water bath for 5 minutes before it was 
transferred to a 50 mL conical tube to quench digestion in 25 mLs of chilled H-DMEM 
supplemented with 10% fetal bovine serum (Sigma). The digest was later centrifuged at 290 x g 
for 10 min. After removing the supernatant, the pellet was re-suspended in T25 culture flasks 
containing H-DMEM.  
  
Stage II:  Mesenchymal stromal cells separation 
Mesenchymal stromal cells (MSCs) were isolated based on their ability to adhere to plastic 
dishes as previously described (De Schauwer et al. 2011). Therefore, the remaining collagenase 
digest, obtained after islet and duct isolation, was incubated at 37°C in an atmosphere 
comprising of 5% CO
2 
for 48- 72 hours.  After culturing the tissue digest for 48 to 72 h, the 
supernatant was removed and flasks were washed in H-DMEM (Life Technologies) media to 
remove the remaining  islet and exocrine cells. Fibroblastoid-like cells (MSCs) seen emerging 
and attaching to the surface were passaged every third to fourth
 
day once they acquired 80-90% 
confluency before co-culturing with isolated islet cells under a microscope. Mesenchymal 
stromal cells (MScs) were propagated and expanded using H-DMEM. In this study, MSCs were 
not analysed for the presence of surface markers by flow cytometry due to financial limitations 
and lack of antibodies on the market that specifically react with rat tissues.  
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2.5.1.3 Passaging (sub-culturing) of MSCs   
Once reached confluence, MSCs were sub-cultured as follows. After carefully removing culture 
medium, MSCs were washed twice with phosphate buffered saline (PBS) (Appendix A, Table 
A2) to remove dead cells and traces of culture medium, which can inhibit the action of trypsin. 
Adherent MSCs at the bottom of the T25 flask were first trypsinized by adding pre-warmed 
0.25% trypsin-EDTA (Appendix A, Table A3) to cover all surfaces of the flask and incubated at 
37°C for 5 minutes. Morphological changes of cells were then observed under an inverted Nikon 
Eclipse TE2000-S microscope (Nippon Kogaku KK, Japan). When cells began to assume a 
rounded shape, the flask was gently tapped to remove the cells from the surface. In some cases, 
incubation time was increased when some cells were still attaching to bottom of the culture flask 
after first gentle tapping. Cells from the surface were later washed by gently pipetting 4 to 5 
times with fresh culture medium until all cells are suspended with no clumps. Cells in suspension 
were thereafter sub-cultured in a 1:5 split ratio by taking 1 mL of cell suspension and adding to a 
new T25 culture flask containing 4 mLs of complete fresh medium to make a total of 5mLs of 
cell suspension. T25 culture flasks containing 5mLs of MSCs suspension in RPMI1640 
supplemented by 1% Pen-streptomycin were incubated at 37°C in a humidified atmosphere of 
95% air and 5% CO2. Media was changed every 2 days.  All the transfer of medium was done 
inside the lamina flow tissue culture hood under aseptic conditions.   
2.6  Islet–mesenchymal stromal cells co- culture  
The first set of experiments was designed to test if direct mesenchymal–islet contact is necessary 
to induce trophic effects on islets in culture.  In addition to direct contact, we also designed the 
second experimental set to test if MSCs secrete soluble molecules that mediate the trophic effects 
on neighbouring islet cells. Therefore, two co-culture configuration systems were used in this 
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study: direct and indirect contact islet-mesenchymal stromal cells monolayer co-culture systems.  
As mentioned in section 2.6.4.3, isolated MSCs were first expanded before co-culturing with 
islets. Approximately 200,000 MSCs of passage 3-6 were seeded into Cell Star 35-mm Petri 
dishes and cultured for 24 h to form a confluent monolayer for the direct and indirect contact 
islet-MSC monolayer co-culture system. The islets were transferred into culture conditions using 
sterile “slick” pipette tips. Since islet cells on plastic in the presence of FBS "de-differentiate" by 
default (become mesenchymal), in our co-culture experiments, mesenchymal and islet cells were 
thereafter, maintained under serum free 50% RPMI 1640 + 50% H-DMEM culture medium. Islet 
cell growth was analyzed by direct cell count under the Nikon Eclipse TE2000-S fluorescent 
microscope (Nippon Kogaku KK, Japan). 
2.6.1 Direct contact islet–MSC co-culturing 
For the direct contact system, 50 fresh islets were seeded directly onto 200,000 adherent MSCs 
monolayer. To preserve morphology of islets, some samples for in vitro analysis were cultured 
on 4 well cell culture slides as shown in Fig. 2.6.  
 
2.6.2 Indirect contact Islet-MSC co-culturing 
For the indirect transwell co-culture system, cell culture inserts with a semi-permeable 
membrane pore size of 1.0 µm (Millicell) were inserted into each 35-mm non-treated Petri dish 
(Cell Star -Greiner Bio-One) containing approx. 200,000 MSCs, and 50 fresh islets were added 
into the inserts as shown in Fig. 2.7. Serum free RPMI 1640 medium (supplemented with 100 
U/mL penicillin/0.1 mg/mL streptomycin) was used for all co-culture configurations. Control 
islets were cultured alone as groups of 50 also in serum free RPMI-1640 medium supplemented 
with 100 U/mL penicillin/0.1 mg/mL streptomycin in non-treated 35-mm Petri dishes.  
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Figure 2.6. Cell culture slide and 35 mm cell culture petri dish. 
 
 
 
Figure 2.7. Transwell for indirect islet and mesenchymal stromal cells co-culture. (A) Six-
well cell culture inserts. (B) Illustrated view of indirect co-culture of islets and mesenchyme.  
 
2.6.3 Passaging (sub-culturing) of islet and MSCs in co-cultures  
In our co-cultures, islets and mesenchymal cells were sub-cultured every time cells reached 
confluence for a period of 4 weeks using serum free 1640 RPMI culture medium.  A similar 
method of sub-culturing was used as described in section 2.6.4.3, for cultures of islets only using 
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serum free culture medium. Once reached confluence in each petri-dish, islets were first counted 
before trypsinization. After carefully removing culture medium, the composite islets and 
mesenchymal cells were rinsed twice in phosphate buffered saline (PBS) to eliminate debris and 
traces of culture medium, which can inhibit the action of trypsin. For direct contact monolayer 
configuration, some islets formed loose attachments with MSCs but could be removed for sub-
culturing by gently pipetting. Adherent composite islet-MSC cells on petri dishes were mildly 
trypsinized to lift the cells from the dish.  To detach adherent islets and mesenchymal cells at the 
bottom of the T25 flask, pre-warmed 0.05% trypsin-EDTA (Appendix A, Table A2) was added 
to cover all surfaces of the flask before incubation at 37° C for 5 minutes. Detached cell 
aggregates (islet/MSC) from the surface were lifted up by gentle tapping the flask, followed by 
gently pipetting  2  to 3 times with PBS until all islet cell aggregates cells were suspended. Islets 
co-cultured with MSCs (Islet/MSC+) were sub-cultured as follows:  Islets that were loosely 
attached to petri dishes were pipetted, and transferred into new petri-dishes and then counted. All 
islet aggregates were pipetted, counted and transferred into new T25 culture flask.The remaining 
MSC cells in suspension were thereafter,  sub-cultured in a 1:5 split ratio by taking 1 mL of 
MSC cell suspension and adding to a new T25 culture flask containing 4 mLs of complete fresh 
medium to make a total of 5mLs of cell suspension. Twenty-five islets were then, seeded on T25 
culture flasks containing 5mLs of MSCs suspension in RPMI1640, supplemented by 1% Pen-
streptomycin and incubated at 37 °C in a humidified atmosphere of 95% air and 5% CO2. The 
medium was changed every 2 days.  All the transfer of medium was done inside the lamina flow 
tissue culture hood under aseptic conditions. 
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2.7 Immunocytochemistry (ICC) of cultured islets  
2.7.1 Preparation of islet and mesenchymal stromal cells suspension for ICC 
Results from our pilot study showed that when islets were cultured together with MSCs in 
suspension co-culture, MSCs adhered to the surface of the islet within 6 h to form composite 
MSC/islets. All islets were handpicked for in vitro analysis at designated times. For direct 
contact monolayer configuration, islets formed loose attachments with MSCs but could be 
removed for in vitro analysis or transplantation experiments by gently pipetting. 
 
For adherent composite islet/MSC cells on petri dishes, mild trypsinization was done to lift the 
cells from the dish.  After carefully removing culture medium, islets and mesenchymal cells were 
rinsed twice in phosphate buffered saline (PBS) to eliminate debris and traces of culture medium, 
which can inhibit the action of trypsin. To detach adherent islets and mesenchymal cells at the 
bottom of the T25 flask, pre-warmed 0.05% trypsin-EDTA was added to cover all surfaces of the 
flask and incubated at 37° C for 5 minutes. Detached cell aggregates (islet/MSC) from the 
surface were lifted up by gentle tapping the flask, followed by gently pipetting 4 to 5 times with 
PBS until all islet cell aggregates were suspended. Cells in suspension were later washed twice in 
PBS and pelleted by centrifugation at 210 x g for 1 minute and then re-suspended in PBS at an 
estimated concentration of 20 islets/µl.  Cells cultured on slides were also washed twice in PBS 
before fixing them in 4% PFA without cytospining.  
 
2.7.2 Cytospin slide preparation 
In a direct contact monolayer configuration, some islets formed loose attachments with MSCs 
and could easily be lifted up on cell culture slides and plastic dishes (Fig. 2.6 A and B). 
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Therefore, care was taken to avoid loss of islets that could result into unrepresentative samples at 
the end of the ICC process. For the samples to be representative, all islets and/or composite 
Islet/MSC were cytospinned in order to stick to the slides. Cytospin pre-coated slides (SPL life 
Sciences, Korea) were positioned to a slide holder with filter cards and sample chamber, and 
then attached to cytocentrifuge rotor (Appendix B). After preparation of the sample chamber, 0.1 
mL of cell suspension was added to the chamber and centrifuged at 210 x g for 14 minutes.  
 
2.7.3 Immunolabeling  
After removing the slides from the chambers, cells were fixed by incubating in 4% 
paraformaldehyde (PFA) diluted in PBS for 20 minutes at room temperature (RT) on two-well 
chambered slides to preserve tissue morphology and retain the antigenicity of the target 
molecules.  Cells cultured on slides were fixed without cytospining.  After rinsing the cells 3 
times with PBS, Slides were placed in a polypropylene Coplin staining jar filled with 10 mM 
Sodium citrate buffer (pH 6) (Life technologies) in a water bath. Slides were briefly boiled in 10 
mM Sodium citrate buffer and then maintained at 95 °C for 10 minutes. After incubation, the 
Coplin jar with retrieval solution and slides were removed from the water bath, and allowed to 
cool down on bench top for about 30 minutes at room temperature before gently rinsing the 
sections in distilled water followed by PBS for 5 minutes each. After heat–induced epitope 
retrieval, slides were subjected to blocking and primary antibody incubation. 
 
After rinsing the cells twice in PBS, cells were blocked by incubating in 2% bovine serum 
albumin (BSA) (Sigma) for 1 h at room temperature in a humidified chamber to minimize 
nonspecific binding of antibodies.  The slides were then incubated overnight at 4oC in diluted 
primary antibodies in a humidified chamber (see Appendix A, Table A4 for antibodies and their 
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corresponding dilutions). For double immunolabeling, cells were incubated with a mixture of 
two primary antibodies in their corresponding dilutions. To verify the specificity of the staining 
generated by primary antibodies, appropriate negative controls were included in the experiment 
where only secondary antibodies were not added.   
 
After rinsing the cells in 2% BSA in PBS, the antigen–antibody complexes were revealed after 
incubating the slides in fluorophore-conjugated secondary antibodies for 1 hour at room 
temperature in a humidified chamber using the corresponding dilutions with primary and 
secondary antibody diluent solutions (Leica) (Appendix A; Table A4 and Table A5). In double 
immunolabeling, a mixture of two corresponding secondary antibodies was applied. The 
secondary antibodies (fluorochrome-conjugated goat anti-rabbit and goat anti-mouse IgG) used 
in this study include: Fluorescein isothiocyanate (FITC), Alexa Fluor 594 and Alexa Fluor 488 
(ABCAM) (Appendix A Table A5). Cells were nuclear stained by 300 ng/mL DAPI (4',6-
diamidino-2-phenylindole) solution in 1% BSA for 10 minutes before cover-slipping using DPX 
as a mounting medium. The primary and secondary antibodies and their dilution factors used in 
this study are presented in Table A4 and Table A5 in the appendix A.  The immunofluorescence 
reactions in cells were visualized by using a Nikon Eclipse TE2000-S fluorescent microscope 
(Nippon Kogaku KK, Japan) quipped with appropriate filters and camera linked to computer 
using NIS-Elements basic research (BR) 3.2 software. 
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2.8 Experiment 2:  Duct-mesenchymal stromal cells (MSCs) co-culture 
Experiment 2 describes the methodology employed to isolate duct fragments and MSCs to 
investigate whether pancreatic-derived mesenchymal stimulate neogenesis in pancreatic duct 
fragments epithelial cells in culture.   
To investigate the response of adult pancreatic duct epithelial cells to MSCs (Fig 2.8 A), we also 
performed an in vitro experiment (Fig. 2.8 B). Immuno-expression of CK7, Ngn3 and insulin on 
proliferating duct-derived cells in co-cultures with MSCs should provide evidence of neogenesis 
that occurs during embryonic development.  
            
Figure 2.8. Experimental approach to test the hypothesis of MSCs as stimulants of beta cell 
neogenesis from duct epithelial cells.  (A) Our hypothesis is that with MSCs stimulation, duct 
epithelial cells regress to a lesser differentiated phenotype and act as progenitors to form new 
insulin producing cells. (B) Duct fragments and MSCs were enzymatically isolated from PPDL 
pancreas and co-cultured.  
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2.8.1 Isolation of pancreatic duct fragments using collagenase 
The pancreatic duct fragments were isolated using the following methods: 
2.8.1.1 Collagenase digestion 
Pancreatic duct fragments were isolated using a modified protocol from that used for islet 
isolation (Bertera et al. 2012, Gotoh et al. 1985, Pipeleers et al. 1981, Githens et al. 1981, 
Githens et al. 1980). Just like islets, all isolations of ducts were done under sterile condition in a 
cell culture hood with filtered air lamina flow. Pancreatic tissues harvested from 250- 350 g 
Wistar rats were first washed with 1X HBSS to remove blood because blood affects the enzyme 
activity of Collagenase A. After thorough washing, each lobe of the pancreas was inflated by 
injecting with 2 mLs of Collagenase A (1.5 mg/mL in HBSS) (Sigma) and kept in a petri dish for 
5 minutes before mincing. The inflated pancreas was then minced into 2 mm pieces using a sharp 
scissors in a petri dish and then quickly returned in a vial containing 5 mLs of 1.5 mg/mL 
Collagenase A (prepared using 1X Hanks balanced salt solution (HBSS)). The vials were then 
capped and incubated for 30 minutes in a water bath at 37oC with intermittent shaking every 5 
minutes to yield a mixture of nerves, blood vessels, ducts, acinar cell clusters and islets. Enzyme 
digestion was stopped by transferring the digest into a conical tube and diluting it with 20 mLs of 
cold ice HBSS. Some ducts fragments were obtained from the digested pancreatic tissue samples 
left over after islet isolation. 
2.8.1.2 Ducts fractionation on sieve  
As an adaptation, fragments of ducts were isolated from the digest by shaking and vigorously 
pipetting the digest and then sieved it on mesh stainless–steel sieve (pore size 200 x 300 µm) that 
was pre-wetted (Merk Millipore).  After elution of the fluid and small duct fragments through the 
sieve, tissues in the supernatant were then left for 2 minutes for lymph nodes and large blood 
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vessels to sediment, which were later harvested and transferred in separate tube containing 20 
mLs of HBSS. The fragments and residues left on the sieve were also harvested by inverting the 
sieve and rinsing it with another 20 mLs of HBSS. 
2.8.1.3  Ducts fractionation on discontinuous Ficoll density gradients 
To sediment the remaining exocrine acinar tissue from less dense ductal structures, the 
supernatant was re-suspended in conical tube by vortexing in HBSS containing 25% Ficoll 
density cushion. This cushion was overlaid by 2 mLs of each of the 23%, 20.5% and 11% Ficoll 
and finally 1X HBSS. The tubes were later centrifuged at 800 x g for 25 minutes. The floating 
tissue fraction, with ducts of different sizes ranging from main ducts to intercalated ducts, were 
collected with a Pasteur pipette and re-suspended in 15 mLs of HBSS and pelleted by 
centrifuging at 453 x g for 5 minutes. The pellet was finally re-suspended in 10 mLs of RPMI 
1640 culture medium in a petri dish, ready for isolation. 
2.8.1.4  Isolation of specific fragment types 
Identification of the duct fragments in the suspension was done under a dissecting microscope 
(Nikon, Japan), relying on specific characteristic gross morphological features and were hand-
picked using a pipette. Specific characteristic morphological features that allowed for the 
isolation of  pancreatic duct fragments for tissue culture were the following: the main intra-
pancreatic pancreatic duct showed large lumen with thick columnal epithelial lining frequently 
disrupted with tubular evaginations (Githens et al. 1981), while intra-lobular pancreatic ducts 
were lined by simple low columnar to cuboidal epithelium.These pancreatic ducts were 
frequently lined by loose connective tissue.  However, some small pancreatic ducts were simply 
lined by simple cuboidal epithelium. Intercalated pancreatic ducts, which were often attached to 
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larger pancreatic ducts, were recognized by a single layer of thick squamous epithelium; 
presenting straight  unbranched duct  with smooth outer lining, terminating in centroacinar cells.  
 Isolated duct fragments were transferred in RPMI 1640 culture medium in T25 tissue flask and 
left for 24 hours to recover from the effects of digestion and isolation.  
2.8.2 Co-culturing of duct fragments with mesenchymal cells 
As only a smaller number of 5 to 6 ducts were cultured per dish ( unlike  50 
islets/200,000MSCs/dish cultured in section 2.7.1), and equivalently smaller number of 
approximately 150,000 MSCs of passages 3-6 were seeded on each Cell Star 15-mm Petri dishes 
(Greiner Bio-One), and cultured for 24 h to form a confluent monolayer for the direct contact 
duct-MSC monolayer co-culture system. For direct contact system, 5-6 fresh duct fragments 
were seeded directly on the MSC monolayer.  The Co-culture system used serum free RPMI-
1640 medium supplemented by 1% Penicillin-streptomycin (10,000 units/mL penicillin/ 10,000 
µg/mL Streptomycin) (GIBCO). Control ducts were cultured alone without mesenchymal cells in 
groups of 5-6 ducts per 15-mm petri dish also in serum free RPMI-1640 culture medium. Culture 
medium was changed every 2 -3 days. Growth morphological changes of duct fragments in 
culture were investigated under the microscope and pictures were taken every 2 days using an 
inverted Nikon Eclipse TE2000-S microscope (Nippon Kogaku KK, Japan). All duct fragments 
including those that were loosely attached to the MSC monolayer and smaller ducts that were 
completely surrounded by MSC were pipetted for an in vitro analysis.   
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2.9 Experiment 3: Islet transplantation under kidney capsule 
Experiment 3 describes the methodology taken to isolate and graft early (24 h) and late (84 h) 
PPDL islets with MSCs under the renal capsule in order to evaluate the efficacy of PPDL islets 
in restoring normoglycemia in STZ-induced diabetic rats.  
2.9.1 Islet and MSCs transplantation in STZ-induced diabetic rats 
2.9.1.1  Induction of diabetes 
Diabetes Mellitus was induced by a single dose of 65 mg/kg of streptozotocin (STZ) in inbred 
syngeneic male Wistar rat recipients (250-350 g) to minimize immune-mediated graft rejection.  
Streptozotocin-induced diabetic recipients (n = 40) received 65 mg/kg streptozotocin (STZ) 
(after establishing a dose curve) (Sigma, St Louis, USA. Product Catalogue no S0130) dissolved 
in 0.1 M citrate buffer (pH 4.5) via abdominal peritoneal cavity under anesthesia as described in 
section 2.4.1. Only animals with blood glucose level (BGL) > 11 mMol/L for three consecutive 
days were included in the study. Diabetic control recipients (n = 10) received same dosage of 
STZ while normal control animals (n = 10) received saline (placebo) (SABAX, Port Elizabeth, 
South Africa). Blood glucose levels were measured three times a week  using a blood strip 
sensored glucose meter (Gluco-plus INC, 2323 Halper, Quebec, Canada). 
2.9.1.2  Donor islets 
Pancreatic endocrine islets were isolated from 24 h PPDL (n = 40), 84 h PPDL (n = 20) and 
normal islet (n = 20) donor groups. The 24 h PPDL and 84 h PPDL groups received pancreatic 
duct ligation, while the normal islet group received sham operation using the same protocol as 
described in sections 2.3.1 up to 2.3.2. Islets were hand-picked under dissecting a microscope. 
Stellenbosch University  https://scholar.sun.ac.za
85 
Purity of islets was verified by dithizone (Sigma-Aldrich) staining and were counted and 
distributed into groups of 300/recipient for transplantation.    
 
Mesenchymal stromal cells were isolated following ligation based on their ability to adhere to 
plastic dishes as described previously (Rackham et al. 2013). 
2.9.2  Transplantation procedure 
In order to avoid normal engraftment alterations caused by immune cell reactions, islet 
transplantations were carried out on inbred syngeneic Wistar male rats.   
2.9.2.1  Animal preparation and transplantation 
As stated in sections 2.9.1.1 only animals with fasting blood glucose level (BGL) >11 mMol/L 
for three consecutive days were used as recipients. Recipient rats were anesthetized, shaved, and 
cleaned with providone-iodine solution containing antiseptic betadine (10 mg/mL) (Adcock 
Ingram Pharmaceuticals, Industria, Johannesburg, RSA). After identifying the position of the 
kidney, a small para-lumbar incision was made on the left side of the animal to expose the 
kidney. Using a saline soaked cotton swab, the kidney was moistened to prevent drying. Then 
using the silicone tube as an adapter, the polyethylene tube (PE50) distal end was attached to a 
Hamilton screw drive syringe containing a pipette tip. With the aid of a Zeiss OPMI-1 operating 
microscope equipped with a zoom and a focus adjustment (Carl Zeiss, AG, Oberkochen, 
Germany), a small shallow cut of the capsule was made on the right side of the kidney, through 
which islet cells were delivered.  
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Three separate transplant combinations were used. 
First combination: Equal halves of STZ-induced diabetic recipient rats (n=10) separately 
received under the kidney capsule, 300 islets/recipient without MSCs or with MSCs (300 
islets/200,000 MSCs/recipient) from 24 h PPDL syngeneic donors. 
Second combination: Ten (n=10) STZ- induced diabetic rats were transplanted with islets (300 
islets/recipient) obtained from 84 h PPDL syngeneic donors. 
Third combination: Ten (n = 10) STZ-induced diabetic rats received islets (300 islets/recipient) 
from unligated health control syngeneic donors as illustrated in Figure 2.1.  
 
To deliver the islets, the beveled end of PE50 tubing carrying islet cells, was carefully inserted 
under the capsule while gently swabbing the capsule with normal saline to avoid tearing. Islets 
were then slowly placed under the renal capsule. Under Isofor anaesthesia, approximately 300 
islets per diabetic recipient were delivered under the superior pole of the left renal capsule (Fig. 
2.9). After delivering the islets, the kidney incision was cauterized with low heat to maintain 
homeostasis. After retroperitoneally placing back the kidney, the muscles and skin were sutured 
using silk sutures.  Rats were immediately treated with Batryl and Temgesic and placed in a cage 
on a heating pad. Animals were given free access to food and water after transplantation and 
under the care of a veterinarian until euthanized 67 days later. All recipients of islet grafts were 
included in the study.  
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Figure 2.9. Transplantation of islets under the kidney capsule. (A) Kidney was popped out 
just before transplantation. (B) PE tubing inserted under kidney capsule with 300 islets from 
syngeneic donor (dotted line). (C) Islets deposited under the kidney capsule (dotted line). 
 
2.10 Assessment of islet function under the kidney capsule. 
Islet functionality was assessed by monitoring body weight and glucose concentrations every 3- 
to 4 days through the tail vein. Blood glucose levels were measured using a strip sensored blood 
glucose meter (Gluco-plus INC, 2323 Halper, Quebec, Canada). Transplanted islets were 
considered to have engrafted when blood glucose levels (BGL) of <11 mMol/L were attained 
within a period of 5 to 10 days and islet grafts survival was defined as the number of days before 
recurrence of diabetes. The day of diabetes occurrence was defined as the first two consecutive 
days of fasting blood glucose readings >11 mMol/L. Reversal of chemically induced diabetes in 
vivo was defined as fasting blood glucose concentrations of <11 mMol/L maintained for a period 
of 30 days or longer. Rats were euthanized later and kidneys bearing grafts were harvested for 
histological analysis. 
2.10.1 Isografts and pancreas harvesting 
Kidneys bearing grafts were harvested and immunohistochemically analysed 69 days post-
transplantation. Five animals of each group (diabetic and non diabetic) were nephrectomized 
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under anaesthesia to perform histology and immunohistochemistry studies. To investigate 
whether reversal of diabetes is due to functional allografts or regeneration of the pancreas, both 
the graft bearing kidneys and pancreas were harvested for histochemical analysis.  
2.11 Immunohistochemistry of islet grafts 
2.11.1 Preparation of tissue sections 
To preserve tissue morphology and retain the antigenicity of the target molecules, all harvested 
kidney allograft and pancreatic tissues for immunohistochemistry were fixed in 4% 
paraformaldehyde in PBS for 24 h at 4 °C. After fixation, tissues were trimmed and placed in 
labelled plastic cassettes and dehydrated in a series of graded alcohols using an automated tissue 
processing machine (Appendix B). After dehydration, tissues were embedded in molten paraffin 
wax (at 60 °C). After paraffin solidification, tissue blocks were kept at 4 °C until section.  
2.11.2 Sectioning 
Using a hand-driven rotary microtome, tissues were sectioned at 5 µm and floated on water bath 
containing de-ionized distilled water at 50 °C. Water was changed between blocks of different 
groups to avoid antigen contamination. Tissue sections were then mounted on positively charged 
slides (BIO-SCAN). Once mounted, the slides were dried by incubating them in an oven at 60 °C 
for 2 h and then stored at room temperature until ready for staining.  
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2.11.3 Immunochromogenic staining assay 
Tissue section from isografts were first de-paraffinized and rehydrated by immersing slides in 
xylene followed by a series of graded alcohols in descending order of concentration (Appendix 
B). Care was taken not let tissue dry until antigenicity is revealed. 
2.11.4 Heat-induced antigen retrieval  
To retrieve the antigenic epitope in the tissue sections, an electric water bath was used. This was 
achieved by placing a polypropylene coplin staining jar filled with 10 mM sodium citrate buffer 
(pH 6) (Life technologies) in a water bath. Slides were briefly boiled in 10 mM sodium citrate 
buffer and then maintained at 95 °C for 10 minutes. After incubation, the coplin jar with retrieval 
solution and slides were removed from the water bath, and allowed to cool down on bench top 
for about 30 minutes at room temperature before gently rinsing the sections in distilled water 
followed by PBS for 5 minutes each. After heat–induced epitope retrieval, slides were subjected 
to blocking and primary antibody incubation. 
2.11.5 Detection system 
Leica BOND polymer refined detection kit (Leica, NovolinkTM polymer detection system - Cat 
No: DS 9800) was acquired to immuno-label the slides.  Slides were immuno-labeled following 
the manufacturer’s protocol (Appendix B). After rinsing tissues samples in PBS, tissues were 
incubated with 1-3 drops of “peroxidase block” (0.3% H2O2 in methanol) (refine kit) for 10 
minutes to quench endogenous peroxidase activity, followed by rinsing with PBS.  
 
After washing in PBS, slides were blocked for 1 h in 2% BSA in PBS at 4°C. The sections were 
incubated overnight (12-16 hours) at 4oC in primary antibodies anti-Ki67 and anti- insulin 
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diluted as described in Table A4. After incubation, slides were washed in PBS followed by 
incubation in “post primary block” (Novolink Kit) for 30 minutes at room temperature. After 
washing in PBS, slides were incubated in “novolink polymer” (Novolink Kit) for 45 minutes at 
room temperature. After washing in PBS, slides were incubated in 3,3’ Diaminobenzidine (DAB, 
brown precipitate) chromogen substrate (Refine Kit) diluted 1: 20 in DAB substrate buffer 
polymer and finally nuclei counterstained with hematoxylin for 5 minutes.  
 
After washing in PBS, followed by distilled water for 5 minutes, tissue sections were dehydrated 
by moving slides in a series of graded alcohols as described above (Appendix B) Tissue sections 
were later cover-slipped using DPX as mounting medium and stored until viewing day.  
2.12 Computer-assisted quantitative image analysis (CAQIA)  
2.12.1 Microscope slide viewing and image capturing. 
Development of islets in culture was monitored using an inverted Nikon Eclipse TE-2000S 
microscope (Nippon Kogaku KK, Japan) and images were taken directly in culture dishes every 
2-3 days to assess any morphological changes in islet growth.  
 
Fluorescent stained tissue slides from islet cells of control [SOC/Normal], post-PDL [24 and 120 
h] cultured with or without MSC on different days in culture viewed under an inverted Nikon 
Eclipse TE-2000S fluorescent microscope (Nippon Kogaku KK, Japan) equipped with colour 
camera and linked to a computer using NIS-Elements BR 3.2 software. Slides were subjected to 
fluorescence light for less that 15 seconds to minimize bleaching and exposure time for image 
capturing was set at 300 milliseconds or 1 second when automated. During image acquisition, 
tissue slides immunofluorescent images were taken at x40 magnification. General morphology of 
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islets and ducts samples was assessed to determine any changes introduced by 
immunofluorescence procedures. Captured images were later quantitatively analysed.  
 
For graft tissue sections, immunochromogenic stained slides were also grouped according to 
animal treatment (STZ-induced diabetic/non diabetic and transplanted/not transplanted). These 
slides were viewed under Zeiss Microscope (Carl Zeiss Vision GmbH, Zepplinstrasse 4, 85399 
München- Hallbergmoor, Germany) equipped with colour camera linked to a computer using 
ZEN lite 2012 software.  Immunochromogenic images were taken at x40 magnification and 
quantitatively analysed using ZEN lite 2012 software.   
2.12.2 Quantitative analysis of cultured islets and duct fragments 
To quantify the absolute numbers of Pdx1-, Ngn3- and Insulin-expressing cells in cultures, all 
immunostained slides of islets were digitized. Digital images obtained from the slides were 
segmented and features of positive labelled cells for specific antigens (e.g. insulin, Pdx-1, Ngn-3 
etc) were programmed using the automeasurement software of NIS-Elements (Basic Research 
[BR] 3.2). On each image, the surface areas of Pdx1, insulin and Ngn3 staining were quantified 
using NIS-Elements BR3.2. Fifty to forty islets were analyzed per culture condition (Pdx1, 
Insulin or Ngn3) and the stained areas were added up (Appendix C, Tables C1, C2, C3). 
To quantify the maintenance of Ngn3 expressing cells, we counted the number of Ngn3 
expressing cells among 1,000 insulin expressing cells. The percentage of de-differentiated Ngn3-
expressing cells was then calculated (Appendix C, Table 2).   
To quantify growth of islets in culture, digital images were obtained and the surface areas of the 
islets per condition were measured and areas of all islets were added up.  
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2.12.3 Assessment of graft morphology 
For each harvested graft bearing kidney, five to eight tissue sections (5 µm thick) obtained from 
different regions of the graft were analysed for beta cell density using insulin immunostaining. 
To evaluate graft morphology, total endocrine area was measured per graft section using digital 
morphometry (Zen lite 2012 software) linked to Zeiss Microscope (Germany). Endocrine cell 
density was assessed by measuring the number and area of individual endocrine aggregates as 
described elsewhere (Figliuzzi et al. 2009, Rackham et al. 2013). An individual endocrine cell 
aggregate was defined as an area occupied by insulin-positive cells separated from any other 
adjacent insulin-positive by > 50 µm of insulin-negative non-endocrine tissue.  Total endocrine 
area was defined as the sum of the areas of all endocrine aggregates within an individual graft 
section. Islet graft was demarcated as an area of endocrine and non-endocrine between the renal 
parenchyma and renal capsule (Appendix C, Table C4).    
 
To assess engraftment of islets, we counted the frequency of Ki67 nuclei among 1,000 insulin β- 
cells per graft bearing kidney. Cell counts were done on a minimum of 1000 cells per sample, 
and percentages were calculated as number of positive cells per 1000 (Appendix C, Table C5)  
2.13 Statistical analysis 
All the digital images were analysed and data was exported to MS Excel (Microsoft Inc, USA) 
and the Statistical Package for Social Sciences (SPSS) version 18.0 for Window (SPSS Inc, 
Chicago, IL, USA) was used for statistical analysis. Each data point is the mean of at least 50 
islets. The data was presented as Mean ± SEM. Statistical analysis used student’s t-test to 
identify differences in islets development cultured under different conditions as well as in 
glycemic levels between groups of rats and statistical significant difference was determined at 
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p≤0.05. Kaplan-Meier survival curve was used to identify differences in time of cure between 
groups. A log rank p value of p < 0.05 was considered significant, (n = 10 animals/group).  
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Chapter 3 Results 
3.1 Development of islets cells in cultures  
3.1.1 Islets obtained from post-PDL pancreas 
3.1.1.1 Modification and adaptation of protocol  for islet isolation for culture 
Results of digesting the pancreatic tissue in varying concentrations of Collagenase A, isolating 
islets from non-islet tissue and counting them in RPMI 1640 culture medium to maintain 
viability are shown in Table 3.1 and in Fig. 3.2.  
   
Figure 3.1. SCHEMATIC REPRESENTATION OF ISLET ISOLATION PROCEDURE. 
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       * Isolated islets were fragmented and small in size   
Table 3.1.  Number of islets isolated from PPDL pancreatic tissue  
 
 
   
 
 
 
  
 
 
Figure 3.2. Morphological features of endocrine islets recovered from pancreatic digest 
using varying concentrations of Collagenase A. In A arrows indicate exocrine tissue attached 
to islet while in B arrows indicate small islet cells 
 
3.1.1.2 Morphology and Number of islets recovered 
The number and size of the islets varied with Collagenase A concentration. Individual rat islets 
from a PPDL pancreas may range from 80 to over 400 microns in size (Fig. 3.2 B). Higher 
Strain Sample 
size (n) 
Weight (g) Collagenase 
A (mg/mL) 
Digestion 
time  (min) 
Av. Islet Yield 
3 180-250 1.4 20-30 174 
3 180-250 1.5 20-30 265 
2 180-250  2.0 20-30 316* 
200 µm 
Pure Islets 
B A 
Exocrine tissue attached 
Endocrine Islets 
200 µm 
1.4 mg/mL 2.0 mg /mL 1.5 mg/mL 
Larger Islets broken down 
into smaller islets 
200 µm 
C 
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average yield and normal sizes of islets were obtained at collagenase concentration of 1.5 mg/mL 
and digestion time of 30 minutes (Table 3.1 & Fig. 3.2 B). Numerous and fragmented smaller 
islets were obtained when Collagenase A concentration was increased to 2.0 mg/mL, digesting at 
the same period of time (Table 3.1 & Fig 3.2 C.).  
Reducing the concentrations of Collagenase A to 1.4 mg/mL resulted into incomplete digestion 
with islets still attached to exocrine tissue (Fig. 3.2 A). However, a 1.4 mg/mL Collagenase A 
enzyme concentration was optimal to yield, at least healthy islets from 84 h and 120 h PPDL 
pancreatic tissue. Results showed that 84- and 120 h PPDL pancreatic tissues were very sensitive 
to enzyme digestion because the tissue, according to previous studies (Tchokonte-Nana, 2011), is 
undergoing massive exocrine destruction during this period. The present study has in addition 
found that it also affects the morphology and integrity of islets. Results also indicate that islets 
from the 84- and 120 h PPDL groups could easily disintegrate into smaller cellular aggregates at 
1.5 mg/mL collagenase A enzyme concentration similar to what was observed with normal 
control and 24 h PPDL tissues when digested with 2.0 mg/mL of the enzyme as shown in Fig. 
3.2 C. 
3.1.1.3 Effect of protocol modification 
This study used a modification of the protocols from Goto et al. 1985 and De Haan et al., 2004. 
This modified protocol allowed collagenase to interact more closely with tissues surrounding 
islets and resulted into higher islet yield. In young male Wistar rats (150-200 g), total number of 
islets increased with age. More islets were recovered from bigger animals (250-350 g). It was 
found that in Wistar rats, higher yields of pure and viable islets could be achieved when 
harvested PPDL pancreas is first injected with 1.5 mg/mL of Collagenase A, minced and 
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digested for 30 minutes. Results also indicated that Collagenase A of 1.5 mg/mL dissolved in 
Hank’s balanced salt solution instead of H-DMEM containing 10 mMol HEPES, and a digestion 
time limited to 30 minutes at 37°C proved essential for reproducibility as shown in Table 3.1.   
3.1.1.4 Purity and viability of islets recovered 
Purity of islets was verified by dithizone staining (red) which specifically binds to zinc found in 
insulin granules (Fig. 3.3). Results showed that islet cells were viable and showed no areas of 
hypoxia (darker area at the center) (Fig. 3.2 B&C). More rounded healthy islets were recovered 
from collagenase digest of 1.5 mg/mL than other concentrations (Fig. 3.2 B).  
 
Figure 3.3 Pancreatic islets during purification procedure. (A) Isolated islets (arrows) kept in 
RPMI 1640 cell culture medium and (B) islets after dithizone staining (red) which specifically 
binds to beta cell insulin granules. Scale bars = 150 µm 
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3.1.2 Mesenchymal stromal cells (MSCs) obtained from PPDL pancreas. 
Adult PPDL pancreatic tissue prepared from islet-depleted digests was cultured for 48- 72 h as 
described in Section 2.6.5. After 48 h, the supernatant was removed and the resultant adherent 
cells usually composed of cellular aggregates primarily of MSCs and some few trapped ductal 
and exocrine cells were observed (Fig. 3.4B).  After 2 days, growing fibroblastic–like MSCs, 
presenting with narrow cell bodies and long cytoplasmic prolongations, were observed (Fig. 
3.4B).  These results show that fibroblastoid-like MSCs can be successfully isolated from the 
PPDL rat pancreas within 48 h of culture by using RPMI 1640 medium (Fig. 3.4B).  
 
Figure 3.4. Morphology of isolated mesenchyme-like cells from PPDL rat pancreas.  Panel 
A: Schematic representation of isolation procedure: Pancreas digested in Collagenase P was 
plated in RPMI 1640 culture medium and adherent cells appeared that were propagated after the 
48 h. Panels B-E shows morphology of isolated fibroblast-like cells and expanded at different 
passages: P0 = before passaging; P10 = passage 10; Scale bar = 50µm. 
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After detaching cell monolayer from the bottom of the petri dish by trypsin EDTA treatment, 
fibroblast-like cells were allowed to expand in cultures as adherent cells and reached confluence 
by day 4. These cells were passaged again and reached confluence within 6 days (Fig 3.4D, E) 
for a total of 24 days in culture medium. The composition of these cells was verified by 
immunocytochemistry through negative screening by staining for the presence of endocrine, duct 
and exocrine cell contaminants. Though not a very accurate method of characterizing MSCs than 
the use of  flow cytometry, it was noted that during the initial culture period (passages 1 to 2), 
some morphological heterogeneity in the adherent cell fraction were observed (Fig. 3.5A, B, C).  
However, as the cultures were subsequently passaged, homogeneity in morphology of the MSC 
cells was gradually achieved with fibroblast/flat cells, bearing nuclei rich in nucleoli, 
predominating (Fig. 3.5 D-I).  
To recapitulate the regenerative process that occurs in a PPDL pancreas, mesenchymal–like cells 
were consistently maintained in a proliferative/undifferentiated state for more than 10 passages 
(68 days). During this period, we observed a 10-fold increase in cell numbers between successive 
passages. However, their proliferation rate drastically reduced by 3-fold beyond passage 7 (42 
days) and morphologically, these cells began to flatten towards passages 8-10 (Fig 3.5 G, H). 
Thus, cells from passages 3 to 6, which were morphologically similar to that of MSCs (Fig. 3.4 
D-E), were used for islets and MSCs co-culture experiments in order to maintain uniform results. 
3.1.3    Islet development from co-culture of PPDL islets and MSCs 
3.1.3.1 Development of Islets in direct co-culture with or without MSCs 
To determine whether MSCs induce neogenesis in cultured islets, islets and mesenchymal cells 
were isolated from rat tail pancreas 24 h PPDL and sham operation (SOC), and cultured islets in 
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direct apposition with or without MSCs in serum free RPMI 1640 culture medium. On this basis, 
islet development was analysed by assessing the morphological changes and the expression of 
Pdx1, Ngn3 and insulin in islet cells cultured with or without MSCs as shown in Fig. 3.6. 
 
Figure 3.5. Morphology of expanded adherent fibroblastic-like cells at different passages. 
Purity of adherent fibroblastic-like MSCs was verified by immunostaining for contaminants 
(negative selection). Left Panels: Mesenchymal stromal cells in culture medium at different 
passages. In Panel B, < 2% of cell population stained positive for Ngn3 (red/orange), Panel C, < 
1% stained positive for CK7(red/orange)/insulin (green) before passaging ( P0-day 2). In Panels 
E,F,H & I, more than 99% of the cells stained negative for Ngn3, CK7 and insulin ( P5- day 1, 
P8- day 6 (confluent culture) Nuclei stained with DAPI. Scale bar  = 100µm.   
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3.1.3.2 First week of islets development in culture with and without MSCs 
Figure 3.6 shows islets in culture with and without MSCs of sham operated controls (SOC) and 
24 h splenic duct ligated tissues. As shown in Figure 3.6, in 24 h PPDL islet cultures without 
MSCs, islets with smooth edges were clearly observed after 1 day of culture (Fig.3.6 I). After 3 
days, small protrusions (lobules) of proliferating cells from the edges of islets were seen, either 
as attached to the islets, or as individual structures (Fig. 3.6 J). Similar results were observed in 
cultures of islets only isolated from sham operated normal controls (SOCs) cultured alone 
(Fig.3.6 A, B).  Between days 5 and 7, these proliferating cells in 24 h PPDL islet cultures 
became elongated, at the same time, some became delaminated and migrated outwards giving a 
serrated morphology of the islets (Fig. 3.6 K, L) which was similarly observed in control SOC 
islets cultured alone (Fig.3.6 C, D).  
 
When cultured with MSCs, in contrast, 24 h PPDL islet cells proliferated rapidly and by day 3 of 
culture, these cells expanded into MSCs with proliferating cells from the edges of the islets 
migrating outward and expanded over MSCs up to day 7 (Fig 3.6 M-P). Comparable 
morphological changes in islet development were also observed in control SOC islets cultured 
with MSCs during the same time period (Fig. 3.6 E-H). The morphological results of the first 
week, therefore, show that the proliferative capacity of the islets is activated in both cultures with 
or without MSCs and PDL does not affect their initial proliferative capacity of islets.  
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Figure 3.6. Early development of isolated rat islets cultured by direct configuration. Islets 
and MSCs were isolated from rat pancreas 24 h post pancreatic duct ligation (PDL) and sham 
operated control (SOC)  respectively and cultured with (PDL islets + PDL MSCs versus SOC 
islets + SOC MSCs ) or without mesenchymal stromal cells (SOC islets only or PDL islets only) 
for different periods.  A-H: Representative pictures in culture medium after 1 (A, E, I and  M), 3 
(B,F, J and N), 5 (C, G, K and O) and 7 (D, H, L and P) days of culture. In M and N, islets are 
completely surrounded MSCs (white arrows). In M, proliferating islet cells migrate outward 
(white arrows) (as observed on live cultures under inverted microscope) to form new aggregates 
(black arrows), (n = 10 animals/group), Bar = 100µm.  
 
To determine whether MSCs induce neogenesis in proliferating islet cells in culture at this stage 
of islet development, the expression pattern of two transcription factors Pdx1 and Ngn3 that are 
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activated in pancreatic and endocrine progenitors during early embryonic development were 
analysed by immunocytochemistry. Pdx1 is first expressed in endodermal cells committed to 
form pancreatic bud and later is restricted to mature beta cells where it activates the insulin gene 
(Ohlsson, Karlsson & Edlund 1993). Ngn3 is expressed in endocrine precursor cells (Gu, 
Dubauskaite & Melton 2002). The study also assessed the insulin gene expression in mature beta 
cells. 
As shown in Fig. 3.7 A&B, in cultures without MSCs, surprisingly, few Pdx+ cells were first 
detected after 3 days of culture in the slides that were analysed and by the end of first week, a 
marginal increase in Pdx1 positive cells, mostly located on the peripheral of the islets, were 
recorded (Fig. 3.7 A-D). In the presence of mesenchymal cells, in contrast, more Pdx1 
expressing cells were detected from day 3 of culture than those cultured without MSCs and their 
numbers were significantly increased from day 3 up to Day 7 (p = 0.01753) when compared to 
cultures without MSCs (Fig. 3.7 F, G, H & K).  
 
Since Pdx1 is also expressed in mature beta cells where it activates the insulin gene (Ohlsson, 
Karlsson & Edlund 1993), analysis of  insulin expression was carried out in the  first week to 
assess whether insulin gene is also activated in Pdx1+ cells in the absence or presence of MSCs. 
As shown in Fig. 3.8 (A-E), cells co-expressing Pdx1 and insulin proteins were detected 
throughout the first week of culture up to day 9. Insulin expression was increased in cultures 
without MSCs throughout the week; however, very low numbers of Ngn3+ cells were detected 
throughout the first week of culture (Fig. 3.7 A-E, L) in the absence of MSCs.  
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Figure 3.7.  Expression of Pdx1 and Ngn3 during early development of islets cultured by 
direct contact with or without mesenchyme(MSCs).  Islets and MSCs were isolated from rat 
pancreas 24 h post pancreatic duct ligation (PDL) and cultured with or without MSCs for 
different periods.  Immunocytochemistry analysis of islets cells cultured with (F-J) or without 
(A-E) MSCs for different days of culture. Islet cells development was evaluated by anti-Pdx1 
(green) and anti-Ngn3 (orange/red). Nuclei were counter-stained in blue with DAPI. K-L: 
Graphs show Ngn3+ cell numbers and  absolute surface areas occupied by Pdx1+ cells in cultures 
with or without MSCs. For each culture condition, forty (40) to fifty (50) islets were analyzed. 
Data are means ± SE. **p < 0.05, (n = 10 animals/group). Scale bar = 100µm 
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Figure 3.8. Co-expression of Pdx1 and Insulin during early development of islets cultured 
by direct contact with or without MSCs. Immunocytochemistry analysis of whole mount islets 
cells isolated from rat pancreas 24-hr post pancreatic duct ligation (PDL) and cultured with (E-G 
) or without (A-D) MSCs  for  different days of culture. Islet cells development was evaluated by 
anti-Pdx1 (green) and anti-insulin (orange/red). Nuclei were counter-stained in blue with DAPI. 
K: Graph shows absolute surface areas occupied by Insulin+  and Pdx1+ cells that developed over 
different  days of culture with (Islet/MSC+) or without (Islet/MSC-) MSCs. For each chlture 
condition, forty (40) to fifty (50) islets were analyzed. Data are means ± SE. **p < 0.05 (p = 
0.0481), (n = 10 animals /group), Scale bar = 100µm. 
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In the presence of MSCs, Pdx1 co-expressed with insulin up to day 7, similar to cultures without 
MSCs (Fig. 3.8 F-I).However, insulin expression gradually decreased by day 7 (Fig. 3.8 J).  Very 
low numbers of Ngn3+ cells were also detected in cultures with MSCs up to day 7 (Fig. 3.7 L).  
At the end of first week of culture, islets were composed of largely Pdx1+/Ngn3- cells in both 
cultures with or without MSCs (Fig 3.7 A-C, G-H). However, the number of Pdx1+ cells was 
significantly higher in cultures with MSCs compared to cultures of islets only in the first 3 days 
of culture (p= 0.01753, Fig. 3.7 K). Similar results were obtained when compared to cultures of 
24 h PPDL islets + 24 h PPDL MSCs versus cultures of 24 h post SOC islets + 24 h post SOC 
MSCs controls in which significantly higher numbers of Pdx1+ cells were observed in cultures 
with MSCs than in cultures of islets only, as shown in Fig. 3.9. In 24 h post SOC islets, Ngn3+ 
cells were not detected throughout the first three days of culture both, with or without SCs, 
possibly suggesting that in the early hours of PPDL, Ngn3 is induced by factors other than those 
arising directly from MSCs.     
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Figure 3.9. Expression of Pdx1 and Ngn3 during early development of islets cultured by 
direct contact with or without MSCs.  Immunocytochemistry analysis of whole mount islets 
cells isolated from rat tail pancreas 24 h post pancreatic duct ligation (24 h PPDL) and sham 
operation (24 h SOC) and cultured without (A-D) for SOC and I-L) for PDL or with MSCs (E-
H) for SOC and  (M-P) for PDL.  Islet cells development was evaluated by anti-Pdx1 (green) and 
anti-Ngn3 (red). PDX1/NGN3 (orange). Nuclei were counter-stained in blue with DAPI. ), Scale 
bar = 100µm 
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3.1.3.3 Second week of islet development in culture with and without MSCs 
As 24 h PPDL islet cell culture with or without MSCs continued for the second week, 
differences in rates of proliferation were observed. In cultures without MSCs; rapid islet cell 
proliferation and elongation was observed between day 9 and 11 (Fig. 3.10 I, J) Elongated islet 
cells formed a mesenchyme-like sheet of proliferating cells (Fig. 3.10 I, J). However, with 
continued culturing, islet cells did not continue expanding in the absence of MSCs and failed to 
reach confluency, even after passaging twice on days 11 and 14, instead, few small spheroid 
clusters of cells began to form within the amorphous mesenchyme-like sheet of cells on day 13 
(Fig. 3.10) K), and became clearly visible on day 15 as large diffusible spheroid bodies (Fig. 3.10 
L). 
 
In the presence of MSCs, however, rapid expansion of islets cells was observed. Most islets that 
were in contact with the monolayer of MSCs expanded extensively over the MSCs (Fig 3.10 N, 
O). By day 11, proliferating islet cells changed their morphology into elongated shape similar to 
what was observed in cultures without MSCs. After similarly passaging on days 11 and 14, 
continued culturing of these cells with MSCs, however, promoted more expansion of up to 80% 
confluence by day 15 (Fig 3.10 P). The expanding islet cells did not form spheroid bodies by the 
end of second week, but appeared as an amorphous sheet of loose cells spreading over MSCs.  
Results of the SOC islets and SOC Islet/MSCs development in the second week of cultures also 
showed similar morphological features. In SOC islets cultured alone, islet-like aggregations were 
similarly observed between 13 and 15 days of culture (Fig 3. 10 C, D) while SOC islet/MSCs 
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cultures showed just few aggregations within the expanding mass of islet cells during the same 
time period (Fig. 3.10 G,H). 
 
Figure 3.10.  Further development of islets cultured by direct configuration.  Islets and 
mesenchymal cells (MSCs) were isolated from rat pancreas 24 h post SOC and pancreatic duct ligation 
(PDL) respectively and cultured with (SOC islets+ SOC MSCs versus PDL islets+ PDL MSCs) or 
without mesenchymal cells (SOC islets only or PDL islets only) for different periods.  A-H: 
Representative pictures in culture medium after 9 (A, E, I and M), 11 (B, F, J and N), 13 (C, G, K and 
O) and 15 (D, H, L and P) days of culture. Proliferating islet cells migrate outward to form new 
aggregates (arrow head), (n = 10 animals/group were analysed),  Bar = 100µm. 
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Figure 3.11. Expression of Pdx1 and Ngn3 during the second week of development of islets 
cultured by direct contact with or without mesenchyme.  Islets and mesenchymal 
cells(MSCs) were isolated from rat pancreas 24 h post SOC and pancreatic duct ligation (PDL) 
respectively and cultured with (SOC islets+ SOC MSCs versus  PDL islets+ PDL MSCs) or 
without mesenchymal cells (SOC islets only or PDL islets only) for different periods.  
Immunocytochemistry analysis of 24 h PPDL islets cells cultured without (A-D) or without (A-
D) with (E-H )  for  9 (A and E), 12 (B and F), 13 (C and G) and 15 (D and H) days of culture. I-
P: Immunocytochemistry analysis of 24 h SOC islets cells cultured without (I-L) or with (M-P) 
MSCs for same period of time. Islet cells development was evaluated by anti-Pdx1 (green) and 
anti-Ngn3 (orange/red). Nuclei were counter-stained in blue with DAPI. (n = 10 animals/group 
were analysed), Bar = 100µm. 
  
M 
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 Analysis of the expression of Ngn3, Pdx1 and insulin in 24 h PPDL islets in the second week of 
culture showed that in cultures without MSCs, Pdx1 expression continued to be expressed in the 
peripheral islet cells and increased in the second week up to day 13 (Fig. 3.11 I, J, K).  
Quantitatively, the number of Pdx1+ cells was significantly higher in cultures without MSCs 
compared to cultures with MSCs at days 9 and 12 (p = 0.01026) (n = 10) (Fig. 3.7 K). In cultures 
of islets only, Ngn3 expression reached undetectable levels in most of the slides analysed on 
days, 9 and 12, however, insulin, often co-expressing with Pdx1, continued to be expressed in 
significantly high levels compared to cultures with mesenchyme (p = 0.0481), (p < 0.05) ( n = 
10) (Fig. 3.8 D, E & K).  
  
 In the presence of MSCs, however, Pdx1 expression gradually decreased in the second week, 
and this was followed by activation of Ngn3 on day 9 such that by day 12 (Fig.3.7 I, J & L and 
Fig. 3.11 M, N), the number of Ngn3+ cells was significantly higher when compared to cultures 
of islets only ( p = 0.00102) (n = 10) (Fig. 3.7 L). Concomitantly, insulin expression decreased to 
very low levels by day 9 such that by day 12, the insulin proteins were almost undetectable in 
cultures with MSCs (Fig. 3.8 I, J & K).  
Immunostaining analysis in cultures of 24 h SOC islets only showed continual expression of 
Pdx1 in second week, however, in 24 h SOC islet/MSCs, a complete down-regulation of both 
Pdx1 and Ngn3 was observed between 9 and 12 days in the second week (Fig 3.11 E, F), but  
Ngn3 and Pdx1 expression re-appeared between 13 and 15 days of culture (Fig.3.11 G, H).   
Taken together, the results show that Pdx1 is activated in islet cells cultured both, with or 
without MSCs during the first week of culture. However, the Pdx1+ cells expanded more in 
Stellenbosch University  https://scholar.sun.ac.za
112 
 
cultures with MSCs than without MSCs and this was followed by activation of Ngn3 which 
continued to expressed up to second week (Fig. 3.7 H, I & J) and Fig.3.11 M, N).   
3.1.3.4 Third and fourth week of Islet development in culture with and without MSCs 
Since islet cells cultured with MSCs did not form islet-like structures by the end of the second 
week, the 24 h PPDL islets were cultured further up to four weeks and the results were compared 
with those that were cultured in the absence of MSCs as shown in Fig. 3.12. Morphologically, in 
islets cultured without MSCs, proliferation of islet cells drastically reduced after day 17 (Fig. 
3.12 A). No more increase in islet size was observed during third and fourth week of culturing 
islets only, even after passaging on day 24 (Fig. 3.12 H). Instead, most individual elongated islet 
cells acquired an almost round shape and continued aggregating to form huge spheroid bodies 
that began to bud off as early as 21 day of culture. (Fig. 3.12 B). Islets failed to aggregate into 
smaller clusters but appeared as a dark unified mass of cells in the absence of MSCs.  
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Figure 3.12. Further development of islets cultured by direct configuration with or without MSCs.  
Islets and MSCs isolated from pancreas 24 h PPDL were further cultured with or without MSCs for 
different periods. A-H: Representative pictures in culture medium after 17 (A and E, 21 (B and F), 24 (C 
and G) and 28 (D and H) days of culture. In A, B, C and D no further expansion was observed and islet 
cells began to form few islet-like spheroid aggregates, which were more visible on day 17. In contrast, in 
E-H, islet cells continued to expand reaching up 80%confluence by day 21, which later formed numerous 
new islet-like aggregates by day 28.  J-Q: Immunocytochemistry analysis of islets cells cultured with (M-
P) or without (I-L) MSCs for 17 (I and M), 21 (J and N), 24 (K and O) and 28 (L and P) days of culture. 
Islet cells development was evaluated by anti-Pdx1 (green) and anti-Ngn3 (orange/red). Nuclei were 
counter-stained in blue with DAPI. (n = 10 animals/group were analysed), Bar = 100µm. 
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With MSCs, few new small islet-like cell aggregates began to form within the expanding islet 
cells after 17 days and this process continued up to day 28 of culture, such that by end of the 
fourth week, numerous but small islet-like clusters were formed (Fig. 3.12 E-H). 
  
Figure 3.13. Effect of MSCs on the growth size of the islets in culture. Islets isolated 24 h 
PPDL were grown for 28 days with or without MSCs. A-F: Representative photographs of islets 
in culture medium before, after 15 days and 28 days in culture. The pictures were taken at the 
same magnification.  Upper Panels: Islets before culture. Middle and lower Panels: Islets 
cultured for 15 and 28 days with or without MSCs respectively. G: Islets after dithizone staining 
which specifically binds to zinc found in insulin granules of beta cells to mark the boundary of 
islets on mesenchymal cells.  H: Quantification of the total size of the islets before, after 15 and 
28 days in culture in the absence or presence of MSCs. The surfaces of the islets after dithizone 
staining were marked and measured and areas of all islets were added up. Thirty (30) to 40 islets 
were analysed in each condition. Data of mean values in µm2 ± SE are shown in the graph. **P < 
0.05 (n = 10 animals/group). 
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 To determine the rate and extent of islet growth during the entire period of the experiment, the 
islets samples were stained with dithizone at three time points: before culturing, on day 15 and 
on day 28, to demarcate the boundaries of beta cells as shown in Fig. 3.13. Although beta cells 
were seen to have changed their morphology and phenotypes (de-differentiated) in cultures with 
MSCs, expansion boundaries of islets were morphologically remarkable by low levels of 
dithizone staining that allowed us to quantify the absolute area occupied by islets that developed 
after 15 and 28 says of culture with or without MSCs (Fig. 3.13 A-F, G). 
 
Quantitatively, in islets cultured alone, their sizes marginally increased during the first 15 days of 
culture (Fig. 3.13 G) In the third and fourth week, their sizes did not increase any further from 
day 15 to day 28 (Fig. 3.13 B, C and G) and islets failed to reach confluence even after passaging 
every 6 days.  Results also showed that during the third and fourth week, islet cells were either 
quiescent or dead in cultures without MSCs.  Although apoptosis (TUNNEL assay) was not 
performed to confirm this, DAPI staining, however, showed intact nuclei of islet cells (Fig. 3.12 
L, M). 
 
 In the presence of MSCs, islet sizes continued to increase such that by day 28 (Fig. 3.13 H) there 
was significant difference in the size of islets (p = 0.001031) in cultures with MSCs compared to 
cultures without MSCs (Fig. 3.13 [C compared with F], H). The final number of new islet-like 
clusters (appeared as dark spots) that developed from individual islets seeded in week one was 
significantly higher in cultures with MSCs compared to those formed from islets cultured 
without MSCs (Fig 3.12 [D compare with H], Fig. 3.13 (C compare with F) though direct 
quantification was not done. 
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Following Pdx1 was downregulation, Ngn3 was highly activated in cultures with MSCs at the 
end of second week and the fate of Ngn3+ cells was further investigated in the third and fourth 
weeks. Immunocytochemical analysis of Pdx1 and Ngn3 expression in islet-like aggregates 
formed during third and forth weeks showed that in cultures without MSCs, Pdx1 expression was 
down regulated at the beginning of third week of culture and the repression of this gene 
continued to the end of third week (Fig. 3.12 J, K) during which few Ngn3+ cells were transiently 
detected between day 17 and 21 of culture (Fig. 3.12 J,K). As expected, Ngn3 was rarely 
detected thereafter. After down regulation of Ngn3 on day 21, Pdx1 continued to be down 
regulation in the fourth week, such that by day 28, Pdx1 proteins were rarely detected in cultures 
without MSCs (Fig. 3.12 L, M).  
 
 3.1.3.5 Ngn3 expression is maintained in islet cells cultured with mesenchyme 
 
Interestingly, in the presence of MSCs, Ngn3+ cells began to be detected in the second week 
from day 9 of culture, a time point when Pdx1 expression was repressed (Fig. 3.7 I, J). Ngn3 co-
expressed with Pdx1 between day 9 and day 12 (Fig. 3.7 I, J).  Ngn3+ cells were continuously 
detected in the third week. On day 24, significant higher levels of Ngn3+ cells were detected in 
cultures with MSCs (p = 0.03702; p < 0.05) when compared with cultures without mesenchyme 
(Fig. 3.12 [L compare with P], Fig. 3.14 [A compare with D], G). We continued detecting high 
levels of Ngn3+ cells with few cells co-expressing Ngn3 and Pdx1 in the fourth week up to day 
28 of culture (Fig. 3.12 Q and Fig. 3.14 [C compare with F], G) possibly suggesting that high 
numbers of Pdx1+ cells have differentiated to Ngn3+ cells.  
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Figure 3.14. Expression of Insulin and Ngn3 during in vitro development of islets cultured 
by direct contact with or without MSCs.  Immunocytochemistry analysis of islets cells isolated 
24 h PPDL and cultured without (A-C) or with (D-F) MSCs for 24, 26 and 28 days of culture. 
Islet cells development was evaluated by anti-insulin (green) and anti-Ngn3 (orange/red). G-H:  
Graphs show the absolute surface areas occupied by insulin+ cells and Ngn3+ cells cultured with 
or without MSCs  for 24, 26 or 28 days. For each condition, forty (40) to fifty (50) islets were 
analyzed. Data are means ± SE. *P < 0.05 (P = 0.03702) (n = 10 animals/group). Scale bar = 
100µm 
 
3.1.3.6 Expression of Insulin is lower in islets cultured with MSCs 
Since Ngn3 was continuously detected in islets in the fourth week of culture with MSCs, analysis 
of insulin expression was carried out to assess the maturity and functionality of islet cells in 
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culture. At the beginning of the fourth week, insulin expression was significantly higher in islets 
cultured alone than those cultured with MSCs (Fig 3.14 [A-C compare with D-F], H). Insulin 
expression gradually increased in cultures with MSCs towards the end of the seventh week; 
however, its expression was lower compared to islets cultured without MSCs (Fig. 3.14 H). In 
addition, in cultures with MSCs, a higher percentage of cells located at the center of islets co-
expressed insulin and Ngn3 up to day 28 of culture (Fig. 3.14 F). Single nuclear Ngn3+ cells 
were detected in the periphery of the islets (Fig. 3.14 C, F). 
3.1.3.7 Development of islets in indirect co-cultures 
To assess whether increased proliferation of Pdx1+ cells and maintenance of Ngn3 expression in 
islet cells were due to their direct cell-to-cell contact with MSCs, rather than to some trophic 
factors released by mesenchymal cells in culture medium, an indirect co-culture system was set 
up with islets and mesenchymal cells isolated from 24 h PPDL tail pancreas. Mesenchymal cells 
were attached as a monolayer at the bottom of the dish while floating islets were physically 
separated by a Transwell membrane that allowed the sharing of the same culture medium by the 
two populations of cells. Different from the results obtained with direct co-cultures, islets cells 
expanded extensively, but without changing their individual cell morphology (Fig. 3.15 [C-D 
compare with K-L]). Islet cells maintained their round/oval shapes during expansion in indirect 
co-cultures. After 3 weeks of indirect co-culture, islets continued to expand but failed to form 
small individual islet-like cell aggregates at the end of the third when compared to islets co-
cultured directly on MSC monolayer (Fig. 3.15 Q-T compare with U-X).  
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Figure 3.15. Development of islets cultured by indirect configuration.  Islets and MSCs were 
isolated from rat pancreas 24 h post pancreatic duct ligation (PDL) and cultured with or without 
MSCs for different periods.  A-X: Representative pictures of islets in culture medium at different 
days of culture by direct and indirect configuration. In Q-T, proliferation of islet cells 
progressively formed islet-like spheroid aggregates while in U-X islet cells continued to 
proliferate and migrated outward and floated in suspension or at liquid-air interface. Bar = 100µ 
   
However, proliferating islets that grew at the liquid-air interface, later formed more islet-like cell 
aggregates that spread over culture medium while those that grew on the transmembrane failed to 
form individual cell aggregates by day 24 of indirect co-culture (Fig.3.16 T, Y), similar to the 
morphology of islets cultured alone directly (Fig.3.12 C, D ). The study did not explore further to 
understand why there is such a difference in their mode of development due to shortage of 
antibodies to test this.  Further investigations are needed to find the reasons for the difference. 
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Figure 3.16. Development of islets cultured by indirect configuration. Q-X: Representative 
pictures of islets in culture medium at different days of culture by direct and indirect 
configuration. In T and Y, proliferating islet cells that floated at liquid-air interface progressively 
formed islet-like spheroid aggregates (dark spots) while in Z islet cells continued to proliferate 
and migrated outward and formed a large cell mass on a filter membrane. Bar = 100µm   
 
3.1.3.8 Pancreatic duct ligation (PDL) has no effect on the developmental potential of islets 
in culture. 
To ascertain whether PDL influences the developmental potential of islets in vitro, islets and 
MSCs were also isolated from the 120 h PPDL tail pancreata and cultured with or without MSCs 
by direct contact. The choice of post-PDL times of 24 and 120 hours was based on evidence 
from previous study (Tchokonte-Nana 2011) that defined the time points as landmarks in which 
similar pancreatic morphological changes and specific gene expressions were observed in the 
pancreas following pancreatic duct ligation.   
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Results were compared with cultures of islets with or without MSCs isolated from 24 h PPDL 
and SOC tail pancreata also cultured by direct contact.  With 120 h PPDL samples, analysis of 
islets development in culture was carried out for only 2 weeks due to scarcity of tissue samples 
and time limitations. 
  
Figure 3.17. Co-expression of Pdx1 and Ngn3 during early development of islets cultured 
by direct contact with or without MSCs.  Islets and mesenchymal cells were isolated from rat 
tail pancreas 24- and 120 h post pancreatic duct ligation (PDL) and cultured with or without 
MSCs for different periods.  Immunocytochemistry analysis of whole mount islet cells cultured 
with (U-X) for 24- and (Y-BB) for 120 h PDL, or without (Q-T) MSCs for 24 h PPDL.  Islet 
cells development was evaluated by anti-Pdx1 (green E) and anti-Ngn3 (red). PDX1/NGN3 
(orange). Nuclei were counter-stained in blue with DAPI.     Bar = 100µm. 
 
3.1.3.9 Comparative development of 24 h- and 120 h PPDL islets in culture 
Fig. 3.17 shows morphological and immunocytological analyses of islets isolated from 24- and 
120 h PPDL pancreata and cultured with or without MSCs for one week.  In cultures without 
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MSCs, similar morphological changes in islet development were observed between the 24- and 
120 h PPDL islets, with peripheral islet cells progressively changing their round outline to 
elongated shapes as they proliferated and migrated away from the islets (Fig. 3.17 [A-D compare 
with I-L]). Similarly, in the presence of MSCs, more expansion of islets cells was observed 
compared to cultures of islets alone (Fig 3.17 A-D compare with E-H versus I-L compare with 
M-P]). When compared to SOC islets, a similar developmental pattern was observed during the 
first week of culture with islets expanding more in cultures with MSCs than without MSCs 
(Fig3.18 A-D compare with E-H versus I-L compare with M-P) in 24- and 120 h post SOC islets 
respectively.  
Immunocytochemical analyses also showed an equivalent Pdx1 expression in cultures of both 
groups (24- and 120 h PPDL islets) with MSCs compared to cultures of islets only (Fig 3.17 Q-S 
compared to U-W and Y-AA) in the first 5 days. However, a co-expression of Pdx1 and Ngn3 
was detected on day 1 in 120 h PPDL islets with MSCs, which disappeared by day 3, while in 24 
h PPDL islets, Ngn3 was rarely detected (Fig. 3.17 U-V and Y-Z).  By day 7, Pdx1 was down 
regulated while Ngn3 was highly activated and co-expressed with Pdx1 in 120 h PPDL islets 
with MSCs (Fig.3.17 BB). A similar but low level of Ngn3-Pdx1 co-expression was also 
observed in 24 h PPDL islets with MSCs (Fig.3.17 X) during the same time period.  
When compared to SOC islet cultures, Pdx1 was highly expressed in both 24- and 120- SOC 
islets cultured with MSCs for the first three days (Fig. 3.19 A-B, E-F).  
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Figure 3.18 Development of islets isolated from sham operated rat pancreata 24- and 120 h 
post surgery. Islets and mesenchymal cells were isolated from Sham operated control (SOC) rat 
pancreata 24- and 120 h post operation and cultured with or without MSCs for different periods.  
Representative pictures of islets in culture medium. Scale bar = 100µm 
 
From day 5 to 7 Pdx1 was down regulated followed by activation of Ngn3. Double positive cells 
for Pdx1 and Ngn3 were detected on day 5 in both SOC groups cultured with MSCs and by day 
7, more Ngn3+ cells were recorded in 120 h SOC cultures than in 24 h SOC cultures (Fig. 3.19 
G-H, K-L; S-T W-X).   Ngn3 was not detected in islets cultured alone throughout the first week 
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and the first 3 days in cultures with mesenchyme (Fig. 3.19 M-P) despite SOC islets displaying 
similar morphological developmental pattern to 24- and 120 h PPDL islets. 
  
Figure 3.19 Expression of Pdx1 and Ngn3 during early development of SOC islets cultured 
by direct contact with or without MSCs.  Islets and MSCs were isolated from Sham operated 
control (SOC) rat pancreata 24- and 120 h post operation and cultured with or without 
mesenchymal cells for different periods.  Representative pictures of immunocytochemistry 
analysis of islets cells cultured without (A-D, M-P) or with (E-H, Q-T) for  24 h SOC; (I-L, U-X) 
for 120 h SOC for  different days of culture. Islet cells development was evaluated by anti-Ngn3 
(orange/red) and anti-Pdx1 (green). Nuclei were counter-stained in blue with DAPI. Scale bar = 
100µm 
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Figure 3.20. Co-expression of Pdx1 and Ngn3 during early development of islets cultured 
by direct contact with or without MSCs.  Islets and MSCs were isolated from rat tail pancreas 
24- and 120 h post pancreatic duct ligation (PDL) and cultured with or without MSCs for 
different periods.  Immunocytochemistry analysis of whole mount islets cells cultured with (Q-
T) for 24 h PPDL and U-X for 120 h PPDL, or without (M-P) for 24 h PPDL.  Islet cells 
development was evaluated by anti-Pdx1 (green) and anti-Ngn3 (red). PDX1/NGN3 (orange). 
Nuclei were counter-stained in blue with DAPI. (n = 10 animals/group were analysed) Scale bar 
= 100µm 
 
In the second week, both 24- and 120 h PPDL islets showed comparable expansion rates in 
cultures with MSCs (Fig. 3.20 E-H, I-L). A few islet-like cell aggregates (appeared as dark 
spots) were observed toward the end of second week in 120 h PPDL but not in 24 h PPDL 
cultures with MSCs (Fig. 3.20 G-H, K-L). Analysis of Ngn3 and Pdx1 in the second week 
showed that Pdx1 is downregulated in both groups cultured with MSCs, while Ngn3 was highly 
activated from day 9 up to day 13 of culture with more Ngn3+cells in 120 h PPDL islet cultures 
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than in the 24 h group (Fig. 3.20 Q-S, U-W). After day 13, Pdx1+ cells reappeared and co-
expressed with Ngn3 which was getting downregulated by day 15 in both groups (Fig. 3.20 T, 
X). Comparable high levels of Pdx1-Ngn3 co-expression were detected in islet-like cell clusters 
that developed within the cultures of islets with MSCs in both 24- and 120 h PPDL islet groups.   
To summarise, in our co-cultures of islets and MSCs, expansion of Pdx1+ / Ngn3- islet cells was 
observed at early hours when co-cultured with or without MSCs; however, islets co-cultured 
with MSCs registered a higher number of Pdx1+ cells. Pdx1 expression was down-regulated in 
these cells at 9 days of culture followed by an up regulation of Ngn3, while Ngn3 expression was 
maintained in islet cells up to 28 days, after which aggregations of numerous spheroid bodies 
resulted in islet-like structures.  
3.2 Development of PPDL duct fragments in culture 
In addition to investigating the effects of MSCs on pre-existing islet cells, it was also tested 
whether MSCs also stimulate duct epithelial cells to regress to a lesser differentiated phenotype 
and act as progenitors to form new insulin producing cells in culture. For this reason, 
assessement of the morphological changes and the expression of Pdx1, Ngn3 and insulin in 
cultured duct fragments were made.  
3.2.1 Morphological changes of ducts in culture. 
3.2.1.1 First and second weeks of ducts in culture 
Figure 3.21 shows early development of ducts in culture with or without mesenchymal stromal 
cells (MCSs). As shown in Fig. 3.21 A, in the absence of MSCs, duct epithelial cells proliferated 
and sealed up the cut ends of the ducts within 3 days of culture (Fig. 3.21 A, B) with some 
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proliferating cells forming small evaginations (growth areas) on the sides and near the tip of 
small ducts on day 3 (Fig. 3.21 B). 
During the same time period, ducts cultured in the presence of MSCs showed similar 
morphological changes by sealing the cut ends and developing epithelial evaginations as growth 
areas (Fig 3.21 D, E). By day 5 of culture, many ducts made point attachments to plastic 
substrate while the rest of the segments were suspended into the medium in both culture 
conditions, only few smaller fragments were still lying attached to the bottom of the dish. 
  
Figure 3.21. Early development of ducts in culture with or without MSCs for different periods.  A-
F: Representative pictures after 1 (A and D), 3 (B and E), and 5 (C and F) days of culture. In C, terminal 
duct cells (centroacinar cells) proliferate at the tip duct epithelium. G-L: Immunocytochemistry  analysis 
of duct cells cultured without(G-I) or with (J-L) MSCs  for  1 (G and J), 3 (H and K ) and 5 (I and L) 
days of culture. Duct fragment development was evaluated by anti-insulin (yellow) and anti-Ngn3 
(orange/red). Nuclei were counter-stained in blue with DAPI. Arrows indicate growth areas. MSC± = 
Mesenchymal stromal cells; PDEC = Pancreatic duct epithelial cells, (n = 10 animals/group were 
analysed), Bar = 100µm 
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At this time, however, a few noticeable differences in morphology of the ducts were observed 
between culture conditions. In ducts cultured alone, their cells continued to proliferate and 
formed more evaginations (growth areas) resulting into ducts becoming thicker and longer (Fig. 
3.21 C). Few cuboidal periductal cell outgrowths were observed on the side of the ducts (Fig 
3.21 C, arrows) and few squamous, possibly centroacinar cells were seen at the tip (Fig.3.21 C), 
while in ducts cultured with MSCs, evaginations became more prominent and a few periductal 
cells began to migrate into suspension (Fig. 3.21 E, F).   
3.2.1.2 Expression of Ngn3 in cultured duct cells 
Previous in vitro studies indicated that MSCs might control the differentiation of epithelial cells 
in embryonic pancreas (Gittes et al. 1996), For this reason, in both cultures, 
immunocytochemistry analysis was carried out for the expression of Ngn3, a transcription factor 
that marks endocrine precursor cells in proliferating duct cells (Gu, Dubauskaite & Melton 2002) 
as stated in sections 3.1.3.2. As shown in Fig. 3.21 (H, K), nuclear Ngn3+ cells were first 
detected in duct epithelial cells on day 3 of culture both, with or without MSCs. At this time, 
more Ngn3 + cells were detected in tips and other zones of cell proliferation (growth areas) in 
both culture conditions (Fig 3.21 H, K). In cultures without MSCs, however, Ngn3 expression 
was also detected in scattered cells around ducts on day 5 (Fig 3.21 I) and this expression 
continued up to day 7, when few cells co-expressing Ngn3 and insulin began to be detected (Fig 
3.24 M).  
 
In ducts cultured with MSCs, Ngn3 was highly expressed within the epithelium cells of ductal 
buds on day 5 (Fig 3.21 L). Ngn3+ cells were clustered in growth areas that were distributed 
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throughout the duct epithelium, typical for this developmental stage (Fig.3.21 L). Ngn3+ cells 
were later scattered around ducts on day 7 (Fig.3.24 P). From day 9, Ngn3+ cells were 
continuously detected in some cell clusters as well as in scattered individual cells up to day 12, 
with some Ngn3+cells often co-expressing insulin (Fig 3.24 Q, R). 
3.2.1.3 Co-expression of Ngn3 with CK7 
To find out whether these Ngn3+ cells arise from duct epithelium, a series of double labeling 
reactions were conducted. Double immunolabeling reactions revealing cytokeratin 7 (CK 7) and 
Ngn3 on whole mounts of duct fragments of 1- to 5-day old cultures showed that in cultures 
without MSCs, the ductal epithelium is largely composed of CK7+ cells with some few cells 
located within the ductal epithelium and periductal areas co-expressing CK7 and Ngn3 (Fig. 3.22 
D, F).  In cultures with MSCs, most epithelial cells in growth areas displayed double 
immunoreactivity of CK7 and Ngn3 from day 1 and by day 5 more periductal cells in the growth 
regions of the ducts co-expressed CK7 and the nuclear Ngn3 proteins (Fig. 3.22 J, K and L), 
providing evidence of the epithelial nature of Ngn3+ cells.  At this stage of duct development, 
we did not detect CK-/Ngn3+ cells in duct epithelial or periductal growth areas in most of the 
slides examined.   
In the second week of culture, ducts showed more morphological changes. In cultures without 
MSCs, more squamous cells proliferated at the tip (Fig. 3.24 G), which later adopted cuboidal 
shapes by day 9 (Fig. 3.24 H). After day 9, few islet-like cell clusters were formed by periductal 
cells (Fig. 3.24 H, I). In contrast, with MSCs, more clusters and cell migrations were observed on 
day 7. These clusters grew and formed islet-like structures within the periductal area (Fig. 3.24 J, 
K, L). By the end of second week, ducts developed more branches in both culture conditions 
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(Fig. 3.25), however, in the presence of MSCs, epithelial lining became thicker and more 
branches developed (Fig. 3.25 O, P) 
 
Figure 3.22. Morphological and immunocytochemical characterization of cells of duct 
fragments cultured without (A-F) or with (G-L) MSCs at different time periods. 
Immunofluorescent reactions showing the distribution of cytokeratin 7+ (CK7+) (green), Ngn3+ 
(red) and double positive CK7+/Ngn3+ (yellow to orange) cells in duct fragments. A-C and G-I: 
Representative pictures of ducts in culture medium. Bar = 100 µm. MSC± = ± Mesenchymal 
stromal cells; PDEC = Pancreatic duct epithelial cells, (n = 10 animals/group were analysed). 
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Figure 3.23. Further morphological and immunocytochemical characterization of cells of 
duct fragments cultured without (A-H) or with (I-P) MSCs at different time periods. 
Immunofluorescent reactions showing the distribution of cytokeratin 7+ (CK7+) (green), Ngn3+ 
(red) and double positive CK7+/Ngn3+ (yellow to orange) cells in duct fragments. A-D and I-L: 
Representative pictures of ducts in culture medium. (n = 10 animals/group were analysed), Bar = 
100 µm; MSC± = ± Mesenchymal stromal cells; PDEC = Pancreatic duct epithelial cells, (n = 10 
animals/group were analysed). 
  
Double reactions carried out on whole mount duct fragments in the second week, revealed the 
continued presence of the double immuno-reactive cells co-expressing CK7/Ngn3 located within 
the ductal epithelia as well as in growth areas up to day 15 in cultures without MSCs and day 12 
in cultures with MSCs (Fig. 3.23 E-H, and M-O, respectively). In cultures with MSCs, single 
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immuno-reactive cells for Ngn3 and CK7 were respectively present in scattered and ductal 
epithelial cells on day 15 (Fig. 3.23 P)  
3.2.1.4 Expression of insulin in cultured duct epithelial cells  
Since Ngn3 was continuously detected in duct epithelial cells in the second week of culture with 
MSCs, double labeling reactions revealing the expression of insulin and Ngn3 were next carried 
out to further assess the differentiation potential of Ngn3+ cells within the duct epithelium as 
well as in cell aggregates located close to ducts.  
In ducts cultured alone, insulin expression was first detected in cell aggregates on day 7, with a 
number of insulin+ cells that transiently co-expressed Ngn3 up to day 9 (Fig.3.24 G, H).  
However, after day 9, double-positive cells for Ngn3 and insulin were not detected while higher 
numbers of single-positive insulin expressing cells were detected in cell aggregates cultured 
alone than those cultured with MSCs up to day 12 (Fig 3.24 [I compare with L]), possibly 
reflecting an early differentiation of Ngn3 expressing cells into insulin-producing cells.  
In ducts cultured with MSCs, insulin expression similarly began to be detected from day 9 but its 
expression was lower compared to ducts-derived cell aggregates cultured alone. In addition, in 
cultures with MSCs, double-positive cells for insulin and Ngn3 were continuously detected up to 
day 12 of culture (Fig. 3.24 K, L ), a result that could possibly suggest a delayed stage of 
differentiation into endocrine cells.  
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Figure 3.24. Later development and immunocytochemical characterization of pancreatic 
epithelial duct cells (PEDC) in culture with or without MSCs for different periods.  A-F: 
Representative pictures in culture medium after 7 (A and D), 9 (B and E), and 12 (C and F) days 
of culture. In C: Cell clusters are formed close to ducts (Arrows). E,F: Cell clusters are formed 
close to and tip of ducts (Arrows) . G-L: Immunocytochemistry  analysis of duct cells cultured 
without (G-I ) or with (J-L) MScs  for  7 (G and J), 9 (H and K ) and 12 (I and L) days of culture. 
Duct fragments development was evaluated by anti-insulin (green/yellow) and anti-Ngn3 
(orange/red). Nuclei were counter-stained in blue with DAPI.  Bar = 100µm;   MSC± = ± 
Mesenchymal stromal cells, L = lumen; PDEC = Pancreatic duct epithelial cells; (n = 10 
animals/group were analysed). 
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Figure 3.25. Later development of ducts in culture with or without MSCs cells for different 
periods.  A-L Representative pictures taken in culture medium after 14 (A and D) and 16 (B and 
E) and 20 (C and F) days of culture. In I and L, more cell clusters are visible around ducts 
(asterisks). Bar = 100µm; MSC± = ± Mesenchymal stromal cells; PDEC = Pancreatic duct 
epithelial cells;  (n = 10 animals/group were analysed). 
3.2.1.5 Third and fourth weeks of ducts in culture. 
In the third week of culture, periductal budding were more visible in cultures without MSCs 
(Fig. 3.25 A, B, C) while in cultures with MSCs, ducts became highly branched up to day 20 and 
22 (Fig .3.25 D-F), with proliferating periductal cells migrating to form a sheet of cells on the 
sides of ducts that were later aggregating into cells clusters (Fig. 3.25 E,F).  This early phase of 
development ended up with ducts becoming highly branched and interspaced between sheets of 
proliferating cells.  
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Observations of later stages in the fourth week showed increase in branching of ducts in both 
conditions (Fig. 3.25). Within the sheets of migrating cells, aggregations of cells began to form 
between branches of ducts in both culture conditions (Fig. 3.25). These clusters of cells were 
more visible on days 24 and 26 in both cultures with or without MSCs (Fig. 3.25). However, cell 
clusters formed more spheroid bodies closer to ducts in cultures with MSCs than around ducts 
cultured alone (Fig. 3.25 [compare G & J, and also H & K]) although this was not verified by 
quantitative data. These cell clusters were morphologically more similar to endocrine islets than 
exocrine acini, suggesting that these proliferating cells possibly continued to differentiate into 
endocrine cells. With continued culturing, our morphological data showed spheroid bodies that 
were attached to ducts and later began to bud off from duct structures (Fig 3.25 I, L).  
 
 
To assess the fate of Ngn3+ cells, immunocytochemical analysis of later stages of duct 
development showed that de-differentiated duct Ngn3+ cells could further differentiate into 
insulin producing cells in both culture conditions. However, in the presence of MSCs, Ngn3 
expression was maintained up to two weeks in periductal cells and scattered cells resulting into 
fewer Ngn3+ cells proceeding to differentiate into insulin producing cells. 
3.3 Efficacy of PPDL islets as donor tissue for treatment of STZ-induced diabetic rats 
In addition to investigating the effects of MSCs on pre-existing islet and duct epithelial cells, the 
study also explored whether MSCs can influence the transplantation outcome of islets isolated 
early PPDL surgery. Streptozotocin-induced diabetic Wistar rats were syngeneically transplanted 
with islets harvested either 24- or 84 hours (h) post ligation. In a second group, 24 h PPDL islets 
were syngeneically transplanted either alone or with PPDL pancreas–derived MSCs underneath 
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the renal capsule. Blood glucose levels were monitored and graft morphology was evaluated by 
immunohistochemistry. Efficacy of these cells was analysed for a period of 67 days.  
 3.3.1 Blood glucose levels (BGLs) trends 
To assess the efficacy of PPDL-pancreas as a donor tissue in diabetic animals, three groups of  
rats with fasting blood glucose >11 mMol/L were used as transplant recipients of PPDL islets 
from syngeneic donors as shown in Fig. 3.26.  The results showed that transplantation of normal 
islets under the renal capsule produced superior glycemic controls compared to those that 
received 24 h and 84 h PPDL islets (p = 0.0362), as shown in Fig.3.26. The 24 h PPDL islet 
transplants group also showed more superior outcome than those implanted with 84 h PPDL 
islets.   The mean concentrations of blood glucose of rats with normal islets isografts were 
significantly lower than that of rats that received islets from both 24- and 84 h PPDL donor 
groups, at the third and seventh weeks   post transplantation (p = 0.0362) (Fig. 3.26). Between 
fourth and fifth weeks post transplantation, both 24 h PPDL and normal islet grafts showed 
recovery from diabetes with no significant difference in glycemic levels observed between 
recipients of normal islets and 24 h PPDL islets (p = 0.537). However, there was a significant 
difference in glycemic levels between 24- and 84 h PPDL islet implant groups within the same 
time frame (p = 0.0015).  
Considering high graft failure in 24 h PPDL syngeneic islet group between 6 weeks and 9 weeks 
post transplantation (Fig. 3.26), another experiment evaluated the effect of MSCs on graft 
survival and function.  As shown in Fig. 3.26, the results showed striking early increase in islet 
function in recipients of islets only compared to recipients of Islet/MSCs co-transplants and this 
trend continued up to 5 weeks. After 6 weeks, however, diabetes recurrence was observed in 
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animals transplanted with islets only, whereas in animals that received co-transplants, islet 
function gradually increased. 
 
Figure 3.26. Transplantation of early PPDL islets into STZ-induced diabetic rats. Graph 
shows different patterns of blood glucose levels in various groups of rats , healthy controls (black 
diamond),  STZ –induced diabetic untreated rats (Diabetic-black rectangle), treated  with normal 
islets without MSCs (red triangle), treated with 24 h PPDL islets without MSCs (dotted line with 
cross), treated with 24 h PPDL islets with MSCs (red line with cross) and treated with 84 h 
PPDL islets without MSCs ( circle) during study time period. Data prresented as means ± SE, p 
< 0.05 (p = 0.0362),  (n = 10 animals/group) 
 
 
 When analysis of fasting blood glucose as a function of time was performed at the time of 
diabetes recurrence (5 weeks post transplantation) within each group, a remarkable trend towards 
an increase in islet function was observed in animals that received islet/MSCs (Fig. 3.26). Mean 
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values of blood glucose levels for animal recipients that received islets only increased drastically 
within the same time frame indicating a decrease in islet function in absence of MSCs (Fig. 3.26) 
3.3.2 Survival and function of islet grafts  
In the 24 h PPDL transplant group that received islets only (Islet/MSC-), 5/10 or (50%) reached 
average fasting blood glucose of 11.7 mMol/L by 3 weeks compared to 1/10 or (10%) rats that 
received islets only isolated from syngeneic donors 84 h post ligation (Fig. 3.26 and Fig. 3.27A). 
By 5 weeks 8/10 or (80%) of the 24 h PPDL transplant group had an average glycemic level of 
10.1 mMol/L compared to 2/10 (20%) of the 84 h PPDL recipients. Glycemic levels were 
monitored for further 7 weeks at which time diabetes recurred in both groups with 8/10 (80%) of 
84 h group and 6/10 (60%) of the 24 h group sustaining hyperglycemia after week 9 (Fig 3.26 
and Fig. 3.27A). Marginal differences in glycemic levels were observed between groups but not 
statistically significant (  = 0.287). The curative capacity of 24 h post islets was better than 84 h 
PPDL islets.  The average time to reverse hyperglycemia in 80% of the 24 h PPDL transplant 
group was 32± 2 days (~4.5 weeks,) whereas only 2 rats (20%) in the 84 h PPDL transplant 
group attained normoglycemia at 61 ± 2 days (~9 weeks) (p = 0.0011, n = 6) post transplantation 
(Fig. 3.27 A). 
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Figure 3.27. Graft survival of syngeneic islets transplanted into STZ induced diabetic rats. 
Panel A: Graph shows number of  rats (%) remaining hyperglycemic (BGL > 11 mMol/L) after 
STZ (untreated diabetic- [black rectangle]), transplantation with 24- (black circle) and 84 h 
(black diamond) PPDL islets. Panel B: Graph shows mean body weights of  healthy control rats,  
diabeteic rats treated with 24 h PPDL islets without mesenchyme (Islet/MSC-) and 84 h PPDL 
islets (Islet/MSC-) groups during 10 week study period (Day 67, black  bar) from time of islet 
transplantation (Day 0, clear bar). Islet/MSC- =  recipients of islets without mesenchyme  
isolated 24- or 84 h post ligation. STZ = Streptozotocin; Data are means ± SE. **p < 0.05, t-test; 
(n = 10 animals/group were analysed). 
 
Stellenbosch University  https://scholar.sun.ac.za
140 
 
 
Next, the proliferative potential of the grafts in both recipients with 24- and 84 h PPDL islets was 
explored using Ki67 immuno-labeling at 7 weeks post syngeneic transplantation. Marginal but 
statistically different  numbers of Ki67+ cells in the islets were observed between the two groups 
(351 of 2,562 [13.7%] versus 345 of 1,990 (17.3%]) for the 24 h post-PDL islets vs. 84 h PPDL 
islet recipient groups respectively, (Fig. 3.29). In addition, no significant differences 
in weights of rats was observed in either transplant group on day 0 (210 ± 1.0 and 209 ± 0.8 g for 
24 h PPDL and 84 h PPDL recipients, respectively, n = 8, p = 0.435) or on day 67 after 
transplantation (181.4 ± 0.3 and 175.9 ± 0.8, p = 0.71, n=8) (Fig. 3.27 B). Accordingly, 
immunohistochemical analysis of the pancreas of the isograft recipients showed very few cells 
that stained positive for insulin indicating no signs of regeneration of beta cells (Fig. 3.30 D). 
Together, these results therefore indicate an early but transiently longer curative capacity by 
syngeneic 24 h PPDL islet grafts which lasted up to 5 weeks compared to 84 h PPDL islet grafts 
that lasted for only two weeks.  
3.3.3   Islet graft histomorphological study 
Decrease in graft function and recurrence of diabetes in both the 24- and 84 h PPDL recipient 
groups was observed at 7 weeks and thereafter post transplantation (Fig. 3.26), a result that 
prompted to histologically examine their grafts. Microscopic examination of hematoxylin and 
eosin graft sections obtained from 2 animals from each group, 7 weeks post transplantation, 
showed a strong lymphocyte mononuclear infiltration on the site of transplantation in both 24- 
and 84 h PPDL grafts as well as in control group transplanted with normal islets (Fig. 3.28 F, G, 
H, and I). Despite lymphocyte mononuclear filtration in both groups (24- and 84 h PPDL grafts), 
islet structure was maintained in normal islet control and among 24 h PPDL islets transplanted 
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groups (Fig.3.28 J, K), whereas in recipients of 84 h PPDL islets, the grafts were mostly 
destroyed after 7 weeks (Fig. 3.28 I, M).  
 
Figure 3.28.  Histomorphometric analysis of grafts in recipients of 24- and 84 h PPDL islets 
at 7 weeks post transplantation. A-D: Hematoxylin and Eosin staining of islet grafts in healthy 
male rats (A) and STZ-induced diabetic rats  treated with 24 h PPDL islets/MSC+ (B), 
Islets/MSC- (C) and with 84 h PPDL islets/MSC- (D) at 5 weeks post transplantation. Panels E-
H: Ki67 staining (brown) in healthy male (E), 24 h PPDL silets/MSC+ (F) islets/MSC- (G) and   
84 h PPDL islets/MSC- (H). Panels I-L insulin staining in the same four groups. Bar = 100 µm. 
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Figure 3.29.  Cell proliferation analysis of grafts in recipients of 24- and 84 h PPDL islets at 
7 weeks post transplantation. Graph shows percentage of Ki67-positive proliferating cells per 
graft section. * P = 0.3226, **P= 0.04207 (n = 10 animals/group were analysed). 
 
   
Figure 3.30. Endocrine cell density in isografts. Quantification of  mean total endocrine area 
stained (A) in graft sections (n= 10 animals per transplant group, P = 0.471, student’s t-test) and  
mean individual endocrine aggregate area (B) in graft sections, n= 10 animals per transplant 
group, *P= 0.0321, student’s t-test. 
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At 9 weeks post transplantation, kidneys with isografts were harvested from recipients of grafts 
with and without MSCs and immunohistochemically analysed. It was possible to identify the 
implanted grafts in both groups but they appeared morphologically different as shown in Fig. 
3.28 A - D. Isografts of recipients that received  24 h islets and MSCs  (Islet/MSC+) showed 
morphologically intact islets with normal architecture (Fig. 3.28 B, J) whereas isografts of 
recipients that received islets only displayed  scattered islet cell aggregates dispersed over larger 
sub-capsular areas of the kidney (Fig. 3.28 C, K).  
 
Quantitatively, there were no significant differences in total endocrine area between islets plus 
MSC grafts and islets-only grafts (287,071 ± 19, 651 vs. 272, 009 ± 31,211, p = 0.471 (Fig. 3.30 
A). However, total graft area (endocrine + non endocrine) was significantly higher in grafts with 
MSCs than in islet-alone grafts (387, 658 ± 29, 818 vs. 290 ± 17,114, p = 0.0321. Quantitatively, 
no significant differences in total endocrine area (immuno-stained with insulin) between rats co-
transplanted with islets and MSCs and those that received islets only (p=0.471) (Fig. 3.30 A) 
were observed, but morphology of the grafts were different. But data on fusion of islet indicated 
that the mean area of individual islet aggregates in sections of isografts of islet/MSC+ recipients 
was 6 times higher than that observed in recipients of islets only (p = 0.00418) (Fig. 3.30 B). In 
accordance, larger areas of endocrine graft tissue were devoid of beta cells (insulin-negative or 
empty space) in grafts consisting of islets only (Fig. 3.28 K, L) whereas in islets with MSC co-
transplanted grafts, beta cells were distributed throughout the endocrine tissue similar to 
endogenous islets (Fig. 3.28 J). 
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3.3.4 Histomorphology of pancreatic tissue in graft recipients 
To ensure that changes in glycemic levels in recipients are due to islet graft function and not 
regeneration of the pancreas after STZ, pancreatic tissues were harvested for 
immunohistochemical analysis and compared the results with glucose levels in both untreated 
STZ-induced diabetic control and graft recipient rats. Hematoxylin and eosin sections showed 
changes in islet architecture with cellular disorganization in pancreata of both untreated STZ 
diabetic controls and graft recipients compared to normal healthy controls (Fig. 3.31 A compare 
with B).  
 
Figure 3.31. Histological analysis of morphology of the pancreas in male control Wistar 
rats. A-B:Hematoxylin and Eosin staining in healthy male rat (A) and STZ-induced diabetic rat  
untreated/ treated with islet with or without mesenchyme (B) after 9 weeks. C-D: Insulin staining 
(brown) in healthy male (C) and STZ induced diabetic rats untreated / treated with islets after 9 
weeks. Panel E shows blood glucose levels of control healthy rats (blue diamond) versus STZ-
induced diabetic rats (brown rectangle). In panel E STZ-induced diabetic rats maintained 
hyperglycemia for the entire periodof 9 weeks of study. (n = 10 animals/group were analysed), 
Bar = 100 µm. 
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Large areas of the islets in STZ-induced diabetic rats consisted of extracellular tissue 
predominantly of loose collagen fibers. Immunohistochemical analysis of the islet cellular 
composition 9 weeks after STZ treatment, showed reduced numbers of beta cells in both 
untreated diabetic rats and graft recipients compared to normal healthy controls as indicated by 
insulin staining (Fig. 3.31 C compare with D). 
When fasting blood glucose levels were monitored for 9 weeks, however, STZ-treated rats 
maintained hyperglycemia for the rest of the experimental period in contrast to normal healthy 
controls (Fig. 3.31 E).  
3.3.5 Morphology of donor islets is altered in 84-hr PPDL pancreas 
To find out whether the transplantation outcome is affected by the condition of the donor islets, 
the pancreatic tissue sections prepared from tail pancreata of donor rats 24- and 84 h following 
ligation and normal control rats were examined by immunohistochemical reactions.  Isolated 
islets from the same animal groups were also examined under inverted microscope. As shown in   
Fig. 3.32 A, B and C, insulin immunostaining of PPDL pancreatic tissue sections showed altered 
morphology of islets in tissue sections from 84 h PPDL compared to 24 h PPDL and normal 
control tissue sections. In the 24 h PPDL pancreata, islets maintained a normal morphology with 
round or oval outline (Fig. 3.32 B), similar to islet structure from normal health control pancreas   
(Fig. 3.32 A), while in the 84 h group, irregular shaped islets with rough edges were observed as 
indicated by irregular distribution of beta cells (by insulin immmunostaining) (Fig. 3.32 C).  
Similar morphological differences in islet structure were observed in isolated islets from the 
same animal groups (Fig. 3.32 D, E and F). Islets isolated 24 h PPDL showed normal round 
shape, similar to islets isolated from normal controls (Fig. 3.32 D & E), while those that were 
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isolated 84 h following ligation displayed rough edges with loose cells attached to islets (Fig. 
3.32 F). It was noted that islets from 84 h group were very sensitive and fragile to collagenase 
enzyme digestion during isolation, suggesting that PDL induces morphological changes that 
affect islet integrity as mentioned in section 3.2.1. 
 
Figure 3.32. Morphology of donor islets. Panels A, B and C show histological pictures of tail 
pancreatic tissue sections immunostained with insulin and counterstained with hematoxylin  
obtained from a control rat pancreas A, PPDL tail pancreas harvested 24- (B) and 84 h (C) 
following ligation. In Panel C, islets show disorganized architecture as indicated by insulin 
staining. Panels D and E show healthy islets with almost smooth round shape isolated from 
control rat pancreas (D) and after 24 h post pancreatic duct ligation (PDL)(E). Panel D: Islets 
isolated 84 h post ligation showing rough edges with cells that are loosely attached.    Bar = 
100µm.    
 
In summary, the results on islet transplantation show that the curative capacity of 24 h post islets 
was better than 84 h PPDL islets. The average glucose levels were lower throughout the 5 weeks 
monitoring period in 24 h PPDL transplanted rats.  The average time to reverse hyperglycemia in 
80% of the 24 h PPDL transplant group was 32± 2 days (~4.5 weeks,) while only 20% in the 84 
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h PPDL transplant group attained normoglycemia at 61 ± 2 days (~9 weeks) (p = 0.0011, n = 6) 
post transplantation. Graft survival rate was higher in islets co-transplanted with MSCs 
compared with islets alone grafts. Islet morphology and distribution of beta cells was normal in 
islet plus MSCs grafts similar to the endogenous islets in the pancreas of normal controls. In 
conclusion, transplantation of early harvested PPDL islets had more beneficial effects on short 
term reversing hyperglycemia. MSCs prolonged graft survival and improved the capacity of 
early PPDL islets to reverse hyperglycemia and may be applicable to clinical transplantation. 
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Chapter 4 Discussion and Conclusions 
Current efforts to regenerate beta cells in adult pancreas as a strategy for cell replacement 
therapy for Type 1 and 2 diabetes mellitus could be an alternative solution to islet donor 
scarcity facing clinical islet transplantation in the treatment of diabetes mellitus. 
This study demonstrates that mesenchymal stromal cells (MSCs) isolated from the duct 
ligated portion of pancreas can induce beta cell neogenesis from ducts and pre-existing islets, 
and favours the expansion of islet cells in vitro. Furthermore, the study showed that the 
efficiency of islet transplantation is harvest-time-dependent; early PPDL islets produce 
superior transplantation outcome and more beneficial effects in diabetic animal models.  
These findings support the previous assumptions by du Toit et al. (du Toit et al. 2013) and 
can be a new strategy for the design of cellular therapies and islet cell regeneration for type 1 
and type 2 diabetes mellitus. 
4.1. Mesenchymal stromal cells (MSCs) induce neogenesis and promote islet cells 
expansion in culture 
In this study, an in vitro model was developed in which islet cells isolated from the PPDL rat 
pancreas were allowed to develop with or without MSCs. The morphological findings show 
that when islets are cultured without MSCs, islet cells undergo a short-term expansion (up to 
two weeks) and display morphological changes that resemble mesenchymal-like cells before 
forming new islet-like clusters. The change of the morphology of these islet cells from in 
vivo 3-dimensinal structure to in vitro 2-dimensional structure in direct contact culture 
system resulted into adhesion of islets to plastic substrate, and then migration of cells. Most 
of the adhered cells were islet cells, although, the presence of intra-islet cells that resembled 
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fibroblasts cannot be ruled out. These results therefore suggest a possible transient de-
differentiation and loss of phenotype during expansion before they re-differentiated into 
functional islet cells. In previous study (Gershengorn et al. 2004), it was reported that 
epithelial cells undergo de-differentiation and lose their phenotype in culture. In cultured 
thyroid cells, for example, epithelial de-differentiation was shown to occur through 
epithelial-mesenchymal transition (EMT) (Jeon et al. 2015, Yang et al. 2015), which leads to 
dissociation of cells, alteration of expression of adhesion molecules, switching from E-
cadherin to N-cadherin (Fanjul et al. 2010) and this is regulated by Snail 1 (Cano et al. 2000). 
Recently, a study suggested that EMT generates cells with properties of stem cells (Yang et 
al. 2015).  
Although this study did not examine the dissociation of cells directly, the morphological 
findings showed changes of cell shapes from polygonal shape to cells with narrow cell bodies 
and extended cytoplasmic prolongations, features that were similarly observed by 
Gershengorn and his group (Gershengorn et al. 2004), who postulated that human cultured 
islet cells undergo EMT upon entrance in their cell cycle. However, long term culture of 
islets alone (up to 3 to 4 weeks) did not promote expansion but resulted into formation of 
spheroid bodies that resembled islets suggesting that when islets are cultured alone, their 
proliferative capacity becomes limited and islet cells quickly undergo re-differentiation and 
become quiescent. In cultures with mesenchymal, in contrast, islet cells extended the period 
of expansion as we continued culturing suggesting that, in vitro, signals from mesenchymal 
cells positively regulate the capacity of proliferation of islet cells and determines the final 
number of mature islets that develop from pre-existing islet cells.  
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4.1.1 Mesenchymal stromal cells (MSCs) promote expansion of Pdx1+ cells and activate 
Ngn3 expression in culture 
Results from the protein expression analysis in cultures with mesenchymal cells showed 
activation of Pdx1 in islet cells and these Pdx1+ cells expanded up to 80% confluence by the 
end of the second week. Pdx1 is a key transcription factor involved in early pancreatic 
development, differentiation of insulin-producing beta cells and maintenance of mature beta 
cells phenotypes (Cerf et al. 2005). In mature beta cells, Pdx1 is one of the key genes that 
regulates the transcription of islet-specific genes, such as insulin, GLUT2 (Waeber et al. 
1996), glucokinase (Watada et al. 1996) and Nkx6.1 (Pedersen et al. 2005;Shih et al. 2002). 
In a study that used a transgene encoding Pdx1 into the liver cells of STZ induced diabetic 
rats, expression of insulin gene was induced and ameliorated hyperglycemia (Ferber et al. 
2000) suggesting that Pdx1 has the capacity to re-program non-pancreatic cells into insulin 
producing cells.  The co-expression of insulin and Pdx1in this study (Fig 3.8) demonstrated 
that MSC significantly enhanced Pdx1 protein expression in insulin producing beta cells 
during the first week.  Further studies are, however, needed to investigate whether Pdx1 
regulated proliferation of beta cells or maintained the identity of mature beta cells in cultures 
at this stage of development. Nevertheless, Pdx1+ cells significantly expanded in islet/MSCs 
co-cultures during the first week and this was followed by high levels of Ngn3 expression in 
the second week (Day 12). Ngn3 is normally downregulated in mature islet cells in vivo (Gu, 
Dubauskaite & Melton 2002).  
When islets were cultured alone, Pdx1 was also activated during the first week and its 
expression extended up to the second week, but this was followed by low levels of Ngn3 that 
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transiently expressed for only 2 days. This observation was similar to what occurs during 
pancreas development in which Ngn3 is expressed transiently, following the down-regulation 
of Notch1 and Hes-1 (Afelik et al. 2012). The transient expression of Ngn3 and Pdx1 in 
cultures with islets only (Fig. 3.14 L, K [at 17-21days]) characterizes the temporal 
heterogeneity of isolated islets whose subpopulations were undergoing different stages of 
development. Although this observation indicates that some insulin producing beta cells 
expressed Pdx1 and Ngn3 in islets cultured with or without MSCs, these findings may 
suggest that secretion of trophic factors by MSCs at the site of islet-MSCs contact and in the 
culture medium, might have altered or changed the microenvironment that promoted growth, 
differentiation and survival that resulted into emergence and expansion of Ngn3+ cells. 
These results, therefore, demonstrate that some cells within the pre-existing islets regress to a 
lesser differentiated phenotype by expressing Pdx1 followed by Ngn3 - markers of endocrine 
precursor cells similar to the differentiation process that occurs during embryonic pancreas 
development.  
The mechanism by which MSCs reactivate neogenic pathway and regulate the proliferation 
and re-differentiation of these mature endocrine cells is not clearly understood. In addition, in 
the absence of lineage tracing experiments, this study cannot justify whether Ngn3 was 
evidently expressed in de-differentiated mature islet cells or in activated progenitor cells 
located within the islets or mesenchymal cells.  Although increase in Pdx1+ cells 
proliferation in cultures with MSCs has been suggested to result into an equivalent increase 
of the population of Ngn3+ cells, these increases in Ngn3+ cell population might have been 
produced by the simultaneous conversion of MSCs to Ngn3+ cells and/or quiescence or 
apoptosis in cultures of islets only. This raises the question of whether MSCs activates 
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neogenesis from pre-existing islet cells. However, immunocytochemical analysis indicated 
increased Ngn3 expression in co-cultures of islets and MSCs suggesting that the 
heterogeneous population (Islet/MSCs) contained stem-cell-like cells with endocrine 
differentiation potential. Results from studies that used MSCs from bone marrow to 
differentiate into insulin producing cells are, however, still very controversial (Lecher et al. 
2004, Gopurappilly, Bhat & Bhonde 2013). Findings from other in vitro and in vivo studies 
demonstrated that islet-derived MSCs can be induced to differentiate into insulin producing 
cells with phenotypes typical of islet cells (Ianus et al. 2003, Davani et al. 2007, Mutskov et 
al. 2007). Mesenchymal stromal cells from these studies were found to express transcription 
factors of epithelial, endocrine and mesenchymal markers (Baertschiger et al. 2008). 
However, evidence from additional studies, failed to support these findings (Lechner et al. 
2004, Choi et al. 2003, Taneera et al. 2006).  Although this study did not assess this directly, 
it is possible that MSCs trophic secretions might have induced expression of endocrine 
developmental genes in precursor-like cells within the heterogeneous population of MSCs 
and islet cells. As suggested by other (Finegood, Scaglia & Bonner-Weir 1995), it may be 
possible that Pdx1 expression maintains the balance between neogenesis and proliferation of 
mature islet cells, and that this is regulated by signals from the MSCs. This study 
demonstrate that MSCs activate the expression of transcription factors (Pdx1 and Ngn3) in 
mature islet cells and promotes proliferation of Pdx1+ cells and maintains Ngn3+ precursor 
phenotype in proliferating islet cells that ultimately increase beta cell numbers. Mesenchymal 
cells acted by increasing the proliferation of Pdx1+ cells and extended the period of 
formation of Ngn3+ precursor-like cells from Pdx1+ islet cells. The number of Ngn3+ cells 
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was amplified in the presence of mesenchymal cells and the period of re-differentiation of 
these Ngn3+ islet cells into insulin producing islets was prolonged.  
Whether such enhancement was primarily due to direct MSC-to-Islet cell contact or by 
means of trophic factors secreted by mesenchymal cells needs more investigation. Other 
studies demonstrated that MSCs differentiate into insulin producing cells only when MSCs 
are in contact with islets (Scuteri et al. 2014), and that Px1 is involved in the activation of the 
endocrine pathway. This, in turn, also affected the behavior of pancreatic islet cells.   The 
true direct co-culture system in our study was difficult to achieve, as only few islets were 
completely attached and surrounded by the mesenchymal cell monolayer, but the rest of the 
islet cells were just slightly sequestrated over MSCs, thereby hampering their floating state, 
but still giving a three-dimensional structure with most cells proliferating in suspension. 
Secondly, since MSCs surround islets in our direct co-culture system, islet-to-MSCs close 
contacts are likely to occur with peripheral islet cells, for example alpha cells in rat islets, 
while the direct contact with beta cells that are centrally located might not be common. 
Whether MSCs contribute to centrally located beta cell mass increase by secretion of growth 
factors or to other peripherally located endocrine such as α- and δ- cells by cell-to-cell 
contact, are questions that could not be explained by the direct co-culture model and need 
further exploration.  
To test whether mesenchymal effects on islet cells development are due to MSC-to-Islet cell 
contact or secretion of growth factors, islets and mesenchyme were cultured in an indirect co-
culture system by physically separating them with filter membrane and the results indicated 
an increase in proliferation of islet cells similar to cultures by direct contact.  These results 
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therefore suggest that some signals from MSCs were secreted in the culture medium and 
might have interacted and activated directly or indirectly the transcription of genes that 
maintain islet cells in a precursor state and consequently determine the time of re-
differentiation of these cells into mature islet cells. Maintenance of Ngn3+ cells by MSCs 
may prevent premature differentiation of endocrine cells and allow these cells ample time for 
expansion thereby increasing the number of re-differentiated islet cells, which is a novel 
finding in this study.  
4.2 Duct fragmentss generate beta cells in culture 
Duct fragments and MSCs from the post ligated tail pancreas were cultured under different 
conditions (with or without MSCs) and sequential changes were observed in their 
differentiation potency in vitro (Fig. 3.20 & Fig. 3.21). This study showed that differentiation 
of epithelial duct cells into ngn3+cells and later into insulin-producing cells can be promoted 
in vitro.  
Morphological and immunocytochemical analyses of cultured ducts showed that when PPDL 
duct epithelial cells are maintained in MSCs or without MSCs, duct fragments initially 
developed growth areas, giving rise to cell populations with proliferative capacity. In contrast 
to duct fragments cultured alone, duct fragments cultured with MSCs resulted into formation 
of growth areas from day 3 and these cells proliferated rapidly and formed sheet of periductal 
cells that migrated sideways. At the tips of some small intercalated ducts, a population of 
proliferating squamous cells, possibly representing centroacinar cells, was also observed. 
This was followed by rapid branching of ducts before cell clusters began to form closer to 
ducts within the migrating monolayer, suggesting that these cells are beginning to adopt a 
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different phenotype. Thereafter, cell clusters formed larger spheroid bodies that were more 
visible on day 24 and 26. Continued culturing resulted into formation of more spheroid 
bodies budding off from ducts suggesting that the budded cells are not of duct phenotype but 
either exocrine or endocrine. The morphological observations, therefore, reveal a possible 
recapitulation, in adult duct epithelial cells, of sequences of events that occur during pancreas 
development (i.e. a wave of proliferation of ductal cells, followed by differentiation of these 
cells). 
4.2.1 Ductal and periductal cells in growth areas give rise to Ngn3 positive cells 
The ductal origin of islet cells has been advocated by vast literature using animal models of 
pancreatic injury including PDL (Bonner-Weir et al. 1993; Gu, Sarvetnick 1993; Rosenberg 
1995; Rooman, Bouwens 2004; Suarez-Pinzon et al. 2005; Xu et al. 2008a; Inada et al. 
2008). However, the hypothesis that new endocrine cells arise from ducts of adult pancreas is 
debated up to date.  In this study, immunocytochemical analysis showed that when duct 
epithelial cells are cultured in presence of MSCs, some mature duct epithelial cells within the 
ductal epithelium de-differentiated and lost their phenotype.  Duct fragments cultured in the 
presence of MSCs developed growth areas from day 3. In 1 to 3-day old cultures, insulin+ 
cells were not detected in growth areas.  In 7-day old cultures, the majority of cells in the 
growth areas revealed some of the features of duct cells expressing CK7 but some activated 
proteins of endocrine precursors, Ngn3. These Ngn3+ cells were intercalated in the CK7+ 
duct epithelial cells and that a subset of Ngn3+ cells co-expressed CK7 and Ngn3 in cultures 
with MSCs. In view of these features, the main population in the growth areas was 
considered to be de-differentiated duct cells. Moreover, the characteristic periductal location 
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and the nuclear expression of Ngn3 is an additional argument supporting de-differentiation (β 
cell neogenesis) process in growth areas of cultured ducts. When these cells began their 
migration, Ngn3+ cells were detected first in periductal cells and then in scattered cells 
within a short distance around ducts. Demonstration by double-labeling duct epithelial cells 
co-expressing CK7 and Ngn3 indicated that some duct cells underwent duct-endocrine 
transdifferentiation. During the migration of the periductal cells, a progressive disappearance 
of CK7, an intermediate filament protein of cells arising from ducts, and a subsequent 
progressive expression of Ngn3, usually a protein expressed in endocrine precursors or 
neurons, were observed. These cellular architectural and cytoskeletal alterations are features 
of duct-endocrine transdifferentiation. Duct-endocrine cell transdifferentiation giving rise to 
Ngn3 has been observed in animal models of pancreatic regeneration (Xu et al. 2008). In this 
study, similar CK7 and Ngn3 expression patterns were observed in ducts cultured alone, 
suggesting that the initiation of de-differentiation leading to expression of Ngn3 does not 
require signals from MSCs. Alternatively, these results might suggest that these duct 
epithelial cells might have already received instructive signals way before isolation. In 
addition, in the absence of expreriments tracing the lineage of duct to endocrine cells 
differentiation in both cultures with or without MSCs, these findings may alternately suggest 
that the Ficoll-based duct isolation protocol resulted in isolation of impure cells comprising 
Ngn3+ duct derived cells and pre-existing islet cells. Cell lineage tracing requires labelling of 
the duct cells and tracking the characteristic changes of the labeled cells and this could not be 
achieved by the present co-localization studies. Nevertheless, these results agrees with the in 
vivo regeneration results that showed activation of Ngn3+ cells located either within the duct 
epithelium or close to ducts (Xu et al. 2008a).  
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Although pancreatic duct epithelial cells have been suggested as a source of new beta cells in 
a regenerating pancreas following injury by duct ligation (Xu et al., 2008), lineage tracing 
studies demonstrated that, in vivo, PDL-induced progenitors (Ngn3+) from ducts do not 
complete the differentiation program to generate insulin producing beta cells (Solar et al. 
2009; Kopp et al. 2011). Several lineage tracing studies showed that, in vivo, duct derived 
Ngn3+ cells contribute to islet cell mass only during embryogenesis and early neonatal stages 
but not in adult or injury following ligation (Solar et al. 2009; Kopp et al. 2011, Furuyama et 
al. 2011). The current in vitro data, however, showed that de-differentiated duct-derived 
Ngn3+ cells can further differentiate into insulin producing cells thereby contributing to islet 
cell mass. The current findings further show that MSCs promote the expansion Ngn3+ cells 
and maintain their de-differentiated state before they proceed to differentiate into insulin 
producing cells. In the presence of MSCs, Ngn3 expression was maintained up to 4 weeks in 
periductal cells and scattered cells with few Ngn3+ cells that subsequently differentiated into 
insulin producing cells. How mesenchymal cells maintain these Ngn3+ cells require further 
investigation.  In a PDL-induced pancreatic injury, proliferation of MSCs is one of the early 
regenerating events that occur distal to the ligature and this is followed by the emergence of 
Ngn3+cells within and next to ducts. Lineage studies did not detect the contribution of these 
Ngn3+ cells to islet cell mass  ( Solar et al. 2009; Furuyama et al. 2011; Kopp et al. 2011).  
One possible explanation for their failure is that the presence of signaling molecules from 
proliferating MSCs might have promoted and maintained Ngn3 expression in these duct-
derived Ngn3+ cells, and only to release few cells at a time to leave the cell cycle and 
differentiate into insulin producing cells, which were not detected by lineage tracing cre-lox-
p-lox systems in these studies.  Evidence from this study supports this notion by detecting 
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Ngn3+ cells for 4 weeks in cultures with MSCs. The molecular mechanisms involved in 
maintenance of Ngn3+ by MSCs are, however, not clearly understood.  
One candidate pathway might be the Notch-Hes1-Ngn3 signaling pathway, which determines 
exocrine versus endocrine specification through lateral inhibition during embryonic pancreas 
development. In the developing pancreas, the role of the Notch-Hes1 pathway is to promote 
precursor cell replication and prevent premature endocrine differentiation (Murtaugh et al. 
2003; Hald et al. 2003; Esni et al. 2004). Several studies show that MSC-derived Fgf10 
activates Notch signaling which promotes proliferation and inhibits differentiation of 
endocrine precursors (Jensen & Jensen 2003; Hart, Papadopoulou & Edlund 2003; Miralles 
et al. 2006). There is also evidence that MSC-derived activin induces Ngn3 through a non-
canonical target of activin, p38 mitogen activator protein K (MAPK) (Ogihara et al. 2003), 
however, this was not tested in our study.         
 Taken together, the observation of cells co-expressing ductal epithelial and endocrine 
markers in PPDL pancreatic duct fragment cultures urgues in support of the hypothesis that 
the observed neogenesis for duct epithelial cells in vitro does not only occur in culture, but 
may also occur in vivo during regeneration of tissues or renewal of beta cells in the pancreas. 
4.3 Efficacy of PPDL islets 
To explore the efficacy of PPDL islets as donor tissue in reverting normoglycemia in STZ-
induced diabetic Wistar rats, syngeneic transplantation model was used with minimal islet 
mass. Two sets of experiments were used to demonstrate the importance the PPDL pancreatic 
tissue in terms of graft survival and function.  In the first experimental set, the results 
indicated that early isolated syngeneic PPDL islets (24 h following ligation) produced 
Stellenbosch University  https://scholar.sun.ac.za
                                                                                                                                                 159 
superior but transient transplantation outcome under the renal capsule compared to islets 
isolated 84 h PPDL when the donor pancreatic tissue distal to the ligation is at the peak of 
destruction. In the second set, the findings demonstrated that pancreatic-derived MSCs 
isolated from PPDL tail pancreas of syngeneic donors 24 h following ligation, prolonged 
graft survival and function when co-transplanted with islets in diabetic rats. 
4.3.1 Efficacy of early and late PPDL islet grafts in vivo  
The results demonstrated a differential efficacy between islets isolated early or late PPDL in 
treating chemically induced diabetic rats. In terms of graft survival and function, more 
beneficial effects were observed when transplanted with 24 h PPDL islets with more than 
60% animals recovering from hyperglycemia for 5 weeks compared to only 10% of the 
animals in the 84 h post group achieving normoglycemia within the same time frame.  
Most animals treated with donor islets from late PPDL pancreatic tissue (84 h PPDL) failed 
to achieve normoglycemia within the same time frame of 5 weeks post transplantation. One 
possible explanation for low graft survival in the late PPDL tissue could come from the 
condition of the PPDL donor pancreas. Although endocrine tissue is less affected, a study 
that chronologically documented the cellular mechanisms in a PPDL pancreas reported that a 
high peak of exocrine destruction occurs between 72 and 84 h post ligation (Tchokonte-Nana 
2011) and this could likely affect the islet microvasculature, the cellular architecture and the 
composition of connective tissue proteins that bind the islet cells together as revealed in our 
present study by morphological changes in islet architecture (Fig. 3.32 C &F). This is 
compounded by enzyme islet isolation, which not only disrupted the external vasculature but 
also compromises the internal cellular organization and vascular network (Fig. 3.32 F). This 
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suggests that maintenance of donor islet morphology is a critical parameter for achieving 
euglycemia in islet transplantation therapy.  
However, treatment with early PPDL islets transiently cured diabetic rats but did not 
permanently prevent the recurrence of diabetes in Wistar rats. In fact, when diabetes 
recurrence was analyszed at 7 weeks post transplantation, no significant differences in graft 
survival and function were detected between the 24- and 84 h PPDL grafts. Surprisingly, 
even grafts with normal islets, displayed a slightly long-term survival and function but did 
not result in permanently preventing further recurrence of diabetes. These observations are at 
par with previously reported findings that used a PPDL pancreatic tissue, instead of isolated 
islets, as a donor tissue harvested 84 h PPDL that only achieved euglycemia in 40% of the 
animals (Page et al. 2004). 
4.3.2.Early PPDL islets and MSCs  co-transplantation promotes graft survival  and 
function. 
Several studies have reported the beneficial effects of MSCs in different transplantation 
models and these effects have been proposed to occur by different mechaniscms (Figliuzzi et 
al. 2009; Ito et al. 2010; Berman et al. 2010; Sordi, Piemonti 2010; Rackham, Jones & King 
2013). Considering high graft failure (as reflected by recurrence of hyperglycemia) in both 
syngeneic recipients of 24- and 84 h PPDL islets between 7 and 9 weeks post transplantation, 
we next tested whether co-transplantation of MSCs and 24 h PPDL could enhance islet 
survival and function in our syngeneic transplantation model.   
 
 Consistent with the observations of others that reported the beneficial effects of MSCs in 
islet transplantation (Figliuzzi et al. 2009; Ito et al. 2010; Berman et al. 2010; Sordi, Piemonti 
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2010; Rackham, Jones & King 2013), the current study demonstrated that co-transplanting 
pancreatic-derived MSCs with islets under the renal capsule of syngeneic diabetic rats 
resulted into a gradual but longer  term attainment of euglycemia compared to those that 
received  islets without MSCs. It was found that MSCs increased the number and rate of 
Islet/MSCs isograft recipients achieving normoglycemia by 5 weeks post transplantation.   
Higher numbers (8/10 or 80%)   of animals that received islets + MSCs grafts sustained 
normoglycemia up to 9 weeks post transplantation without recurrence of diabetes between 7 
and 9 weeks post transplantation when compared to (4/10 or 40%) recipients of islet-alone 
grafts. 
 
 Evidence from other studies, however, showed that both human (Lee et al. 2006) and mouse 
(Xu et al. 2008b) MSCs induced regeneration of endogenous pancreatic islets that eventually 
ameliorated hyperglycemia in STZ-induced diabetic mice. The histological analysis of the 
pancreas of MSCs+ islet graft recipients, however, showed no evidence of islet regeneration 
of endogenous islets by the end of the experiment (Fig. 3.31).  These findings are promising 
and suggest that MSCs may help prolog islet graft survival in diabetic animals.  Several 
reports indicate that MSCs provide a graft microenvironment that limit beta cell damage by 
secreting several paracrine  angiogenic, mitogenic, immuno-regulatory and anti-
inflammatory factors (Di Nicola et al. 2002; Le Blanc 2006; Nauta, Fibbe 2007; Abdi et al. 
2008; Figliuzzi et al. 2014). MSCs have been shown to reduce autoimmune-mediated islet 
attack in models of autoimmunity induced diseases including type 1 diabetes (Molano et al. 
2001) which may contribute to prevention of post transplantation islet cell loss.        
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The morphological analysis of islet grafts suggest that MSCs may also play a role in islet 
graft remodeling that occurs soon after transplantation.  In rat recipients of islets and MSCs, 
graft morphology was maintained similar to in vivo islets, unlike the fragmented endocrine 
cell aggregates that were observed at graft site of animals transplanted with islets only. The 
morphological findings reaffirm previous transplantation studies that reported similar MSC-
induced graft morphological changes (Biarnes et al. 2002; Rackham, Jones & King 2013). 
These changes may influence graft survival and function through promotion of 
revascularization. Previous studies reported that revascularization is more efficient in smaller 
islets than in large amorphous aggregates (Kampf, Mattsson & Carlsson 2006), an effect that 
was observed in grafts of islets only in our study.  
Taken together, our results indicate that a PPDL pancreatic tissue is a potential source of 
islets for transplantation in diabetic animals. PPDL islets harvested in the early hours of post-
surgery produced superior transplantation outcomes compared to islets harvest late PPDL. 
More beneficial effects were observed when transplanted with 24 h PPDL islets with more 
than 60% animals recovering from hyperglycemia for 5 weeks. Co-transplantation of MSCs 
and early PPDL islets significantly increased islet engraftment, survival and function, with 
80% of the animals reversing diabetes and may be applicable to clinical transplantation 
programs. 
4.4 Strength and limitations of the study 
The strength of this study is based on enzymatic isolation of the two cell populations (islets 
and mesenchymal cell populations), the development of long-term in vitro culture system and 
the immunocytochemical analysis of the expressions and co-expressions of transcription 
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factor proteins regulating islet cell development and function. The study has also strongly 
demonstrated that the PPDL derived MSCs can be included to promote engraftment, prolog 
islet graft survival and function and provide sustainable adequate insulin levels to ameliorate 
STZ-induced diabetic animals. The data demonstrate that the islet/MSC-based transplantation 
therapy is time dependent in treatment of diabetes mellitus.  
Firstly, this study was however, limited by not evaluating the contribution of the paracrine 
factors of MSCs to beta cell development in vitro and beta cell survival in grafts.   
Secondly, there was no evaluation of the contribution of MSCs to beta cell mass through 
MSC-beta cell transdifferentiation, though there is some debatable evidence that MSCs can 
differentiate into insulin producing cells that are able to normalize hyperglycemia after 
transplantation into diabetic animal models (Hao et al. 2013, Kong et al. 2014). 
Thirdly, the use of flow cytometry and Fluorescence activation cell sorter (FACS) to isolate 
and characterize MSCs, and demonstrate their multipotency, could have been a better tool to 
ascertain that these cells were true MSCs.  
4.5 Conclusions 
The study findings demonstrated that pancreatic–derived MSCs promote expansion of Pdx1+ 
cells, followed by differentiation of Ngn3+ cells into insulin producing cells; MSCs also 
enhanced aggregation of islet-like structures and engraftment of islet cells, and prolong graft 
survival and sustain normoglycemia in diabetic animal models. These results suggest that 
MSCs regulate neogenesis and islet development through cell-to-cell contact and by 
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secretion of a various growth factors that can promote the expression of Pdx1 and Ngn3 in 
islet cells and maintain normoglycemia in diabetic animal models.  
4.6 Implications and clinical perspectives of the study 
The clinical significance of the study relies on the hope that the design of novel syngeneic 
self-renewing MSCs from the ligated pancreas may help to reactivate regeneration of beta 
cells in patients with type 1 diabetes. MSCs secrete several factors that favour the 
stimulation, regeneration and repair of various injured or defective tissues (Chapel et al. 
2003, Chapel 2012).  
The information provided in this thesis, indicates that duct epithelial and pre-existing islet 
cells have the capacity to respond to signals (factors) from the MSCs. Based on these 
findings and other published data, it can be postulated that in an injured pancreas following 
duct ligation, inductive signals for islet regeneration might arise from the mesenchymal 
tissue surrounding pre-existing islets and proliferating ductules.  Identification of the 
mesenchymal-derived signaling molecules that trigger de-differentiation and re-
differentiation in pre-existing islets and duct progenitors in a regenerating pancreas will be an 
important step towards generating islet cells for transplantation or endogenously generating 
beta cells as a therapy for diabetes. Fgf10 was previously shown to promote the proliferation 
of Pdx1+ cells (Bhushan et al. 2001); and a recent study demonstrated that survivin is 
required for the expansion of beta-cell mass after PDL (Wu et al. 2012) and appears to 
promote proliferation of pre-existing beta cells. The in vitro protocols that have been 
developed to expand human islets for transplantation, however, only drives human 
embryonic stem cells (hESC) to generate pancreatic progenitor cells, but do not proceed to 
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generate differentiated insulin-producing beta cells. The current findings demonstrate that 
MSCs provide essential factors for both the expansion and differentiation of Pdx1 expressing 
islet cells and Ngn3+ precursor cells into insulin-producing cells.  The study, therefore, 
proposes that in-vitro strategies to attain increased islet mass for transplantation should 
include the use of extracellular factors from mesenchyme that stimulate the expression of 
relevant transcription factors (Pdx1 and Ngn3). This will help obtain a high enough 
proportion of de-differentiated precursor-like islet cells that ultimately re-differentiate into 
large number of beta cells.    
4.6.1 Recommendations  
Based on the findings of this study, the following are recommendations for further research 
or application in the analysis of factors involved in adult pancreas regeneration. 
 
First, it is recommended that present findings can be the applied in the development of in 
vivo strategies to induce and promote regeneration of the beta cells in type 1 diabetic patients 
or the development of in vitro strategies in obtaining adequate numbers of beta cells for 
transplantation and promoting graft survival in recipients.  
    
Second, the findings presented in this report indicate that MSCs and/or MSC-derived factors 
are continuously required in regulation of islet development in culture; from the onset of 
Pdx1 expression and expansion, followed by Ngn3 activation up to the end of insulin 
expression. Therefore, it is recommended that evaluation of MSCs functions in vivo is 
required to determine whether MSCs extert the same effects at different stages of endocrine 
pancreas regeneration. In addition, further investigations are also needed to determine 
Stellenbosch University  https://scholar.sun.ac.za
                                                                                                                                                 166 
whether MSCs functions are affected by hyperglycemia in diabetic patients with problems of 
wound healing.  
 
Third, lineage tracing analysis of the cells in vitro, coupled by RT-PCR analysis would be 
more informative than snapshot immunocytochemical analysis of the phenotypic changes of 
pre-existing islet and duct epithelial cells during development.   
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Appendix A. Preparation of solutions 
Table A1. Preparation of Ficoll (Type 400) 
Reagent/vol. 25% stock 
solution 
23% working 
Solution 
20.5% working 
Solution 
11% working 
solution 
Ficoll Type 400 
33.35 g 46 mL stock 
solution 
41 mL stock solution 22 mL stock 
solution 
HBSS  Adjust up to 100 4 mL 9 mL 28 mL 
Final volume  100 mL 50 mL 50 mL 50 mL 
 
Table A2.  Phosphate-buffered saline (PBS) 
Reagent  Amount to add 
( 1X) 
Final conc. 
(1X) 
Amount to add 
(10X stock) 
Final conc. 
(10X) 
NaCl  8 g 137 mM 80 g M 1.37 
KCl  0.2 g 2.7 mM 2 g 27 mM 
Na2HPO4  1.44 g 10 mM 14.4 g 100 mM 
KH2PO4  0.24 g 1.8 mM 2.4 g 18 mM 
dH
2
O  800 mL  800 mL  
dH
2
O Adjust to 1000 mL  Adjust to 1000 mL  
 
Table A3. Preparation of 10X Trypsin-EDTA 
Reagents / Vol.  10 mL 50 mL 100 mL 500 mL 
Trypsin 0.05 g 0.25 g 0.5 g 2.5 g 
0.5 M EDTA 0.1 mL 0.5 mL 1.0 mL 5.0 mL 
10X PBS 1.0 mL 5.0 mL 10.0 mL 50.0 mL 
Deionized water Adjust to 10.0 mL Adjust to 50.0 mL Adjust to 100 mL Adjust to 500 mL 
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Table A4.  Primary antibodies used in the study 
Antibody  Cat No. Raised 
in 
Clonality Working 
Dilution 
source 
Anti-Pdx1  ab47267 Rabbit polyclonal 1:1000 ABCAM 
Anti-Insulin  ab7842 Guinea 
pig 
polyclonal 1:800 ABCAM 
Anti-Ngn3  AB5684 Rabbit polyclonal 1:1000 Millipore 
Anti-Ki67  Ab9260 Rabbit monoclonal 1:200 ABCAM 
Anti-insulin  HB125 Mouse monoclonal Pre-diluted BioGenex 
Anti-CK 7  ab9021 Mouse monoclonal 1:200 ABCAM 
 
Table A5. Secondary antibodies used in this study 
Antibody Cat No. Raised in Clonality Working 
dilution 
source 
Goat anti-Rabbit (IgG)H&L 
(Alexa fluor 594) 
ab150080 Goat polyclonal 1:800 ABCAM 
Goat anti-Rabbit (IgG)H&L 
(FITC) 
ab97050 Goat polyclonal 1:500 ABCAM 
Goat anti-mouse (IgG) H&L 
(Alexa fluor 594) 
Goat anti-mouse (IgG) H&L 
(Alexa fluor 488) 
Ab150116 
 
Ab150113 
Goat 
 
Goat 
polyclonal 
 
polyclonal 
1:400 
 
1:1000 
ABCAM 
 
ABCAM 
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Appendix B.  Immunohistochemistry 
Immunochromogenic  labeling  
• Antigen retrieval using citrate buffer (pH 6.0)  
 
 Step Apply Incubation Time 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
Peroxide Block (Refine kit) 
PBS Wash Solution 
Primary Antibody 
PBS Wash Solution 
Post Primary  block (Refine kit) 
PBS Wash Solution 
“Novolink Polymer” (Refine Kit) 
PBS Wash Solution 
Mixed DAB (Diaminobenzidine) (refine Kit) 
De-ionised water (wash) 
Counterstain with Hematoxylin (Refie Kit) 
De-ionised water     (wash) 
10 minutes 
3 x 5 minutes 
24 hrs 
3 x 5 minutes 
30 minutes 
3 x 5 minutes 
45 minutes 
3 x 5 minutes 
10 minutes 
5 x 3 minutes 
5 minutes 
5 x 3 minutes 
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Appendix C. Immunomorphological analysis 
 
 
  Table C1. Expression of Pdx1 in cultured islets cultured with or without MSCs 
 
Days in 
culture 
  
3 
 
5 
 
9 
 
12 
    Pdx1 + Area (µm2) 
Slide ID Islet 
No. 
MSC+ MSC- MSC+ MSC- MSC+ MSC- MSC+ MSC- 
Pdx124MS 1 3998.75 217.15 166.28 762.84 998.67 6754.82 154.41 274.57 
Pdx124MS 2 1552.6 753.05 8225.36 150.78 925.63 5405.32 229.66 922.57 
Pdx124MS 3 2343.28 328.96 601.69 419.61 2778.8 5378.23 181.93 360.37 
Pdx124MS 4 1357.48 128.36 249.88 759.36 1412.82 8037.78 882.45 1672.74 
Pdx124MS 5 3900.71 179.88 284.17 955.53 336.83 1536.58 544.75 368.86 
Pdx124MS 6 7212.4 532.89 1501.23 442.49 602.95 8427.22 217.15 625.38 
Pdx124MS 7 15846.41 229.66 5458.62 332.96 258.15 1473.71 753.05 2189.11 
Pdx124MS 8 244.74 181.93 1525.96 446.96 1998.8 1851.26 828.96 523.04 
Pdx124MS 9 1607.44 882.45 543.56 334.43 1417.8 9870.49 728.36 217.72 
Pdx124MS 10 1537.86 544.75 2967.66 336.89 1302.62 1684.11 679.88 8011.9 
Pdx124MS 11 1283.44 154.41 982.28 324.16 841.61 1071.22 532.89 463.81 
Pdx124MS 12 1320.62 250.46 775.49 581.51 608.87 1212.46 792.87 17016.98 
Pdx124MS 13 5289.25 2297.9 478.84 404.2 609.43 1617.96 344.59 133.03 
Pdx124MS 14 2150.21 757.71 937.97 208.68 852.64 6856.52 587.61 880.99 
Pdx124MS 15 4930.77 220.39 9022.63 246.77 796.04 18228.12 1410.14 630.49 
Pdx124MS 16 1839.8 418.16 1857.72 329.56 655.87 1455.47 1800.97 740.73 
Pdx124MS 17 849.76 136.89 997.35 205.12 1088.78 1994.44 3197.96 403.72 
Pdx124MS 18 4991.95 445.77 1027.02 1998.67 1807.81 1786.87 239.97 662.4 
Pdx124MS 19 931.59 3197.96 800.53 1925.63 1012.06 10120.91 441.87 718.61 
Pdx124MS 20 1657.91 239.97 676.59 2778.8 5037.58 4994.4 819.72 1274.95 
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Pdx124MS 21 7920.44 441.87 342.47 412.82 1594.27 1675.67 601.01 778.66 
Pdx124MS 22 2378.2 819.72 561.61 1336.83 1583.51 927.79 567.36 841.61 
Pdx124MS 23 458.09 601.01 645.66 602.95 1066.75 1772.9 183.35 852.64 
Pdx124MS 24 1858.09 567.36 603.9 958.15 389.55 3131.16 316.69 1055.87 
Pdx124MS 25 1618.01 109.52 505.53 1998.8 1502.75 5665.03 250.46 807.81 
Pdx124MS 26 405.86 202.36 2980.15 1417.8 2371.91 3091.99 12297.9 12.06 
Pdx124MS 27 1649.11 2672.7 902.61 1302.62 839.06 4018.91 757.71 937.58 
Pdx124MS 28 203.86 428.01 12542.44 8841.61 394.81 1571.3 220.39 725.27 
Pdx124MS 29 1046.57 247.97 569.55 608.87 725.27 4910.2 418.16 373.68 
Pdx124MS 30 1944.16 839.42 887.51 609.43 506.03 2238.11 136.89 2241.48 
Pdx124MS 31 741.08 702.36 665.37 4852.64 1568.4 3001.52 445.77 912.62 
Pdx124MS 32 288.18 5672.7 576.54 796.04 373.68 1436.18 809.52 9101.98 
Pdx124MS 33 31844.76 428.01 1385.54 655.87 371.77 1620.59 202.36 2310.87 
Pdx124MS 34 908.81 699.97 2629.5 911.78 570.4 1959.1 2672.7 8224.57 
Pdx124MS 35 2185.42 439.42 6165.76 807.81 241.48 1944.97 428.01 7117.06 
Pdx124MS 36 115.61 932.77 311.09 3012.06 921.62 1049.66 647.97 22100.66 
Pdx124MS 37 1599.27 912.28 3791.22 8037.58 621.39 7743.38 439.42 7131.93 
Pdx124MS 38 122.94 701.81 8677.14 821.27 729.98 1502.56 532.77 2211.96 
Pdx124MS 39 453.15 751.28 870.79 1883.51 340.87 1100.82 212.28 5218.36 
Pdx124MS 40 7192.29 799.43 647.68 658.09 55.82 2201.95 401.81 9201.88 
Pdx124MS 41 961.81 815.98 621.88 958.09 664.57 1332.09 451.28 5114.87 
Pdx124MS 42 498.85 935.94 1158.64 1682.01 913.06 1540.91 319.43 8313.59 
Pdx124MS 43 524.76 998.65 1400.11 487.86 529.93 2810.46 15.98 527.61 
Pdx124MS 44 337.44 809.52 1178.56 649.11 230.69 1612.05 235.94  
Pdx124MS 45   586.12 1203.86  1350.35 438.65  
  Mean 3002.358 787.0173 2006.40 1321.165 1010.258 3577.056 874.9556 3121.083 
  ST.DEV 5292.133 981.8982 2758.37 1789.371 855.7655 3413.759 1864.033 4676.291 
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 Table C2. Expression of Ngn3 in islets cultured with or without MSCs  
Days in culture      1 3 5 7 9 12 
  NUMBER OF  NGN3+ CELLS 
Slide ID  ISLET 
NO.  
MSC+ MSC- MSC+ MSC- MSC+ MSC- MSC+ MSC- MSC+ MSC- MSC+ MSC- 
Ngn324MS 1 2 3 3 8 11 3 6 6 14 5 8 1 
Ngn324MS 2 1 10 4 2 9 7 7 7 44 4 2 2 
Ngn324MS 3 0 5 7 4 5 7 7 7 23 7 11 2 
Ngn324MS 4 1 11 2 8 11 5 4 4 45 7 13 2 
Ngn324MS 5 1 9 6 6 9 6 6 6 32 3 17 1 
Ngn324MS 6 4 14 1 5 13 5 10 10 34 1 17 0 
Ngn324MS 7 2 6 0 3 7 3 9 9 1 0 14 0 
Ngn324MS 8 1 8 8 11 8 10 7 9 51 4 44 2 
Ngn324MS 9 0 5 2 9 8 10 8 4 21 7 23 4 
Ngn324MS 10 0 9 5 5 2 5 8 5 7 5 16 7 
Ngn324MS 11 0 11 5 11 4 11 7 5 6 5 34 2 
Ngn324MS 12 3 7 7 9 8 9 7 11 8 6 34 9 
Ngn324MS 13 1 7 4 13 6 14 3 5 7 34 1 1 
Ngn324MS 14 0 5 3 7 5 6 9 1 16 8 5 1 
Ngn324MS 15 0 6 2 8 3 8 4 1 11 2 33 0 
Ngn324MS 16 3 5 2 5 5 5 5 1 23 5 12 2 
Ngn324MS 17 0 3 4 9 9 9 5 0 10 7 40 3 
Ngn324MS 18 3 10 3 4 4 11 11 2 10 6 18 7 
Ngn324MS 19 0 8 7 8 8 8 5 0 11 3 2 0 
Ngn324MS 20 0 7 6 7 7 7 1 1 21 5 22 1 
Ngn324MS 21 1 4 4 4 4 4 1 4 52 4 3 1 
Ngn324MS 22 1 5 6 5 5 5 1 4 17 6 14 5 
Ngn324MS 23 2 4 8 4 4 4 0 3 13 9 17 2 
Ngn324MS 24 0 6 5 6 6 6 2 2 2 2 14 2 
Ngn324MS 25 1 8 4 8 8 8 0 4 15 2 44 2 
Ngn324MS 26 1 5 9 5 5 5 1 6 14 1 23 4 
Ngn324MS 27 0 13 6 2 2 13 4 7 40 1 52 1 
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Ngn324MS 28 0 4 3 4 4 4 4 6 19 0 41 6 
Ngn324MS 29 0 4 5 4 4 4 3 8 19 3 34 8 
Ngn324MS 30 3 5 9 5 5 5 2 7 32 3 1 1 
Ngn324MS 31 0 3 8 3 3 3 4 7 17 3 30 0 
Ngn324MS 32 0 8 9 8 8 8 6 7 20 5 13 2 
Ngn324MS 33 4 4 8 4 4 4 7 6 30 4 25 3 
Ngn324MS 34 1 5 7 1 1 5 6 4 31 6 20 5 
Ngn324MS 35 0 8 9 6 6 8 8 4 27 3 30 6 
Ngn324MS 36 0 6 8 8 8 6 7 5 31 4 67 5 
Ngn324MS 37 0 5 5 2 2 5 7 2 24 5 43 9 
Ngn324MS 38 1 3 8 6 6 3 7 5 21 5 21 2 
Ngn324MS 39 2 4 7 4 4 4 12 2 22 3 17 3 
Ngn324MS 40 3 2 6 2 2 2 13 6 54 7 17 8 
Ngn324MS 41 1 5 7 5 5 5 11 5 13 2 14 7 
Ngn324MS 42 0 8 8 3 3 8 9 5 43 4 22 1 
Ngn324MS 43 0 3 7 8 8 3 16 6 24 5 23 6 
Ngn324MS 44 0 5 9 3 5 5 12 4 34 6 31 4 
Ngn324MS 45 0 4 8 4 4 4 7 4 1 2 22 0 
Ngn324MS 46 2 9 5 9 3 9 10 2  4 21 2 
Ngn324MS 47 1 3 8 3 3 3 11 9  5 56 1 
Ngn324MS 48 4 5 7 5 5 5 10 5  4 43 9 
Ngn324MS 49 1 2 9 11 2 2 9 2   33 3 
Ngn324MS 50 2 5  4 4 5 13 0   37 2 
Ngn324MS 51  6  5 5 6 12 2   40 1 
Ngn324MS 52  4  12 4 4 7 3   22 6 
Ngn324MS 53  3  6 3 3 7 4      
MEAN   1.06 5.981 5.8 5.87 4.756 5.981 6.755 4.604 22.4 4.83 24.2 3.15385 
STDEV  1.236 2.735 2.4 2.82 2.612 2.735 3.679 2.634 13.9 4.77 14.8 2.68171 
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Table C3.  Insulin expression in islet cultured 24- 30 days  
Days in culture   24 26 28 30 
  Insulin fraction (%) 
SLIDE ID Islet No. MSC+ MSC- MSC+ MSC- MSC+ MSC- MSC+ MSC- 
INS24PPDL 1 6.96 85.74 23.61 79.07 50.74 74.15 21.60 61.61 
INS24PPDL 2 11.05 91.O4 80.45 60.48 81.04 73.32 91.27 44.44 
INS24PPDL 3 10.95 83.54 60.4 80.35 83.12 89.67 25.18 91.04 
INS24PPDL 4 18.61 94.26 10.98 96.68 52.02 96.03 68.86 89.67 
INS24PPDL 5 51.48 89.93 69.49 93.69 92.97 88.02 30.30 74.96 
INS24PPDL 6 36.88 99.54 82.3 85.24 95.61 95.49 24.21 78.61 
INS24PPDL 7 1.19 99.17 84.63 76.58 77.39 97.71 2.87 77.51 
INS24PPDL 8 23.61 88.02 77.39 80.36 47.57 90.08 1.80 85.84 
INS24PPDL 9 6.18 95.49 17.41 90.01 87.14 88.55 1.28 75.56 
INS24PPDL 10 60.4 97.71 87.38 96.36 77.38 88.22 7.66 66.37 
INS24PPDL 11 18.61 90.08 70.66 62.03 77.36 89.51 0.97 68.53 
INS24PPDL 12 6.96 79.49 75.48 97.43 88.02 73.96 80.42 89.75 
INS24PPDL 13 34.57 83.3 80.99 66.2 70.66 77.32 15.43 60.02 
INS24PPDL 14 27.82 81.63 24.85 67.81 75.48 85.02 25.18 86.31 
INS24PPDL 15 68.45 78.39 29.87 67.49 80.99 87.39 27.28 42.04 
INS24PPDL 16 7.88 67.81 80.45 92.58 24.85 95.15 13.51 74.63 
INS24PPDL 17 11.89 82.19 61.71 86.17 127.3 76.82 30.42 61.19 
INS24PPDL 18 2.01 92.11 63.67 84.65 92.76 95.06 67.23 98.5 
INS24PPDL 19 0.61 88.24 52.02 79.28 59.38 88.28 61.97 45.67 
INS24PPDL 20 14.86 61.82 92.36 54.73 80.45 93.19 75.82 90.29 
INS24PPDL 21 0.08 78.72 50.74 91.35 53.02 90.72 78.99 7.56 
INS24PPDL 22 33.07 60.12 81.04 47.12 78.3 85.37 91.96 10.9 
INS24PPDL 23 7.56 92.83 32.8 86.83 58.1 96.3 83.33 92.34 
INS24PPDL 24 7.77 76.92 52.02 80.41 55.94 94.38 34.00 96.06 
INS24PPDL 25 1.22 99.97 92.97 93.03 80.45 94.68 43.22 89.9 
INS24PPDL 26 18.31 99.75 95.61 36.61 65.93 82.82 64.59 95.55 
INS24PPDL 27 24.73 72.66 79.43 93.02 83.12 92.58 39.98 88.97 
INS24PPDL 28 8.63 74.48 85.64 75.4 68.45 94.47 79.93 88.95 
INS24PPDL 29 34.83 77.99 63.79 90.89 87.39 79.94 70.66 50.09 
INS24PPDL 30 30.74 61.97 69.21 60.46 81.63 84.62 90.28 88.96 
INS24PPDL 31 37.3 75.82 30.87 97.05 91.99 75.06 7.10 75.99 
INS24PPDL 32 8.64 94.85 77.27 50.53 88.45 85.71 80.34 77.11 
INS24PPDL 33 9.42 84.63 8.29 83.99 73.29 91.84 35.57 94.95 
INS24PPDL 34 5.2 78.39 39.83 70.59 87.32 83.34 66.16 90.27 
INS24PPDL 35 36.43 64.81 46.29 68.98 80.18 86.69 68.53 77.98 
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INS24PPDL 36 8.66 99.63 27.77 77.26 84.65 90.73 80.16 61.04 
INS24PPDL 37 11.63 71.66 62.6 6.58 92.99 94.55 85.19 88.51 
INS24PPDL 38 29.86 75.01 51.39 17.84 79.56 97.3 92.99 86.05 
INS24PPDL 39 24.04 76.99 65.76 27.28 85.64 95.37 87.24 93.84 
INS24PPDL 40 59.8 74.85 34.45 43.71 90.33 94.26 66.82 91.05 
INS24PPDL 41 5.98 87.3 43.53 55.35 69.49 88.16 70.72 85.91 
INS24PPDL 42 32.23 82.76 155.12 64.48 82.3 98.54 68.12 92.09 
INS24PPDL 43  69.38 67.53 65.92 84.63 88.35 98.39 81.58 
INS24PPDL 44  81.45 28.56 15.97 87.39 95.34 63.87 82.31 
INS24PPDL 45  71.63 29.35 20.37 63.81 87.93 68.57 85.68 
MEAN   20.41 82.26 63.03 69.29 77.26 88.71 53.11 76.36 
STDEV   17.47 11.12 28.22 24.08 16.63 6.95 30.69 20.71 
 
 
Table C4. Endocrine density of the isografts 
  Total endocrine area of 
isograft 
Total endocrine area of individual 
Aggregates  
    
  Insulin+ Area (µm2) Insulin + Area (µm2) Density index 
Islet No. MSC+ MSC- MSC+ MSC- MSC+ MSC- 
1 4946.18 52575.94 1946.18 2625.38 0.39 0.05 
2 777132.4 6756.54 677132.43 4994.4 0.87 0.74 
3 242116.1 786972 241116.1 8037.78 1.00 0.01 
4 253106.6 9796.84 157106.59 4063.52 0.62 0.41 
5 150674.4 30851.39 50694.4 3091.99 0.34 0.10 
7 38945.35 5832.57 9945.35 5427.22 0.26 0.93 
8 26465.56 346619.3 25956.11 9870.49 0.98 0.03 
9 83732.97 33690.1 13732.97 5378.23 0.16 0.16 
10 1448.35 31483.44 1448.35 5405.32 1.00 0.17 
11 404811.1 76144.4 404813.11 23131.16 1.00 0.30 
12 286781.7 7678.28 26785.65 6754.82 0.09 0.88 
13 70056.63 14191.39 69056.63 856.52 0.99 0.06 
14 137690.5 1976.69 137690.49 228.12 1.00 0.12 
15 86976.15 84483.38 36976.15 10120.91 0.43 0.12 
16 47681.84 237859.3 7388.84 15665.03 0.15 0.07 
17 6578.71 32885.57 6558.71 19063.52 1.00 0.58 
18 9846.73 28030.38 9746.11 15091.99 0.99 0.54 
19 3518.44 503118.9 4518.48 18427.22 1.28 0.04 
Mean 146250.5 127274.8 104589.59 8790.756667 0.70 0.29 
STDEV 196070.7 214020.4 177873.38 6758.803572 0.38 0.31 
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Table C5. Cell proliferation in isografts 
 Control MSC- MSC+ 
Slide 
No. 
Total Ki67+ % Ki67+ 
cells 
Total Ki67+ % Ki67+ 
cells 
Total Ki67+ % 
Ki67+ 
cells 
1 98 12 12 89 7 8 48 9 19 
2 11 7 67 65 11 17 39 9 22 
3 27 24 89 77 15 19 75 12 16 
4 83 13 16 29 14 48 87 11 12 
5 49 13 26 64 14 21 65 12 19 
6 80 11 13 48 6 13 90 15 16 
7 93 11 12 125 11 9 53 14 26 
8 77 5 7 159 11 7 35 16 45 
9 67 44 66 33 33 100 90 7 8 
10 62 4 6 144 15 10 138 17 12 
11 82 34 41 138 9 6 55 11 21 
12 148 3 2 100 12 12 101 15 15 
13 44 14 32 72 5 7 52 11 20 
14 78 12 15 183 11 6 84 7 8 
15 129 10 8 111 7 6 97 5 5 
16 101 5 5 90 14 15 99 10 10 
17 99 17 17 41 23 55 64 19 29 
18 98 53 54 37 9 24 74 17 22 
19 46 9 20 139 12 8 68 6 9 
20 36 24 68 72 7 10 31 11 36 
21 47 9 19 44 10 23 38 13 34 
22 39 10 25 140 12 9 34 14 41 
23 71 26 36 141 17 12 140 6 4 
24 84 12 14 44 8 18 80 12 15 
25 69 30 44 58 13 23 56 15 27 
26 61 11 18 49 13 26 91 21 23 
27 49 10 20 80 11 13 46 9 20 
28 37 15 40 127 11 9 33 16 50 
29 44 18 41 64 12 19 28 7 25 
Total 2009 466 833 2563 353 553 1991 347 609 
Mean 69.28 16.07 28.72 88.38 12.17 19.07 68.66 11.97 21.00 
STDEV 30.59 11.79 22.35 43.49 5.42 19.36 29.99 4.14 11.65 
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Table C6. Ngn3 expression in islets cultured with or without MSCs 
 
DAYS IN 
CULTURE 
 
24 26 28 
  
Ngn3+ area (µm2 ) 
SLIDE ID 
Islet 
No. MSC+ MSC- MSC+ MSC- MSC+ MSC- 
Ngn324PPDL 1 12863.5 815.74 23.61 6579.07 3107.71 474.15 
Ngn324PPDL 2 117065.1 921.O4 80.45 660.48 1292.42 743.32 
Ngn324PPDL 3 53257.4 873.54 60.4 4580.35 25758.14 1189.67 
Ngn324PPDL 4 32574.5 974.26 1770.98 946.68 22551.71 926.03 
Ngn324PPDL 5 49674.3 189.93 8769.49 793.69 30929.07 828.02 
Ngn324PPDL 6 26306.9 699.54 4182.3 2285.24 31156.02 195.49 
Ngn324PPDL 7 37908.1 939.17 6684.63 4776.58 23226.56 3397.71 
Ngn324PPDL 8 52984.9 848.02 2277.39 2110.36 4299.88 930.08 
Ngn324PPDL 9 35247.0 945.49 17.41 2110.01 1628.13 858.55 
Ngn324PPDL 10 17771.0 917.71 87.38 956.36 3725.23 188.22 
Ngn324PPDL 11 51357.1 390.08 70.66 682.03 3618.43 389.51 
Ngn324PPDL 12 38533.1 79.49 75.48 1767.43 941.96 1473.96 
Ngn324PPDL 13 15467.6 183.3 80.99 6126.2 16243.87 777.32 
Ngn324PPDL 14 99986.3 81.63 24.85 67.81 12037.93 85.02 
Ngn324PPDL 15 37989.5 378.39 29.87 67.49 11663.13 827.39 
Ngn324PPDL 16 21991.6 67.81 80.45 92.58 5528.94 795.15 
Ngn324PPDL 17 18826.9 862.19 61.71 86.17 37380.76 756.82 
Ngn324PPDL 18 116024.1 912.11 63.67 84.65 3087.86 295.06 
Ngn324PPDL 19 11521.6 188.24 52.02 79.28 1883.3 2288.28 
Ngn324PPDL 20 10878.0 161.82 92.36 54.73 1203.71 9113.19 
Ngn324PPDL 21 16532.1 378.72 50.74 91.35 21581.17 4390.72 
Ngn324PPDL 22 247238.5 1260.12 81.04 47.12 6197.02 585.37 
Ngn324PPDL 23 29380.0 92.83 32.8 86.83 55117.27 296.3 
Ngn324PPDL 24 10849.8 76.92 52.02 80.41 6755.99 914.38 
Ngn324PPDL 25 11433.4 99.97 92.97 93.03 93076.14 394.68 
Ngn324PPDL 26 50379.64 5099.75 95.61 36.61 7271.13 182.82 
Ngn324PPDL 27 545224.6 672.66 79.43 93.02 8509.04 912.58 
Ngn324PPDL 28 166525.3 9774.48 85.64 75.4 8929.96 594.47 
Ngn324PPDL 29 41134.95 577.99 63.79 90.89 3498.29 779.94 
Ngn324PPDL 30 13933.58 6651.97 69.21 60.46 9056.6 874.62 
Ngn324PPDL 31 91248.27 7095.82 30.87 97.05 13060.36 975.06 
Ngn324PPDL 32 978195.3 994.85 77.27 50.53 17213.6 3815.71 
Ngn324PPDL 33 27601.52 784.63 7198.29 83.99 10339.9 4911.84 
Ngn324PPDL 34 141161.1 978.39 3449.83 70.59 3036.75 4873.34 
Ngn324PPDL 35 11233.06 8764.81 46.29 68.98 5244.07 896.69 
Ngn324PPDL 36 467755.7 2399.63 6527.77 77.26 5459.48 3590.73 
Ngn324PPDL 37 237041.5 3471.66 6102.6 456.58 116351.2 694.55 
Ngn324PPDL 38 39735.39 975.01 951.39 817.84 9327.39 1897.3 
Ngn324PPDL 39 15894.96 1176.99 3265.76 527.28 91248.27 955.37 
Ngn324PPDL 40 42870.3 1674.85 1134.45 243.71 45195.25 2294.26 
Ngn324PPDL 41 122547.6 3867.3 4113.53 565.35 27601.52 3878.16 
Ngn324PPDL 42 5367.82 2882.76 2155.12 674.48 41161.1 3398.54 
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 Ngn324PPDL 43 63263.4 969.38 6887.53 65.92 71233.06 5488.35 
Ngn324PPDL 44 29663.44 4781.45 28910.56 175.97 4755.74 3195.34 
Ngn324PPDL 45 8168.34 3741.63 17629.35 990.37 57041.46 1287.93 
Ngn324PPDL 46 67134.09 9912,4 1975.01 2855.8 7399.63 7334.01 
Ngn324PPDL 47 90776.09 7769.11 1176.99 1712.9 7471.66 2433.11 
Ngn324PPDL 48 99090.01 4768.05 21248.27 809,88 
 
799.02 
Ngn324PPDL 49 109775.1 6222.08 1799.09 845.01 
 
4626.45 
Ngn324PPDL 50 88875.01  9971.34 1912.99 
 
5713.52 
MEAN   94565.16 2123.84 5527.03 978.67 21767.26 1990.36 
STDEV   164692.8 2390.68 5291.37 24.08 27117.29 2048.84 
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Table C7. Surface area of islets (µm2) 
  
Total  size of islets (µm2) 
0 DAY 15 DAYS 28 DAYS 
ISLET NO. ISLETS/MSC+ ISLET/MSC- ISLETS/MSC+ ISLET/MSC- ISLETS/MSC+ ISLET/MSC- 
1 14655.87 3441.87 31156.02 3998.75 50379.64 2831.01 
2 8037.58 2819.72 23226.56 3438.16 545224.57 438.16 
3 10725.27 1601.01 4299.88 2461.82 166525.33 461.82 
4 9373.68 1567.36 1628.13 2178.19 41134.95 178.19 
5 4996.62 1183.35 3725.23 6022.9 13933.58 6022.9 
6 2664.57 1316.69 3618.43 20737.14 91248.27 876.66 
7 3181.93 1250.46 12941.96 4729.14 8195.25 1095.22 
8 10828.96 2297.9 16243.87 63472.69 27601.52 8737.14 
9 7728.36 5757.71 12037.93 7956.24 41161.1 729.14 
10 7679.88 2920.39 11663.13 6493.01 11233.06 3472.69 
11 4792.87 4418.16 5528.94 16276.39 344755.74 34956.24 
12 8344.59 3136.89 37380.76 8657.89 127041.46 3493.01 
13 8468.14 4945.77 3087.86 2321.11 223735.39 16276.39 
14 9601.01 909.52 221883.3 1986.05 801894.96 1657.89 
15 9071.22 2702.36 19203.71 10891.7 872870.3 6321.11 
16 1212.46 21672.7 21581.17 30291.38 111547.56 1986.05 
17 1617.96 1428.01 6197.02 14917.1 545367.82 10891.7 
18 6856.52 1647.97 55117.27 47804.89 312263.4 1291.38 
19 18228.12 1439.42 60755.99 27126.09 2663.44 14917.1 
20 1455.47 2632.77 93076.14 7564.91 8168.34 7804.89 
21 1994.44 6292.28 7271.13 14954.91 3107.71 7126.09 
22 1786.87 8401.81 8509.04 10272.37 1292.42 7564.91 
23 10120.91 4551.28 8929.96 7379.74 25758.14 14954.91 
24 4994.4 359.43 3498.29 2023.87 22551.71 10272.37 
25 1675.67 1315.98 9056.6 31715.45 30929.07 7379.74 
26 927.79 9335.94 13060.36 1356.04 31156.02 2023.87 
27 1772.9 8438.65 17213.6 15966.35 23226.56 715.45 
28 3131.16 6762.84 10339.9 1732.12 4299.88 956.04 
29 5665.03 8150.78 3036.75 1393.01 1628.13 966.35 
30 3091.99 1419.61 5244.07 1062.46 3725.23 732.12 
31 4018.91 759.36 5459.48 844.76 3618.43 393.01 
32 1571.3 1055.53 116351.2 26753.62 941.96 562.46 
33 11910.2 2442.49 9327.39 13258.7 16243.87 9307.5 
34 2238.11 7332.96 91248.27 1501.72 12037.93 753.62 
35 14063.52 1446.96 45195.25 119.88 11663.13 3258.7 
36 7436.18 1334.43 27601.52 4358.06 5528.94 501.72 
37 12620.59 1336.89 41161.1 1515.91 37380.76 119.88 
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38 108959.1 1324.16 71233.06 1424.44 3087.86 358.06 
39 7944.97 2581.51 4755.74 1204.99 11883.3 1515.91 
40 9049.66 5404.2 4991.95 619.64 1203.71 924.44 
41 6743.38 2108.68 9931.59 1013.84 21581.17 704.99 
42 9502.56 8246.77 14657.91 3575.76 6197.02 619.64 
43 10174.82 9329.56 7920.44 2831.01 55117.27 913.84 
44 7201.95 2205.12 27378.2 1552.6 1755.99 1575.76 
45 6332.09 1944.16 5458.09 843.28 23076.14 777.75 
46 13543.91 4741.08 1858.09 1357.48 7271.13 505.46 
47 2815.46 6288.18 31618.01 1900.71 8509.04 661.53 
48 14612.05 5070.12 41005.86 244.74 8929.96 744.84 
49 5358.35 2185.42 1649.11 1607.44 3498.29 1930.4 
50 9274.57 1320.62 7203.86 1537.86 9056.6 634.11 
51 922.57 5289.25 1046.57 1283.44 13060.36 834.21 
MEAN 8842.68 3879.73 25442.46 8755.52 93260.07 4014.28 
STDEV 14924.05 3618.32 38104.85 12689.66 195174.05 6123.03 
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Table C8. Co-expression of Pdx1 and insulin in islets cultured with or without MSCs     
  1 3 5 7 9 
  Fraction of Pdx1+/ Insulin+ area (%)     
SLIDE ID Islet No. MSC+ MSC- MSC+ MSC- MSC+ MSC- MSC+ MSC- MSC+ MSC- 
PDX1/INS24MS  1 12.5 43.2 9.2 9.2 10.9 12.8 3.0 70.8 1.3 31.8 
PDX1/INS24MS  2 15.0 15.0 8.8 8.8 37.5 20.4 4.4 45.2 1.2 19.4 
PDX1/INS24MS  3 5.9 2.2 1.1 1.1 2.6 4.4 5.9 95.2 2.9 18.2 
PDX1/INS24MS  4 8.7 4.5 27.3 97.3 7.6 97.0 8.7 62.3 0.8 12.8 
PDX1/INS24MS  5 10.1 10.8 3.9 3.9 18.2 16.8 1.1 64.8 1.5 39.0 
PDX1/INS24MS  6 10.7 2.8 15.9 15.9 42.3 8.2 1.7 0.5 1.0 47.7 
PDX1/INS24MS  7 12.5 57.7 6.7 32.5 3.3 16.1 1.5 5.1 2.3 53.4 
PDX1/INS24MS  8 15.0 3.7 7.5 24.8 4.8 4.7 1.0 2.4 1.1 50.3 
PDX1/INS24MS  9 16.3 4.6 2.1 30.2 8.6 6.7 1.3 2.3 1.4 12.9 
PDX1/INS24MS  10 18.0 47.8 2.0 18.4 8.2 6.6 2.0 5.6 1.7 10.9 
PDX1/INS24MS  11 36.3 6.6 6.7 61.2 15.8 4.1 1.3 32.5 2.0 17.2 
PDX1/INS24MS  12 40.2 32.4 40.0 43.0 5.1 22.4 2.2 24.8 1.6 99.6 
PDX1/INS24MS  13 50.4 30.6 3.2 3.2 3.8 1.9 1.4 30.2 1.2 6.3 
PDX1/INS24MS  14 52.5 2.8 34.6 2.0 1.9 0.9 52.5 18.4 2.7 3.0 
PDX1/INS24MS  15 70.4 57.7 9.9 20.0 1.8 10.7 2.4 7.8 0.6 14.1 
PDX1/INS24MS  16 95.2 3.7 4.0 3.2 1.2 20.4 1.2 16.5 2.2 3.3 
PDX1/INS24MS  17 76.8 4.6 6.3 6.3 8.0 12.7 2.8 6.2 1.9 8.1 
PDX1/INS24MS  18 51.5 6.7 3.6 3.6 9.7 3.7 1.5 3.5 1.4 6.9 
PDX1/INS24MS  19 36.1 52.5 18.4 18.4 2.8 16.6 3.1 29.2 2.2 51.0 
PDX1/INS24MS  20 14.5 4.7 16.4 6.4 12.90 9.3 0.5 31.4 1.3 13.9 
PDX1/INS24MS  21 11.9 9.7 64.4 34.4 5.53 89.1 1.9 3.1 5.7 39.4 
PDX1/INS24MS  22 8.2 7.3 75.6 34.7 2.60 76.9 0.2 18.1 0.9 14.7 
PDX1/INS24MS  23 7.3 0.5 5.7 5.9 7.63 19.4 1.6 21.9 0.1 17.3 
PDX1/INS24MS  24 3.5 19.4 14.2 14.2 2.25 16.5 1.3 20.1 1.5 18.6 
PDX1/INS24MS  25 3.3 20.4 11.0 11.0 6.26 19.3 3.3 3.2 1.0 19.4 
PDX1/INS24MS  26 2.9 4.4 14.9 24.9 12.32 38.4 2.9 31.3 1.6 19.6 
PDX1/INS24MS  27 2.6 0.3 67.5 29.2 4.81 31.3 2.6 11.9 2.7 11.3 
PDX1/INS24MS  28 1.3 12.8 24.3 3.4 8.60 11.9 1.3 10.4 0.2 16.1 
PDX1/INS24MS  29 1.0 20.4 5.7 16.5 8.24 4.3 1.0 2.0 1.5 19.0 
PDX1/INS24MS  30 0.6 4.4 24.3 94.3 3.81 10.2 0.6 1.1 1.5 13.3 
PDX1/INS24MS  31 0.5 57.7 33.4 33.4 4.13 35.2 0.5 29.2 1.2 10.4 
PDX1/INS24MS  32 2.0 9.7 14.0 24.0 3.76 43.2 2.0 3.4 1.6 12.7 
PDX1/INS24MS  33 64.1 4.6 18.9 18.9 1.92 15.0 2.1 16.5 2.6 14.5 
PDX1/INS24MS  34 2.0 17.8 4.6 4.6 1.82 2.2 2.0 0.4 0.9 14.8 
PDX1/INS24MS  35 12.9 97.0 23.9 1.3 1.17 4.5 1.9 31.2 1.4 11.8 
PDX1/INS24MS  36 12.7 16.8 45.0 2.8 1.02 10.8 6.7 2.8 2.1 15.7 
PDX1/INS24MS  37 1.6 22.4 5.8 15.8 2.65 2.8 1.6 10.0 1.2 15.4 
PDX1/INS24MS  38 7.4 11.9 17.3 19.8 2.83 57.7 1.4 49.9 0.7 16.1 
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PDX1/INS24MS  39 1.2 0.9 4.6 11.5 9.7 3.7 1.2 64.3 5.4 13.9 
PDX1/INS24MS  40 1.8 10.7 6.3 16.3 7.3 4.6 0.8 2.5 1.3 15.0 
PDX1/INS24MS  41 1.8 15.2 27.6 27.6 0.5 47.8 1.8 61.7 0.3 14.7 
PDX1/INS24MS  42 1.4 16.1 18.1 18.1 0.3 16.6 7.4 2.9 2.0 19.9 
PDX1/INS24MS  43 21.2 23.7 24.1 20.1 23.7 32.4 5.2 31.2 0.4 1.0 
PDX1/INS24MS  44 1.3 11.19 14.9 44.9 5.3 63.6 5.3 41.2 7.1 12.8 
PDX1/INS24MS  45 11.2 10.19 19.3 25.3 6.5 36.7 9.2 2.0 0.3 0.5 
PDX1/INS24MS  46 1.3 30.98 35.4 37.4 1.6 62.5 12.3 1.0 3.6 0.6 
PDX1/INS24MS  47 24.3 42.04 31.5 33.5 9.5 24.7 7.3 16 13.6 9.5 
PDX1/INS24MS  48 40.5 16.5 18.1 22.9 12.4 9.5   44.8 15.0 20.4 
PDX1/INS24MS  49 70.6 50.4   36.0   4.4     5   
  MEAN 19.8 19.6 18.7 22.3 7.6 22.3 3.9 22.7 2.3 19.3 
  SDEV 23.63 20.1 17.0 20.2 8.3 23.1 7.6 22.7 2.8 17.2 
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